,Start Date,Start Price,End Date,End Price,Weekly Returns,Bin Label,News,Basics
0,2023-01-08,170.93350219726562,2023-01-15,164.4659881591797,-0.0378364332032588,D4,[],{}
1,2023-01-15,164.4659881591797,2023-01-22,160.01840209960938,-0.027042588618782837,D3,[],{}
2,2023-01-22,160.01840209960938,2023-01-29,159.5347442626953,-0.003022513851956843,D1,[],{}
3,2023-01-29,159.5347442626953,2023-02-05,156.1018829345703,-0.021517954248714166,D3,[],{}
4,2023-02-05,156.1018829345703,2023-02-12,153.76902770996094,-0.014944440007729987,D2,[],{}
5,2023-02-12,153.76902770996094,2023-02-19,153.19395446777344,-0.0037398509358608223,D1,[],{}
6,2023-02-19,153.19395446777344,2023-02-26,148.97225952148438,-0.027557843003374938,D3,[],{}
7,2023-02-26,148.97225952148438,2023-03-05,147.10975646972656,-0.012502348140119413,D2,[],{}
8,2023-03-05,147.10975646972656,2023-03-12,144.80787658691406,-0.01564736383263743,D2,[],{}
9,2023-03-12,144.80787658691406,2023-03-19,145.54335021972656,0.005078961518858227,U1,[],{}
10,2023-03-19,145.54335021972656,2023-03-26,145.8012237548828,0.00177179881297862,U1,[],{}
11,2023-03-26,145.8012237548828,2023-04-02,148.04579162597656,0.015394712151848955,U2,[],{}
12,2023-04-02,148.04579162597656,2023-04-09,157.7404022216797,0.0654838647504119,U5+,[],"{""assetTurnoverTTM"": 0.4209, ""bookValue"": 70869, ""cashRatio"": 0.13313898597054974, ""currentRatio"": 1.0665, ""ebitPerShare"": -0.494, ""eps"": -0.0261, ""ev"": 452426.44, ""fcfMargin"": 0.1146, ""fcfPerShareTTM"": 6.2375, ""grossMargin"": 0.68, ""inventoryTurnoverTTM"": 1.9918, ""longtermDebtTotalAsset"": 0.1782, ""longtermDebtTotalCapital"": 0.2822, ""longtermDebtTotalEquity"": 0.4929, ""netDebtToTotalCapital"": 0.3625, ""netDebtToTotalEquity"": 0.6331, ""netMargin"": -0.0033, ""operatingMargin"": -0.0616, ""pb"": 5.7509, ""peTTM"": 32.0306, ""pfcfTTM"": 25.147, ""pretaxMargin"": -0.0616, ""psTTM"": 5.2617, ""ptbv"": 17.4014, ""quickRatio"": 0.806, ""receivablesTurnoverTTM"": 4.8496, ""roaTTM"": 0.0691, ""roeTTM"": 0.1704, ""roicTTM"": 0.1117, ""rotcTTM"": 0.1071, ""salesPerShare"": 8.0192, ""sgaToSale"": 0.32, ""tangibleBookValue"": 23421, ""totalDebtToEquity"": 0.7465, ""totalDebtToTotalAsset"": 0.27, ""totalDebtToTotalCapital"": 0.4274, ""totalRatio"": 1.5665, ""period"": ""2023-04-02""}"
13,2023-04-09,157.7404022216797,2023-04-16,158.39942932128906,0.0041779220182487364,U1,[],"{""assetTurnoverTTM"": 0.4209, ""bookValue"": 70869, ""cashRatio"": 0.13313898597054974, ""currentRatio"": 1.0665, ""ebitPerShare"": -0.494, ""eps"": -0.0261, ""ev"": 452426.44, ""fcfMargin"": 0.1146, ""fcfPerShareTTM"": 6.2375, ""grossMargin"": 0.68, ""inventoryTurnoverTTM"": 1.9918, ""longtermDebtTotalAsset"": 0.1782, ""longtermDebtTotalCapital"": 0.2822, ""longtermDebtTotalEquity"": 0.4929, ""netDebtToTotalCapital"": 0.3625, ""netDebtToTotalEquity"": 0.6331, ""netMargin"": -0.0033, ""operatingMargin"": -0.0616, ""pb"": 5.7509, ""peTTM"": 32.0306, ""pfcfTTM"": 25.147, ""pretaxMargin"": -0.0616, ""psTTM"": 5.2617, ""ptbv"": 17.4014, ""quickRatio"": 0.806, ""receivablesTurnoverTTM"": 4.8496, ""roaTTM"": 0.0691, ""roeTTM"": 0.1704, ""roicTTM"": 0.1117, ""rotcTTM"": 0.1071, ""salesPerShare"": 8.0192, ""sgaToSale"": 0.32, ""tangibleBookValue"": 23421, ""totalDebtToEquity"": 0.7465, ""totalDebtToTotalAsset"": 0.27, ""totalDebtToTotalCapital"": 0.4274, ""totalRatio"": 1.5665, ""period"": ""2023-04-02""}"
14,2023-04-16,158.39942932128906,2023-04-23,155.39076232910156,-0.018994178230812175,D2,[],"{""assetTurnoverTTM"": 0.4209, ""bookValue"": 70869, ""cashRatio"": 0.13313898597054974, ""currentRatio"": 1.0665, ""ebitPerShare"": -0.494, ""eps"": -0.0261, ""ev"": 452426.44, ""fcfMargin"": 0.1146, ""fcfPerShareTTM"": 6.2375, ""grossMargin"": 0.68, ""inventoryTurnoverTTM"": 1.9918, ""longtermDebtTotalAsset"": 0.1782, ""longtermDebtTotalCapital"": 0.2822, ""longtermDebtTotalEquity"": 0.4929, ""netDebtToTotalCapital"": 0.3625, ""netDebtToTotalEquity"": 0.6331, ""netMargin"": -0.0033, ""operatingMargin"": -0.0616, ""pb"": 5.7509, ""peTTM"": 32.0306, ""pfcfTTM"": 25.147, ""pretaxMargin"": -0.0616, ""psTTM"": 5.2617, ""ptbv"": 17.4014, ""quickRatio"": 0.806, ""receivablesTurnoverTTM"": 4.8496, ""roaTTM"": 0.0691, ""roeTTM"": 0.1704, ""roicTTM"": 0.1117, ""rotcTTM"": 0.1071, ""salesPerShare"": 8.0192, ""sgaToSale"": 0.32, ""tangibleBookValue"": 23421, ""totalDebtToEquity"": 0.7465, ""totalDebtToTotalAsset"": 0.27, ""totalDebtToTotalCapital"": 0.4274, ""totalRatio"": 1.5665, ""period"": ""2023-04-02""}"
15,2023-04-23,155.39076232910156,2023-04-30,156.35546875,0.006208261073173071,U1,[],{}
16,2023-04-30,156.35546875,2023-05-07,155.38119506835938,-0.006231145539260963,D1,[],{}
17,2023-05-07,155.38119506835938,2023-05-14,153.56646728515625,-0.011679198260798218,D2,[],{}
18,2023-05-14,153.56646728515625,2023-05-21,151.78036499023438,-0.011630809293836752,D2,[],{}
19,2023-05-21,151.78036499023438,2023-05-28,148.53726196289062,-0.021367078854714894,D3,[],{}
20,2023-05-28,148.53726196289062,2023-06-04,151.05860900878906,0.016974508702929603,U2,[],{}
21,2023-06-04,151.05860900878906,2023-06-11,153.98411560058594,0.01936669886604525,U2,[],{}
22,2023-06-11,153.98411560058594,2023-06-18,158.04518127441406,0.026373276607062346,U3,[],{}
23,2023-06-18,158.04518127441406,2023-06-25,159.2481231689453,0.0076113797638828196,U1,[],{}
24,2023-06-25,159.2481231689453,2023-07-02,159.28662109375,0.00024174805981136416,U1,[],{}
25,2023-07-02,159.28662109375,2023-07-09,153.25274658203125,-0.03788061087796846,D4,[],"{""assetTurnoverTTM"": 0.4391, ""bookValue"": 75149, ""cashRatio"": 0.14768321949418498, ""currentRatio"": 1.1181, ""ebitPerShare"": 2.4481, ""eps"": 1.997, ""ev"": 462321.78, ""fcfMargin"": 0.1421, ""fcfPerShareTTM"": 5.599, ""grossMargin"": 0.6997, ""inventoryTurnoverTTM"": 2.0888, ""longtermDebtTotalAsset"": 0.1769, ""longtermDebtTotalCapital"": 0.2808, ""longtermDebtTotalEquity"": 0.4511, ""netDebtToTotalCapital"": 0.3114, ""netDebtToTotalEquity"": 0.5004, ""netMargin"": 0.239, ""operatingMargin"": 0.293, ""payoutRatioTTM"": 0.6871, ""pb"": 5.6517, ""peTTM"": 32.5356, ""pfcfTTM"": 29.1964, ""pretaxMargin"": 0.293, ""psTTM"": 5.1576, ""ptbv"": 14.6947, ""quickRatio"": 0.8359, ""receivablesTurnoverTTM"": 5.0035, ""roaTTM"": 0.0696, ""roeTTM"": 0.1756, ""roicTTM"": 0.1117, ""rotcTTM"": 0.12, ""salesPerShare"": 8.3539, ""sgaToSale"": 0.3003, ""tangibleBookValue"": 28903, ""totalDebtToEquity"": 0.6068, ""totalDebtToTotalAsset"": 0.2379, ""totalDebtToTotalCapital"": 0.3777, ""totalRatio"": 1.6449, ""period"": ""2023-07-02""}"
26,2023-07-09,153.25274658203125,2023-07-16,153.84938049316406,0.003893136824229426,U1,[],"{""assetTurnoverTTM"": 0.4391, ""bookValue"": 75149, ""cashRatio"": 0.14768321949418498, ""currentRatio"": 1.1181, ""ebitPerShare"": 2.4481, ""eps"": 1.997, ""ev"": 462321.78, ""fcfMargin"": 0.1421, ""fcfPerShareTTM"": 5.599, ""grossMargin"": 0.6997, ""inventoryTurnoverTTM"": 2.0888, ""longtermDebtTotalAsset"": 0.1769, ""longtermDebtTotalCapital"": 0.2808, ""longtermDebtTotalEquity"": 0.4511, ""netDebtToTotalCapital"": 0.3114, ""netDebtToTotalEquity"": 0.5004, ""netMargin"": 0.239, ""operatingMargin"": 0.293, ""payoutRatioTTM"": 0.6871, ""pb"": 5.6517, ""peTTM"": 32.5356, ""pfcfTTM"": 29.1964, ""pretaxMargin"": 0.293, ""psTTM"": 5.1576, ""ptbv"": 14.6947, ""quickRatio"": 0.8359, ""receivablesTurnoverTTM"": 5.0035, ""roaTTM"": 0.0696, ""roeTTM"": 0.1756, ""roicTTM"": 0.1117, ""rotcTTM"": 0.12, ""salesPerShare"": 8.3539, ""sgaToSale"": 0.3003, ""tangibleBookValue"": 28903, ""totalDebtToEquity"": 0.6068, ""totalDebtToTotalAsset"": 0.2379, ""totalDebtToTotalCapital"": 0.3777, ""totalRatio"": 1.6449, ""period"": ""2023-07-02""}"
27,2023-07-16,153.84938049316406,2023-07-23,163.78074645996094,0.06455252491080499,U5+,[],"{""assetTurnoverTTM"": 0.4391, ""bookValue"": 75149, ""cashRatio"": 0.14768321949418498, ""currentRatio"": 1.1181, ""ebitPerShare"": 2.4481, ""eps"": 1.997, ""ev"": 462321.78, ""fcfMargin"": 0.1421, ""fcfPerShareTTM"": 5.599, ""grossMargin"": 0.6997, ""inventoryTurnoverTTM"": 2.0888, ""longtermDebtTotalAsset"": 0.1769, ""longtermDebtTotalCapital"": 0.2808, ""longtermDebtTotalEquity"": 0.4511, ""netDebtToTotalCapital"": 0.3114, ""netDebtToTotalEquity"": 0.5004, ""netMargin"": 0.239, ""operatingMargin"": 0.293, ""payoutRatioTTM"": 0.6871, ""pb"": 5.6517, ""peTTM"": 32.5356, ""pfcfTTM"": 29.1964, ""pretaxMargin"": 0.293, ""psTTM"": 5.1576, ""ptbv"": 14.6947, ""quickRatio"": 0.8359, ""receivablesTurnoverTTM"": 5.0035, ""roaTTM"": 0.0696, ""roeTTM"": 0.1756, ""roicTTM"": 0.1117, ""rotcTTM"": 0.12, ""salesPerShare"": 8.3539, ""sgaToSale"": 0.3003, ""tangibleBookValue"": 28903, ""totalDebtToEquity"": 0.6068, ""totalDebtToTotalAsset"": 0.2379, ""totalDebtToTotalCapital"": 0.3777, ""totalRatio"": 1.6449, ""period"": ""2023-07-02""}"
28,2023-07-23,163.78074645996094,2023-07-30,167.90919494628906,0.025207166138648596,U3,[],{}
29,2023-07-30,167.90919494628906,2023-08-06,162.67405700683594,-0.031178387467867608,D4,[],{}
30,2023-08-06,162.67405700683594,2023-08-13,167.30291748046875,0.02845481669789729,U3,[],{}
31,2023-08-13,167.30291748046875,2023-08-20,165.994140625,-0.007822797564911221,D1,[],{}
32,2023-08-20,165.994140625,2023-08-27,161.1507110595703,-0.029178316458600473,D3,[],{}
33,2023-08-27,161.1507110595703,2023-09-03,155.55770874023438,-0.034706656164045446,D4,[],{}
34,2023-09-03,155.55770874023438,2023-09-10,155.63523864746094,0.0004983996476577435,U1,[],{}
35,2023-09-10,155.63523864746094,2023-09-17,156.49795532226562,0.005543196272913997,U1,[],{}
36,2023-09-17,156.49795532226562,2023-09-24,155.5770721435547,-0.005884314442413108,D1,"[{""date"": ""20230923043000"", ""headline"": ""Johnson & Johnson: The Bull Case Can No Longer Be Ignored"", ""summary"": ""JNJ's best-in-class ""}, {""date"": ""20230924074100"", ""headline"": ""3 Best Stocks to Buy in September and Hold Forever"", ""summary"": ""There will always be a healthcare industry, and it will always be a place to find great long-term stocks.  You probably know healthcare conglomerate Johnson & Johnson for some of its former brands, like Tylenol and Band-Aids.""}, {""date"": ""20230924125249"", ""headline"": ""Dividend Stock Portfolio: 15 Stocks To Buy According to Reddit"", ""summary"": ""In this article, we discuss 15 dividend stocks to buy according to Reddit. You can skip our detailed analysis of dividend stocks and the role of retail investors in today\u2019s stock market, and go directly to read Dividend Stock Portfolio: 5 Stocks To Buy According to Reddit. While tech stocks outperformed dividend stocks in the [\u2026]""}]",{}
37,2023-09-24,155.5770721435547,2023-10-01,150.9727783203125,-0.029594938121689895,D3,"[{""date"": ""20230924074100"", ""headline"": ""3 Best Stocks to Buy in September and Hold Forever"", ""summary"": ""There will always be a healthcare industry, and it will always be a place to find great long-term stocks.  You probably know healthcare conglomerate Johnson & Johnson for some of its former brands, like Tylenol and Band-Aids.""}, {""date"": ""20230924125249"", ""headline"": ""Dividend Stock Portfolio: 15 Stocks To Buy According to Reddit"", ""summary"": ""In this article, we discuss 15 dividend stocks to buy according to Reddit. You can skip our detailed analysis of dividend stocks and the role of retail investors in today\u2019s stock market, and go directly to read Dividend Stock Portfolio: 5 Stocks To Buy According to Reddit. While tech stocks outperformed dividend stocks in the [\u2026]""}, {""date"": ""20230925054500"", ""headline"": ""3M, Merck share losses lead Dow's nearly 100-point drop"", ""summary"": ""Shares of 3M and Merck are trading lower Monday morning, sending the Dow Jones Industrial Average into negative territory. Shares of 3M and Merck are...""}, {""date"": ""20230925063500"", ""headline"": ""(JNJ) - Analyzing Johnson & Johnson's Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230925065600"", ""headline"": ""Alvotech partner starts biosimilar threat to JNJ\u2019s Stelara in Japan"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230925122300"", ""headline"": ""Cooper Offers A Great Business But A Somewhat Tricky Valuation"", ""summary"": ""The Cooper Companies, Inc. has above average growth and margin leverage potential. Click here to find out why COO stock is rated as a buy.""}, {""date"": ""20230925123100"", ""headline"": ""Johnson & Johnson stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Johnson & Johnson slumped 0.15% to $160.26 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20230925142338"", ""headline"": ""Retirement Passive Income Snowball: VYM May Be All You Need"", ""summary"": ""Vanguard High Dividend Yield Index Fund's trailing 12-month dividend yield is 3.2%. Compared to major equity indexes, the yield is actually quite high. Learn more on VYM ETF here.""}, {""date"": ""20230925212400"", ""headline"": ""Immunovant drives OmniAb higher after data update; argenx slips"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230926061500"", ""headline"": ""This Is the Holy Grail of Investing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230926074100"", ""headline"": ""2 Monster Stocks to Buy Without Any Hesitation"", ""summary"": ""Johnson & Johnson, one of the largest healthcare companies in the world, has been around for decades, has historically crushed the market, and continues to generate steady revenue and profits.  First, the company is a proven innovator in healthcare.  There is always a need for better, safer, more effective therapies or medical devices.""}, {""date"": ""20230926122600"", ""headline"": ""Novartis' (NVS) Sandoz Gets EC Nod for Tysabri's Biosimilar"", ""summary"": ""Novartis' (NVS) Sandoz broadens its biosimilar portfolio with Tyruko's approval, a biosimilar of the multiple sclerosis drug Tysabri in the EU.""}, {""date"": ""20230926123200"", ""headline"": ""Johnson & Johnson stock falls Tuesday, still outperforms market"", ""summary"": ""Shares of Johnson & Johnson slipped 0.77% to $159.02 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""20230926153326"", ""headline"": ""15 Best Dividend Aristocrat Stocks To Buy Now"", ""summary"": ""In this article, we discuss 15 best dividend aristocrat stocks to buy now. You can skip our detailed analysis of dividend stocks and their performance, and go directly to read 5 Best Dividend Aristocrat Stocks To Buy Now. Dividend Aristocrats are a select group of publicly traded companies in the S&P 500 that have raised [\u2026]""}, {""date"": ""20230926174519"", ""headline"": ""Johnson & Johnson (JNJ) Stock Moves -0.77%: What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) closed the most recent trading day at $159.02, moving -0.77% from the previous trading session.""}, {""date"": ""20230926213500"", ""headline"": ""Almost 1,500 high-grade corporate bonds are on sale. Here\u2019s how you could add cheap Apple bonds to your portfolio."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230926223500"", ""headline"": ""Notable Wednesday Option Activity: JNJ, RIVN, KRTX"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230927032036"", ""headline"": ""Arm, Instacart, Birkenstock ... the IPOs of 2023 and beyond"", ""summary"": ""The most well known IPOs so far this year that have made headlines and moved the markets.""}, {""date"": ""20230927053000"", ""headline"": ""3 Things About Johnson & Johnson That Smart Investors Know"", ""summary"": ""J&J recently spun off its consumer health business into a separate entity called Kenvue, and the healthcare giant is even changing its famous logo -- red printed letters will replace the cursive.  Meanwhile, J&J's share price doesn't reflect the idea of these exciting new times.  J&J's consumer health business brought in about $14 billion in revenue last year, so you may be wondering why spinning this unit off is a good idea.""}, {""date"": ""20230927063100"", ""headline"": ""Relative Strength Alert For Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230927063500"", ""headline"": ""Looking At Johnson & Johnson's Recent Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230927064800"", ""headline"": ""Biden's Urgent Action Against Antibiotic-Resistant Bacteria - Allocates $100M to Battle Deadly Superbugs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230927065300"", ""headline"": ""Dow falls nearly 100 points on losses for Walgreens Boots, Johnson & Johnson stocks"", ""summary"": ""The Dow Jones Industrial Average is falling Wednesday morning with shares of Walgreens Boots and Johnson & Johnson delivering the stiffest headwinds for the...""}, {""date"": ""20230927080600"", ""headline"": ""Johnson & Johnson, Verizon share losses contribute to Dow's 186-point fall"", ""summary"": ""Shares of Johnson & Johnson and Verizon are seeing declines Wednesday afternoon, dragging the Dow Jones Industrial Average into negative territory. Shares of...""}, {""date"": ""20230927091200"", ""headline"": ""The Kellogg Split"", ""summary"": ""Why Kellogg is splitting up its business.  Motley Fool host Ricky Mulvey and sports journalist John Nash analyze newly listed TKO Holdings, the company that runs both WWE and UFC, and address the challenges it may face.  To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center.""}, {""date"": ""20230927092700"", ""headline"": ""Dow's 270-point fall led by losses in shares of Walgreens Boots, Johnson & Johnson"", ""summary"": ""The Dow Jones Industrial Average is falling Wednesday afternoon with shares of Walgreens Boots and Johnson & Johnson facing the biggest declines for the...""}, {""date"": ""20230927103300"", ""headline"": ""Almost 1,500 high-grade corporate bonds are on sale. Here's how you could add cheap Apple bonds to your portfolio."", ""summary"": ""Almost 1,500 high-grade corporate bonds issued by some household names are currently trading between 50 and 80 cents on the dollar.""}, {""date"": ""20230927123200"", ""headline"": ""Johnson & Johnson stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson shed 1.20% to $157.11 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""20230927224000"", ""headline"": ""What to Note in the AI Megatrend"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230928032100"", ""headline"": ""Johnson & Johnson posts Phase 3 win for lung cancer therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230928041500"", ""headline"": ""Needham medtech/diagnostics analysts hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230928045300"", ""headline"": ""SCHX ETF: A Large-Cap ETF for Large Gains"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230928052100"", ""headline"": ""Pharma Giants Shift Stance, Embrace Medicare Negotiations Amid Rising Drug Costs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230928062100"", ""headline"": ""There\u2019s a sale on corporate bonds. How to add cheap Apple, Disney and Microsoft bonds to your portfolio."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230928062800"", ""headline"": ""Interesting JNJ Put And Call Options For November 10th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230928071400"", ""headline"": ""J&J hit with 11,000 new talc complaints after settlement tossed, Bloomberg says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230928074732"", ""headline"": ""UPDATE 1-J&J's lung cancer therapy combo succeeds in late-stage study"", ""summary"": ""Johnson & Johnson said on Thursday its cancer therapy combination met the main goal in a late-stage study testing it as a treatment for patients with a type of lung cancer.  The drugmaker said an interim analysis of data from the study showed a trend \""favoring\"" the combination of its antibody treatment Rybrevant and experimental drug lazertinib, when compared to AstraZeneca's cancer drug osimertinib or Tagrisso.  J&J said it plans to submit data for an upcoming scientific conference, including additional details on certain secondary goals from the study.""}, {""date"": ""20230928083700"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230928101500"", ""headline"": ""3 Dividend Kings With Recession-Proof Payouts"", ""summary"": ""These names, which have raised their payouts for over 50 straight years, have dividends that are well-covered even during a recession.""}, {""date"": ""20230928123200"", ""headline"": ""Johnson & Johnson stock falls Thursday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson shed 0.15% to $156.88 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20230928211700"", ""headline"": ""IN BRIEF: J&J reports positive results for Rybrevant in combination"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230929002300"", ""headline"": ""IN BRIEF: Fresenius Kabi gains European marketing review for FYB202"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230929010200"", ""headline"": ""Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Maravai Lifesciences Holdings (MRVI), Johnson & Johnson (JNJ) and Amicus (FOLD)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230929021342"", ""headline"": ""Dividend Aristocrats Ranked By Yield: Top 25"", ""summary"": ""In this article, we discuss top 25 dividend aristocrats ranked by yield. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read Dividend Aristocrats Ranked By Yield: Top 10. At the start of the year, there was a lot of excitement surrounding tech stocks. However, [\u2026]""}, {""date"": ""20230929031500"", ""headline"": ""Don\u2019t Miss Out: 3 Dividend Stocks to Buy on EVERY. SINGLE. DIP."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230929043122"", ""headline"": ""Unitaid urges Johnson & Johnson to improve access to TB drug bedaquiline"", ""summary"": ""Global health aid agency Unitaid has written to Johnson & Johnson's (J&J) CEO Joaquin Duato, urging him to take \""immediate action\"" to expand access to the company's tuberculosis drug bedaquiline.  While J&J has already lowered the price of bedaquiline which is used to treat drug-resistant tuberculosis (TB), Unitaid said this was an \""incomplete solution\"", saying countries like South Africa, Belarus and Ukraine were not benefiting.""}, {""date"": ""20230929043553"", ""headline"": ""Aid agency urges Johnson & Johnson to improve access to tuberculosis drug"", ""summary"": ""GENEVA (Reuters) -Global health aid agency Unitaid has written to Johnson & Johnson's (J&J) CEO Joaquin Duato, urging \""immediate action\"" to expand access to the company's tuberculosis drug bedaquiline, which is protected by patents hindering generic alternatives.  While J&J has already lowered the price of bedaquiline which is used to treat drug-resistant tuberculosis (DR-TB), Unitaid said this was an \""incomplete solution\"" and countries like South Africa, Belarus and Ukraine were not benefiting.""}, {""date"": ""20230929052100"", ""headline"": ""These 7 Dividend Stocks Pay $98 Billion Annually, Combined, to Their Shareholders"", ""summary"": ""Seven brand-name, time-tested businesses are doling out between $11.2 billion and $22.3 billion to their shareholders each year.""}, {""date"": ""20230929052100"", ""headline"": ""As Merck, AstraZeneca and other drugmakers sign on, Medicare price negotiations face critical moment"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230929062000"", ""headline"": ""As Merck, AstraZeneca and other drugmakers sign on, Medicare price negotiations face critical moment\u00a0"", ""summary"": ""A deadline looms to sign drug-price negotiation agreements as industry watches for legal reprieve.""}, {""date"": ""20230929064119"", ""headline"": ""UPDATE 1-Aid agency urges Johnson & Johnson to improve access to tuberculosis drug"", ""summary"": ""Global health aid agency Unitaid has written to Johnson & Johnson's (J&J) CEO Joaquin Duato, urging \""immediate action\"" to expand access to the company's tuberculosis drug bedaquiline, which is protected by patents hindering generic alternatives.  While J&J has already lowered the price of bedaquiline which is used to treat drug-resistant tuberculosis (DR-TB), Unitaid said this was an \""incomplete solution\"" and countries like South Africa, Belarus and Ukraine were not benefiting.""}, {""date"": ""20230929083159"", ""headline"": ""Recession-Proof Royals: 3 Stocks That Thrive in Tough Economic Times"", ""summary"": ""In the new century, economic uncertainty often looms. Finding investment opportunities that can weather the storm is a quest every investor undertakes. The article lists the \u201cRecession-Proof Royals\u201d, three titans of their respective industries who have not only stood the test of time but have thrived during economic downturns. These can be considered recession proof stocks. The first one\u2019s diverse product categories maintain stable demand, regardless of the economic climate. The second one\u2019s mul""}, {""date"": ""20230929123200"", ""headline"": ""Johnson & Johnson stock falls Friday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson shed 0.72% to $155.75 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""20230930053300"", ""headline"": ""LLY, ISRG, or JNJ: Which Healthcare Stock Could Generate the Best Returns?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230930065500"", ""headline"": ""3 Magnificent Dividend Stocks to Buy in October"", ""summary"": ""There's no better time than October to invest in high-quality dividend stocks.  Three Motley Fool contributors believe they've identified magnificent dividend stocks to buy in October.  Here's why they chose AbbVie (NYSE: ABBV), Gilead Sciences (NASDAQ: GILD), and Johnson & Johnson (NYSE: JNJ).""}, {""date"": ""20230930115408"", ""headline"": ""15 Warren Buffett Stocks That Are On Sale Now"", ""summary"": ""In this article, we will discuss the 15 Warren Buffett stocks that are on sale now. If you want to explore similar stocks, you can also take a look at 5 Warren Buffett Stocks That Are On Sale Now. Warren Buffett stands out as the most successful investor after nearly six decades of making waves [\u2026]""}, {""date"": ""20231001060000"", ""headline"": ""Could Kenvue Follow in the Footsteps of Johnson & Johnson and Become a Top Dividend Stock?"", ""summary"": ""When you think of the products populating your medicine cabinet -- like Band-Aid bandages or Tylenol -- you might not think of Kenvue (NYSE: KVUE).  After all, these items have Johnson & Johnson written all over them -- literally.  Speaking of rewarding shareholders, Kenvue is off to a good start, initiating a dividend during its very first months of operation as an independent company.""}]",{}
38,2023-10-01,150.9727783203125,2023-10-08,152.80479431152344,0.012134743836561324,U2,"[{""date"": ""20231001060000"", ""headline"": ""Could Kenvue Follow in the Footsteps of Johnson & Johnson and Become a Top Dividend Stock?"", ""summary"": ""When you think of the products populating your medicine cabinet -- like Band-Aid bandages or Tylenol -- you might not think of Kenvue (NYSE: KVUE).  After all, these items have Johnson & Johnson written all over them -- literally.  Speaking of rewarding shareholders, Kenvue is off to a good start, initiating a dividend during its very first months of operation as an independent company.""}, {""date"": ""20231001215200"", ""headline"": ""Cantor biotech/biopharma analysts to hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231001220100"", ""headline"": ""Drugmakers comply with Medicare pricing talks despite lawsuits"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231002003200"", ""headline"": ""Food Stocks: Worth a Bite"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231002071600"", ""headline"": ""Cantor Fitzgerald Remains a Buy on Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231002073200"", ""headline"": ""Johnson & Johnson Urged To Expand Access Tuberculosis Medication"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231002085300"", ""headline"": ""Corporate bonds are on sale. How to add cheap Apple, Disney and Microsoft bonds to your portfolio."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231002104500"", ""headline"": ""J&J's (JNJ) Rybrevant Combo Meets Primary Goal in NSCLC Study"", ""summary"": ""J&J (JNJ) meets the primary goal in the late-stage study of the combination therapy of Rybrevant and lazertinib against Tagrisso for EGFR-mutated first-line NSCLC.""}, {""date"": ""20231002123100"", ""headline"": ""Johnson & Johnson stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Johnson & Johnson sank 0.39% to $155.15 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""20231002174518"", ""headline"": ""Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) closed at $155.15 in the latest trading session, marking a -0.39% move from the prior day.""}, {""date"": ""20231002194500"", ""headline"": ""My Dividend Growth Portfolio September Update - Fall Bargains Are Here"", ""summary"": ""Discover dividend growth bargains in the market, as cash yields at 5%. Despite a slight dip in 2023, unaccounted income from a cash pile prevails. Read here for more.""}, {""date"": ""20231002205743"", ""headline"": ""Cantor Fitzgerald Reiterates Johnson & Johnson (JNJ) Overweight Recommendation"", ""summary"": """"}, {""date"": ""20231002215300"", ""headline"": ""Sanofi, Janssen Team Up to Develop, Commercialize Vaccine for E. Coli"", ""summary"": ""By Adria Calatayud Sanofi and Johnson &amp; Johnson's Janssen Pharmaceuticals have entered into an agreement to jointly develop and commercialize a vaccine...""}, {""date"": ""20231002220000"", ""headline"": ""Sanofi announces deal for potential E. coli vaccine with Janssen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003010700"", ""headline"": ""Sanofi announces pact with J&J to develop and commercialize E. coli vaccine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003030100"", ""headline"": ""Medicare drug price negotiations move forward with all drugmakers participating, White House says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003031500"", ""headline"": ""Johnson & Johnson in pact with Sanofi for E. coli vaccine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003032800"", ""headline"": ""Pharma Giants Sanofi, Johnson & Johnson Join Forces To Develop E.coli Vaccine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003040000"", ""headline"": ""Medicare drug price negotiations move forward with all drugmakers participating, White House says\u00a0"", ""summary"": ""Novo Nordisk is latest drugmaker to challenge negotiation program in court.""}, {""date"": ""20231003041800"", ""headline"": ""Higher Rates, Lower Leverage: Growth Stocks To Struggle While AI Offers Hope, Goldman Sachs Analysts Say"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003042100"", ""headline"": ""Berenberg: Get defensive with healthcare, utilities and telecoms"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003045800"", ""headline"": ""Court throws out $223.8M verdict against J&J in talc case, Reuters reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003050911"", ""headline"": ""12 Best Places to Retire in Dominican Republic"", ""summary"": ""This article looks at the 12 best places to retire in Dominican Republic. If you wish to skip our detailed analysis of Dominican Republic\u2019s economic growth and foreign investments, you may go to the 5 Best Places to Retire in Dominican Republic. Dominican Republic\u2019s Economic Growth and Foreign Investments According to the World Bank, the [\u2026]""}, {""date"": ""20231003052600"", ""headline"": ""NJ appeals court throws out $223.8M talc verdict against J&J: report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003062000"", ""headline"": ""10 U.S. drugmakers agree to participate in price negotiations with Medicare"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003070300"", ""headline"": ""See How Johnson & Johnson Ranks Among Analysts' Top Dow 30 Picks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003073000"", ""headline"": ""Video: Dow Analyst Moves: JNJ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003080000"", ""headline"": ""Drugmakers agree to US government price talks amid pushback"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003083900"", ""headline"": ""Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003095105"", ""headline"": ""Court tosses $223.8 million verdict against J&J in talc cancer case"", ""summary"": ""(Reuters) -A New Jersey appeals court on Tuesday threw out a $223.8 million verdict against Johnson & Johnson that a jury had awarded to four plaintiffs who claimed they developed cancer from being exposed to asbestos in the company's talc powder products.  The Superior Court of New Jersey, Appellate Division found that a lower court judge should not have allowed some of the scientific expert testimony the plaintiffs presented to jurors at trial.  J&J Worldwide Vice President of Litigation Erik Haas said in a statement that the decision \""resoundingly rejects ... the 'junk science' advanced by purported 'experts' paid by the mass tort asbestos bar.\""""}, {""date"": ""20231003100730"", ""headline"": ""UPDATE 1-Court tosses $223.8 million verdict against J&J in talc cancer case"", ""summary"": ""A New Jersey appeals court on Tuesday threw out a $223.8 million verdict against Johnson & Johnson in a trial over four plaintiffs' claims that they developed cancer from being exposed to the company's talc powder products.  The Superior Court of New Jersey, Appellate Division found that a lower court judge should not have allowed some of the scientific expert testimony the plaintiffs presented to jurors in the case.  A lawyer for the plaintiffs did not immediately respond to a request for comment.""}, {""date"": ""20231003100806"", ""headline"": ""The 10 pharma companies participating in Medicare price negotiations"", ""summary"": ""Ten pharmaceutical manufacturers are signing the Inflation Reduction Act's Medicare drug price negotiation program. These companies are Bristol Myers Squibb (BMY), AstraZeneca (AZN), Boehringer Ingelheim, Immunex, Janssen Pharmaceuticals, Pharmacyclics, Merck & Company (MRK), Janssen Biotech, Novartis (NVS), and Novo Nordisk (NVO), according to the Biden administration. Yahoo Finance Health Care Reporter Anjalee Khemlani discusses the news. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.""}, {""date"": ""20231003104500"", ""headline"": ""Sanofi (SNY) Inks Deal With J&J to Develop E. coli Vaccine"", ""summary"": ""Per the terms of the deal, Sanofi (SNY) and J&J will co-fund current and future R&D costs to develop a potential first-in-class vaccine against extraintestinal pathogenic E. coli.""}, {""date"": ""20231003112910"", ""headline"": ""Behind the new malaria vaccine endorsed by the World Health Organization"", ""summary"": ""The Serum Institute of India has received a recommendation from WHO for malaria doses using a Novavax adjuvant.""}, {""date"": ""20231003121120"", ""headline"": ""'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals: Today's Top Stories"", ""summary"": ""Benzinga Microsoft's Nadella Criticizes Google's Exclusive Content Deals Amid Antitrust Case In a significant development, Microsoft Corp's (NASDAQ: MSFT) CEO, Satya Nadella, has voiced concerns over the competitive landscape of content acquisition essential for training artificial intelligence (AI). Nadella's remarks came during his testimony in a landmark antitrust trial in the U.S., where he highlighted the challenges posed by exclusive deals that tech giants, notably Alphabet Inc (NASDAQ: GO""}, {""date"": ""20231003121614"", ""headline"": ""October Dogs Of The Dow: 3 Buyable, 7 Watchable"", ""summary"": ""Discover how the Dow Jones adds and selects stocks, the highest-yielding stocks in October, and the leading performers in the Dow Industrial Index. Click for more.""}, {""date"": ""20231003123100"", ""headline"": ""Johnson & Johnson stock rises Tuesday, outperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.12% higher to $155.34 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the...""}, {""date"": ""20231003130000"", ""headline"": ""Novartis to Complete Spinoff of Generic Drug Division"", ""summary"": ""Swiss pharmaceutical maker Novartis plans to spin off its Sandoz generic drugs division starting Wednesday, to focus on its core drug R&D business.""}, {""date"": ""20231003230443"", ""headline"": ""U.S. Wide-Moat Stocks On Sale - The October 2023 Heat Map"", ""summary"": ""Discover the 3-step process of selecting wide-moat stocks, with a focus on attractively valued candidates. See a heat map of investment candidates here.""}, {""date"": ""20231003233300"", ""headline"": ""Johnson & Johnson stock rises Wednesday, still underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231004023900"", ""headline"": ""BofA\u2019s Alpha Surprise Model: Lots of Energy additions, Con. Dis. deletions"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231004035600"", ""headline"": ""Johnson & Johnson initiated with an Outperform at RBC Capital"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231004035700"", ""headline"": ""Johnson & Johnson Sees Legal Win In Talc Powder Cancer Claims"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231004072900"", ""headline"": ""Needham biotechnology analysts to hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231004090010"", ""headline"": ""Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know"", ""summary"": ""Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.""}, {""date"": ""20231004140219"", ""headline"": ""14 Best Bear Market Stocks To Buy Now"", ""summary"": ""In this article, we discuss the 14 best bear market stocks to buy now. If you want to see more stocks in this selection, go directly to the 5 Best Bear Market Stocks To Buy Now. The US economy successfully avoided a recession owing to its resilient job market. However, it\u2019s worth noting that the job [\u2026]""}, {""date"": ""20231004143739"", ""headline"": ""Palantir And PwC Team Up To Accelerate Data-Driven Operations, OpenAI Rival Secures Billions In Big Tech Backing, Six US States Brace For Healthcare Strike: Today's Top Stories"", ""summary"": ""Benzinga AI Powerhouse: Palantir And PwC Team Up To Accelerate Data-Driven Operations Palantir Technologies Inc (NYSE: PLTR) is expanding its collaboration with PwC to combine its latest AI capabilities. The collaboration will combine Palantir's latest AI capabilities with PwC's industry experience to help clients realize value with data and AI-enabled operations. Palantir has chosen the U.K. as its European headquarters for AI research and development. Anthropic Navigating The AI Landscape With""}, {""date"": ""20231004200841"", ""headline"": ""7 Top Healthcare Stocks That Pay Dividends"", ""summary"": ""Facing an uncertain market environment, investors ought to consider the top healthcare stocks that pay dividends. Sure, the Federal Reserve may be in a position to facilitate a soft landing for the economy, per bullish analysts. Genuinely, I hope that\u2019s the case. But you can wish on one hand and, well, you know the rest. Primarily, the core benefit of top healthcare stocks that pay dividends centers on the \u201cpermanent\u201d relevance of the underlying sector. To be clear, all sectors suffer the vulner""}, {""date"": ""20231004222400"", ""headline"": ""Notable Thursday Option Activity: JNJ, BE, GE"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231004232200"", ""headline"": ""IN BRIEF: J&J notes study showing long-term efficacy of Spravato"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231004233300"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231004234100"", ""headline"": ""What You Missed On Wall Street On Thursday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005030200"", ""headline"": ""Expert Ratings for Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005033800"", ""headline"": ""Johnson & Johnson draws bullish initiation at RBC on consumer spinoff"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005041200"", ""headline"": ""Howard Hughes Holdings spinning off Seaport Entertainment to shareholders"", ""summary"": ""Houston conglomerate names former MGM executive Anton D. Nikodemus as chief executive of Seaport Entertainment as an independent company.""}, {""date"": ""20231005052100"", ""headline"": ""3 Historically Cheap Dow Stocks to Buy Hand Over Fist in October"", ""summary"": ""These profitable, time-tested Dow Jones stocks are cheaper than they've been in at least a decade, if not well beyond.""}, {""date"": ""20231005060000"", ""headline"": ""2 Magnificent Dividend Kings to Buy Now"", ""summary"": ""The three major stock market indexes have progressively declined over the past month, and the Dow Jones Industrial Average even slipped into negative territory for the year.  A look at the list of Dividend Kings is the perfect place to start because these players have track records of at least 50 years of dividend growth.  Let's take a look at two magnificent Dividend Kings that make great buys right now -- and could reward you with growing passive income over time.""}, {""date"": ""20231005060100"", ""headline"": ""November 24th Options Now Available For Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005060400"", ""headline"": ""Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005061800"", ""headline"": ""RBC Analyst Bullish on Johnson & Johnson (NYSE: JNJ) Post-Spinoff"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005070100"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005074200"", ""headline"": ""Johnson & Johnson Has Potential To Drive Its Pharma And MedTech Franchises, Says Bullish Analyst"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005080000"", ""headline"": ""3 Ways AI Can Help Healthcare Companies Grow"", ""summary"": ""If you want to invest in artificial intelligence (AI), tech stocks aren't your only options.  There are plenty of ways that AI can and will help transform the healthcare industry.  One of the big benefits of AI assistants is that they can summarize notes in meetings.""}, {""date"": ""20231005084100"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005084500"", ""headline"": ""Johnson & Johnson Wins an Analyst's Heart, but Its Charts Aren't So Hot"", ""summary"": ""The pharmaceutical giant's technical signals lean toward the bearish side even as it gains a buy recommendation.""}, {""date"": ""20231005174849"", ""headline"": ""S&P 500 Gains and Losses Today: Clorox Shares Dip After Warning of Cyberattack's Impact"", ""summary"": ""The S&P 500 was little changed on Thursday, Oct. 5, 2023 ahead of Friday's jobs report, and Clorox shares tumbled after warning a cyberattack would have a significant negative impact on its quarterly earnings.""}, {""date"": ""20231005224300"", ""headline"": ""Johnson & Johnson Dividend Stock Analysis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005224500"", ""headline"": ""Buy/Sell: Wall Street's top 10 stock calls this week"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005233300"", ""headline"": ""Johnson & Johnson stock rises Friday, still underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231006071245"", ""headline"": ""Job Market Keeps Humming As Payrolls Surge"", ""summary"": ""The Fed's December meeting is now uncertain, with a coin toss between a quarter-point hike and no move. Click here to read more.""}, {""date"": ""20231006073900"", ""headline"": ""IPOs are out of fashion. Here's what companies are doing instead."", ""summary"": ""Companies under pressure to unlock value unfurled a mini-flurry of spinoff activity in recent days, but some spinoff stocks have gotten a cool reception.""}, {""date"": ""20231006075200"", ""headline"": ""IN BRIEF: J&J applies for indication extension to EMA for Rybrevant"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231006081200"", ""headline"": ""Wall Street Lunch: Job Market Keeps Humming As Payrolls Surge"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231006121011"", ""headline"": ""Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report?"", ""summary"": ""Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.""}, {""date"": ""20231006140948"", ""headline"": ""Biotech-Pharma Trade: Buying Opportunities On The Horizon"", ""summary"": ""Concerns over interest rates, pricing erosion, and Medicare's drug price negotiation plan weigh on biotech and pharma sectors. Learn what investors need to know.""}, {""date"": ""20231006143137"", ""headline"": ""11 Best Stocks to Buy in Falling Markets According to Hedge Funds"", ""summary"": ""In this piece, we will take a look at the 11 best stocks to buy in falling markets according to hedge funds. For more recession-resilient stocks, head over to 5 Best Stocks to Buy in Falling Markets. Recessions are inevitable and the market has been forecasting a recession in the near future for quite some [\u2026]""}, {""date"": ""20231007053000"", ""headline"": ""5 Relatively Safe And Cheap Dividend Stocks To Invest In - October 2023"", ""summary"": ""In addition to the primary list that yields just over 3%, we present two other groups of five DGI stocks each. Explore more details here.""}, {""date"": ""20231007234000"", ""headline"": ""Wall Street's Top 10 Stock Calls This Week - Sunday, Oct. 8"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231008030600"", ""headline"": ""3 Pharma Stocks to Dump Before the Damage Is Done"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.4518, ""bookValue"": 71228, ""cashRatio"": 0.15138607167004733, ""currentRatio"": 1.2103, ""ebitPerShare"": 2.0461, ""eps"": 10.2083, ""ev"": 396807.4, ""fcfMargin"": 0.3055, ""fcfPerShareTTM"": 6.5375, ""grossMargin"": 0.7012, ""inventoryTurnoverTTM"": 2.2396, ""longtermDebtTotalAsset"": 0.1569, ""longtermDebtTotalCapital"": 0.2576, ""longtermDebtTotalEquity"": 0.3657, ""netDebtToTotalCapital"": 0.2294, ""netDebtToTotalEquity"": 0.3258, ""netMargin"": 1.2191, ""operatingMargin"": 0.2443, ""payoutRatioTTM"": 0.257, ""pb"": 5.2452, ""peTTM"": 10.7903, ""pfcfTTM"": 23.7404, ""pretaxMargin"": 0.2443, ""psTTM"": 4.4634, ""ptbv"": 10.3185, ""quickRatio"": 0.8634, ""receivablesTurnoverTTM"": 5.4551, ""roaTTM"": 0.1869, ""roeTTM"": 0.471, ""roicTTM"": 0.2997, ""rotcTTM"": 0.1218, ""salesPerShare"": 8.3739, ""sgaToSale"": 0.2988, ""tangibleBookValue"": 36207, ""totalDebtToEquity"": 0.4201, ""totalDebtToTotalAsset"": 0.1802, ""totalDebtToTotalCapital"": 0.2958, ""totalRatio"": 1.7511, ""period"": ""2023-10-01""}"
39,2023-10-08,152.80479431152344,2023-10-15,152.03903198242188,-0.005011376328548978,D1,"[{""date"": ""20231007234000"", ""headline"": ""Wall Street's Top 10 Stock Calls This Week - Sunday, Oct. 8"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231008030600"", ""headline"": ""3 Pharma Stocks to Dump Before the Damage Is Done"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231008214700"", ""headline"": ""3 Artificial Intelligence Stocks That Could Outperform the \u2018Godfather of AI\u2019"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231008220600"", ""headline"": ""Looking At Johnson & Johnson's Recent Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231008220800"", ""headline"": ""J&J Medtech gets FDA clearance for DePuy TriALTIS Spine System"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231009020315"", ""headline"": ""14 Best Cancer Stocks To Buy Now"", ""summary"": ""In this article, we discuss 14 best cancer stocks to buy. If you want to skip our detailed discussion on the oncology industry, head directly to 5 Best Cancer Stocks To Buy Now. The global oncology landscape continues to evolve, with ongoing efforts to discover, develop, and provide innovative treatments aimed at improving outcomes for [\u2026]""}, {""date"": ""20231009021100"", ""headline"": ""Protagonist Therapeutics announces advancement of JNJ-2113 across indications"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231009023300"", ""headline"": ""Janssen announces 30 company sponsored presentations at EADV Congress"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231009052100"", ""headline"": ""Meet the 3 Dividend Kings Warren Buffett Is Betting $21 Billion On"", ""summary"": ""Three dividend stocks that have each increased their base annual payout for more than 60 years account for $21 billion of Berkshire Hathaway's $337 billion of invested assets.""}, {""date"": ""20231009072100"", ""headline"": ""Analysts Are Bullish on Top Healthcare Stocks: Bristol-Myers Squibb (BMY), Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231009111000"", ""headline"": ""J&J (JNJ) Seeks EU Nod for Rybrevant for First-Line NSCLC"", ""summary"": ""J&J (JNJ) files an application in Europe seeking expanded approval for Rybrevant as a first-line combination treatment in patients with advanced or metastatic EGFR exon 20 insertion mutation-positive NSCLC.""}, {""date"": ""20231009123200"", ""headline"": ""Johnson & Johnson stock rises Monday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.57% higher to $158.54 Monday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""20231009230200"", ""headline"": ""Johnson & Johnson Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231010054500"", ""headline"": ""Cantor biotech/biopharma analysts to hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231010082738"", ""headline"": ""High Yield Stock Watchlist - October 2023"", ""summary"": ""The majority of the stocks on my watchlist are undervalued based on dividend yield theory. Read more here.""}, {""date"": ""20231010085500"", ""headline"": ""Johnson & Johnson (JNJ) Receives a Hold from DBS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231010100016"", ""headline"": ""Earnings Preview: Johnson & Johnson (JNJ) Q3 Earnings Expected to Decline"", ""summary"": ""Johnson & Johnson (JNJ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.""}, {""date"": ""20231010123200"", ""headline"": ""Johnson & Johnson stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson shed 0.11% to $158.36 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20231010130500"", ""headline"": ""Family Dollar recalls dozens of P&G, J&J, Colgate products in 23 states due to incorrect temperature storage"", ""summary"": ""Family Dollar voluntarily recalled dozens of OTC drugs and medical devices sold at its stores because they had been stored at improper temperatures.""}, {""date"": ""20231010131620"", ""headline"": ""DSTL: A Cash Flow-Focused ETF"", ""summary"": ""Distillate US Fundamental Stability & Value ETF picks stocks based on criteria including cash flow yield, cash flow stability & debt. Read more on DSTL ETF here.""}, {""date"": ""20231010212100"", ""headline"": ""J&J reports 510(k) clearance from FDA for TriLEAP System"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231010222200"", ""headline"": ""September 2023 Passive Income Update"", ""summary"": ""Fortis\u00c2\u00a0decided to get king status and boost their dividend by 4.4%. This raise adds $23.60 to our forward income. Check out our income update for September.""}, {""date"": ""20231011013300"", ""headline"": ""Bert's September Dividend Income Summary"", ""summary"": ""We received $3,570.87 in September dividend income. This was a 16.52% dividend increase compared to September 2022.""}, {""date"": ""20231011054500"", ""headline"": ""Needham biotechnology analysts to hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231011080851"", ""headline"": ""25 Most Innovative Companies in the World in 2023"", ""summary"": ""In this article, we will take a look at the most innovative companies in the world in 2023. If you want to explore similar companies, you can go to 5 Most Innovative Companies in the World in 2023. Innovation doesn\u2019t arrive straight away. Governments and organizations invest heavily in research and development, scientific publications, and [\u2026]""}, {""date"": ""20231011084500"", ""headline"": ""2 No-Brainer Dividend King Stocks to Buy Right Now"", ""summary"": ""Buying stocks may not seem all that attractive at the moment.  Investors, though, should bear in mind that high-quality dividend stocks have consistently outperformed most other asset classes over the long term, especially during times of economic uncertainty.  Blue chip dividend stocks, in effect, have often been a source of strength for investors in turbulent markets.""}, {""date"": ""20231011093807"", ""headline"": ""Will The Recent Spin-Off be Beneficial for Johnson & Johnson (JNJ)?"", ""summary"": ""ClearBridge Investments, an investment management company, released its \u201cClearBridge Large Cap Value Strategy\u201d third quarter 2023 investor letter. A copy of the same can be downloaded here. U.S. equities fell from the first-half highs amid fears of slowing consumer spending and higher interest rates. The strategy performed strongly in this environment outperforming the Russell 1000 Value [\u2026]""}, {""date"": ""20231011110908"", ""headline"": ""Birkenstock has an advantage that others in the 2023 IPO class don't have"", ""summary"": ""The brand's origin story is older than the United States.""}, {""date"": ""20231011121500"", ""headline"": ""Generative AI is top of mind for all types of leaders, from Treasury Secretary Janet Yellen to J&J CEO Joaquin Duato"", ""summary"": ""This week\u2019s episode of Fortune\u2018s Leadership Next podcast features conversations from the Fortune CEO Initiative conference.""}, {""date"": ""20231011123100"", ""headline"": ""Johnson & Johnson stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson shed 1.38% to $156.18 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""20231011212300"", ""headline"": ""Eli Lilly (NYSE:LLY) Slips despite Positive Phase 3 Results"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231011214600"", ""headline"": ""Beat the Market With These 7 Warren Buffett Stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231011225000"", ""headline"": ""Peering Into Johnson & Johnson's Recent Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012000500"", ""headline"": ""Where can you find entertainment, beaches, jobs, low cost of living and more? Here are some of the best places to live in Florida."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012002110"", ""headline"": ""Morgan Stanley Maintains Johnson & Johnson (JNJ) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""20231012002110"", ""headline"": ""Cantor Fitzgerald Reiterates Johnson & Johnson (JNJ) Overweight Recommendation"", ""summary"": """"}, {""date"": ""20231012011500"", ""headline"": ""Johnson & Johnson price target raised to $162 from $158 at Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012015600"", ""headline"": ""Alvotech biosimilar for JNJ\u2019s Stelara rejected in U.S."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012033500"", ""headline"": ""Eli Lilly succeeds in Phase 3 trial for Crohn's disease therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012051500"", ""headline"": ""Attention Medicare Recipients: You Could See Lower Costs for These 10 Drugs in the Not-Too-Distant Future"", ""summary"": ""Prescription drugs can be expensive. That's especially problematic for retirees living on fixed incomes. Sure, insurance can partially offset those high costs. However, seniors age 65 and older still pay for more than half of prescription drug costs out of their own pockets, according to the Health Policy Institute.""}, {""date"": ""20231012052800"", ""headline"": ""Eli Lilly Treatment For Crohn's Tops Placebo In Latest Study, Makes Plans For 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012063200"", ""headline"": ""Stocks to watch out in the Health Care sector as earnings close in"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012064900"", ""headline"": ""Stocks to watch in the Health Care sector as earnings close in"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012083900"", ""headline"": ""Supreme Court to hear arguments on Purdue Pharma bankruptcy case on Dec. 4"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012085300"", ""headline"": ""7 High-Growth S&P 500 Stocks to Buy Now"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012095915"", ""headline"": ""Retirement Stock Portfolio: 10 Low Risk Investments"", ""summary"": ""In this article, we discuss the 10 best low-risk investment options to add to your retirement portfolio. You can skip our detailed analysis of the retirement phenomenon within the U.S., and go directly to read the Retirement Stock Portfolio: 5 Low Risk Investments. In 2021, the economy faced persistent challenges due to the COVID-19 pandemic\u2019s [\u2026]""}, {""date"": ""20231012111000"", ""headline"": ""Dow ETF in Focus Ahead of Q3 Earnings"", ""summary"": ""With some of the blue-chip companies having reasonable chances of coming up with an earnings surprise, investors should closely monitor the movement of the Dow ETF and grab any opportunity that arises from a surge in any of the 30 stocks.""}, {""date"": ""20231012123100"", ""headline"": ""Johnson & Johnson stock underperforms Thursday when compared to competitors despite daily gains"", ""summary"": ""Shares of Johnson & Johnson inched 0.10% higher to $156.33 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the...""}, {""date"": ""20231012165251"", ""headline"": ""15 Worst Performing Dow Stocks YTD"", ""summary"": ""In this article, we discuss 15 worst performing Dow stocks year-to-date. If you want to skip our detailed discussion on stock market performance overall, head directly to 5 Worst Performing Dow Stocks YTD. In a July report by J.P. Morgan, it was stated that global economic growth is expected to slow down in the latter [\u2026]""}, {""date"": ""20231012193735"", ""headline"": ""Barclays Maintains Johnson & Johnson (JNJ) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""20231012220500"", ""headline"": ""Catalyst watch: Tesla earnings, Jerome Powell speech, UAW drama and Baidu event"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012233900"", ""headline"": ""Israel-Hamas War Shakes Middle East, Inflation Reawakens, Oil Surges: The Week In The Markets"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231013072100"", ""headline"": ""Over Delivering: Big Banks Beat Expectations After Tough Quarter, But Market Eyes Middle East Warily"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231013075606"", ""headline"": ""Johnson & Johnson Q3 Earnings Preview: Don't Count On Different Proposition Post Kenvue Spin-Out"", ""summary"": ""Johnson & Johnson (JNJ) will announce its Q3 earnings on October 17. Read why I would not be surprised to see an earnings miss followed by a selloff.""}, {""date"": ""20231013094900"", ""headline"": ""J&J (JNJ) to Report Q3 Earnings, Its First After Unit Spin-Off"", ""summary"": ""J&J's (JNJ) third-quarter results are the first quarterly update for the new company after the Consumer Health spin-off.""}, {""date"": ""20231013123200"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.33% higher to $156.85 Friday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""20231013124641"", ""headline"": ""Top 30 Oncology Companies in the World"", ""summary"": ""In this article, we shall cover the top 30 oncology companies in the world. To skip our detailed analysis of the global oncology industry in 2023, go directly and see Top 10 Oncology Companies in the World. According to a report by McKinsey and Company, the economic outlook for the US healthcare industry in 2023 [\u2026]""}, {""date"": ""20231013150204"", ""headline"": ""How big companies from EY to Johnson & Johnson are learning to master AI prompts"", ""summary"": ""Embracing AI is the easy part\u2014firms have already moved on to harder parts like making AI actually work for their business.""}, {""date"": ""20231014040600"", ""headline"": ""Johnson & Johnson Stock: Is Now the Time to Sell?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231014065200"", ""headline"": ""3 Dividend Growth Stocks You Can Buy and Hold Forever"", ""summary"": ""What's better than a stock that pays dividends?  A stock with growing dividends and a business that's built for long-term success.  Here's why they believe that AbbVie (NYSE: ABBV), Eli Lilly (NYSE: LLY), and Johnson & Johnson (NYSE: JNJ) are dividend growth stocks that you can buy and hold forever.""}, {""date"": ""20231015030300"", ""headline"": ""Earnings week ahead: Tesla, Bank of America, AT&T, Netflix, American Airlines and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231015084400"", ""headline"": ""ClearBridge Large Cap Value Strategy Q3 2023 Portfolio Manager Commentary"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.4518, ""bookValue"": 71228, ""cashRatio"": 0.15138607167004733, ""currentRatio"": 1.2103, ""ebitPerShare"": 2.0461, ""eps"": 10.2083, ""ev"": 396807.4, ""fcfMargin"": 0.3055, ""fcfPerShareTTM"": 6.5375, ""grossMargin"": 0.7012, ""inventoryTurnoverTTM"": 2.2396, ""longtermDebtTotalAsset"": 0.1569, ""longtermDebtTotalCapital"": 0.2576, ""longtermDebtTotalEquity"": 0.3657, ""netDebtToTotalCapital"": 0.2294, ""netDebtToTotalEquity"": 0.3258, ""netMargin"": 1.2191, ""operatingMargin"": 0.2443, ""payoutRatioTTM"": 0.257, ""pb"": 5.2452, ""peTTM"": 10.7903, ""pfcfTTM"": 23.7404, ""pretaxMargin"": 0.2443, ""psTTM"": 4.4634, ""ptbv"": 10.3185, ""quickRatio"": 0.8634, ""receivablesTurnoverTTM"": 5.4551, ""roaTTM"": 0.1869, ""roeTTM"": 0.471, ""roicTTM"": 0.2997, ""rotcTTM"": 0.1218, ""salesPerShare"": 8.3739, ""sgaToSale"": 0.2988, ""tangibleBookValue"": 36207, ""totalDebtToEquity"": 0.4201, ""totalDebtToTotalAsset"": 0.1802, ""totalDebtToTotalCapital"": 0.2958, ""totalRatio"": 1.7511, ""period"": ""2023-10-01""}"
40,2023-10-15,152.03903198242188,2023-10-22,148.30712890625,-0.024545690849987367,D3,"[{""date"": ""20231015030300"", ""headline"": ""Earnings week ahead: Tesla, Bank of America, AT&T, Netflix, American Airlines and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231015084400"", ""headline"": ""ClearBridge Large Cap Value Strategy Q3 2023 Portfolio Manager Commentary"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231015220000"", ""headline"": ""Stock market today: Wall Street rises, and oil and gold slip as some of last week's moves unwind"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231015221800"", ""headline"": ""Tesla, Netflix Grab Earnings Spotlight This Week As Analysts Divided On Q3 Reporting Season: What's On Investors' Radar?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231015225347"", ""headline"": ""Pfizer's Sequel: Return Of The Value Stock"", ""summary"": ""Pfizer focuses on core growth and strategic acquisitions in oncology to offset downgraded revenue projections. Learn why I rate PFE stock a hold.""}, {""date"": ""20231015235100"", ""headline"": ""LONDON MARKET OPEN: Stocks steady as eyes on oil, Israel, US earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016023700"", ""headline"": ""US Stocks On Track For A Strong Start To Week, Buoyed By Earnings Optimism: Analyst Flags 13-14% Upside As Bull Market Enters Its Second Year"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016030300"", ""headline"": ""LONDON MARKET MIDDAY: Stocks mixed on conflict and US earnings nerves"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016030500"", ""headline"": ""Johnson & Johnson: A Conservative High-Yield Dividend Aristocrat Buy"", ""summary"": ""Johnson & Johnson is a defensive pick with a renewed focus on its pharmaceutical and medtech segments. Find out why JNJ stock is a Buy.""}, {""date"": ""20231016050000"", ""headline"": ""WSJ\u2019s Take on the Week Podcast: A Key Fed Official on What\u2019s Next for Interest Rates"", ""summary"": ""This week, we\u2019re looking at what the Federal Reserve is focused on as it plots the course of interest rates. Minutes revealed that in their most recent meeting a majority of rate-setting officials said one more rate hike would be appropriate.""}, {""date"": ""20231016052400"", ""headline"": ""Notable earnings before Tuesday's open"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016064428"", ""headline"": ""AbbVie: Successfully Navigating Humira's Patent Cliff With 4% Yield And 270% DGR Since 2014"", ""summary"": ""Despite declining Humira sales, AbbVie remains resilient, focusing on new therapies, M&A, and R&D for sustained growth. Find out why ABBV stock is a Hold.""}, {""date"": ""20231016064500"", ""headline"": ""Johnson & Johnson Resumed The Bearish Cycle"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016070300"", ""headline"": ""Companies with lower implied volume have higher potential for earnings surprise - BofA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016075000"", ""headline"": ""Monday's Market Minute: This Week's Focus: Earnings & Consumer Spending"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016075300"", ""headline"": ""LONDON MARKET CLOSE: Europe boosted by bullish open in New York"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016080800"", ""headline"": ""Pendulum Swings: Markets Recover Slightly After Friday's Anxious Trading, But Middle East Worries Dominate"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016081200"", ""headline"": ""4 Dividend Stocks Yielding 4% or More to Buy Without Hesitation"", ""summary"": ""The Federal Reserve has significantly ratcheted up interest rates over the past several quarters to help cool inflation.  As their share prices have fallen, their dividend yields have increased, which compensates investors for their higher risk profiles relative to bonds and CDs.  Kenvue is new to paying dividends.""}, {""date"": ""20231016082600"", ""headline"": ""My Dividend Growth Portfolio - Q3 2023 Summary"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016114928"", ""headline"": ""Bank of America reports, Johnson & Johnson, retail sales: 3 things to watch"", ""summary"": ""Investing.com -- Stocks surged on Monday as investors turned their attention to a wave of earnings reports from big banks, big tech firms such as Netflix (NASDAQ:NFLX), and Tesla (NASDAQ:TSLA) this week.""}, {""date"": ""20231016123200"", ""headline"": ""Johnson & Johnson stock rises Monday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.43% higher to $157.53 Monday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""20231016170000"", ""headline"": ""Johnson & Johnson\u2019s Earnings Are Coming. They\u2019ll Be the First Since the Kenvue Spinoff."", ""summary"": ""An update in August after the split leaves investors with fewer questions for Tuesday's results.""}, {""date"": ""20231016173405"", ""headline"": ""Bank earnings, Fedspeak, House Speaker: What to watch"", ""summary"": ""Goldman Sachs (GS) and Bank of America (BAC) report their third-quarter earnings on Tuesday, October 17. September retail sales data is also expected out tomorrow while Fed regulators are set to speak. Lastly, House lawmakers will vote on Rep. Jim Jordan's (R-Oh.) candidacy as the next Speaker of the House. Yahoo Finance's Josh Lipton previews what investors should pay attention to tomorrow. For more expert insight and the latest market action,\u00a0click here\u00a0to watch this full episode of Yahoo Finance Live.""}, {""date"": ""20231016184200"", ""headline"": ""Markets Pop on Bargain Hunting, Stronger Economy"", ""summary"": ""The small-cap Russell 2000, still under water over the past month, led the way higher today.""}, {""date"": ""20231016213500"", ""headline"": ""Johnson & Johnson's Q3 2023: $21.3B Rise In Sales, 'Sharpened Focus' On Innovation & Biotech Solutions"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016214100"", ""headline"": ""Back for Another Round: Rate Hike Fears Grow After Strong Retail Sales Sends Yields Spinning Higher"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016214500"", ""headline"": ""Cantor biotech/biopharma analysts hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016215000"", ""headline"": ""LONDON MARKET EARLY CALL: FTSE to edge lower; wage data due"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016215700"", ""headline"": ""Johnson & Johnson\u2019s Strong Q3 Performance and Upward Guidance Evokes Buy Rating: An Analysis of the Innovative Medicine Sector\u2019s Influence"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016220200"", ""headline"": ""J&J lung cancer drug combo had superior progression-free survival in study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016221500"", ""headline"": ""Johnson & Johnson earnings: What to expect"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016233700"", ""headline"": ""Stock market today: Wall Street drifts after a strong retail sales report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016234900"", ""headline"": ""LONDON MARKET OPEN: Stocks rise as UK wage inflation eases"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017003300"", ""headline"": ""S&P 500 futures drift as Goldman Sachs and Bank of America earnings awaited"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017012100"", ""headline"": ""As Q3 earnings season revs into high gear, here's what to expect"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017012100"", ""headline"": ""Johnson & Johnson reports Q3 adjusted EPS $2.66, consensus $2.51"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017012300"", ""headline"": ""Johnson & Johnson raises FY23 adjusted EPS to $10.07-$10.13 from $10.00-$10.10"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017012500"", ""headline"": ""Genmab reports Q3 worldwide net sales of DARZALEX $2.499B"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017013200"", ""headline"": ""Johnson & Johnson Non-GAAP EPS of $2.66 beats by $0.14, revenue of $21.35B beats by $300M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017013953"", ""headline"": ""Intuitive Surgical: When Paying A Premium Makes Sense"", ""summary"": ""Intuitive Surgical is launching new products to complement its flagship da Vinci product line, pointing to continued growth. Find out why ISRG stock is a Buy.""}, {""date"": ""20231017014500"", ""headline"": ""Johnson & Johnson\u2019s stock climbs after company beats earnings estimates and raises profit guidance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017015000"", ""headline"": ""Johnson & Johnson in charts: Segment sales continue to grow in Q3, while regional sales decline"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017020800"", ""headline"": ""Johnson & Johnson (NYSE:JNJ) Gains After Impressive Q3 Results"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017020900"", ""headline"": ""Earnings Scheduled For October 17, 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017021300"", ""headline"": ""Johnson & Johnson powers to Q3 beat as pharma outperforms"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017023700"", ""headline"": ""Johnson & Johnson in charts: Sales grow Y/Y for both major segments"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017023800"", ""headline"": ""US Stock Futures Slide As Traders Look Past Positive Earnings News Flow; Analysts Predict Year-End Rally And Strong 2024 Ahead"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017023900"", ""headline"": ""J&J\u2019s stock rallies after profit and sales rise above expectations, full-year outlook increased"", ""summary"": ""Shares of Johnson & Johnson rallied 0.8% in premarket trading Tuesday, after the drug maker and medical technology company reported third-quarter profit and...""}, {""date"": ""20231017024600"", ""headline"": ""TOP NEWS: J&J raises full-year sales outlook after \""solid\"" quarter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017024800"", ""headline"": ""Johnson & Johnson (NYSE:JNJ) Gains on Impressive Q3 Results"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017032300"", ""headline"": ""Morning Brew: Microsoft's Accelerated Growth, Lockheed Martin's Q3 Earnings Beat, and Apple ..."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017040000"", ""headline"": ""Johnson & Johnson says continues to make progress on new product launches"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017040200"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Johnson & Johnson (JNJ) and Thermo Fisher (TMO)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017041500"", ""headline"": ""U.S. stock futures lower amid earnings beats and strong retail sales"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017041500"", ""headline"": ""Invest in millennials and these \u2018once-in-a-lifetime opportunity\u2019 stocks, says this fund manager"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017041500"", ""headline"": ""Johnson & Johnson says continues to pursue four-pronged talc litigation strategy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017041900"", ""headline"": ""5 stocks to watch on Tuesday: J&J, Bank of America, United Airlines and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017043235"", ""headline"": ""These Stocks Are Moving the Most Today"", ""summary"": ""Johnson & Johnson, Bank of America, and Goldman Sachs are scheduled to report third-quarter earnings on Tuesday, Ericsson slumps after withdrawing margin guidance, and NetScout reduces its outlook for fiscal 2024.""}, {""date"": ""20231017044000"", ""headline"": ""Unusually active option classes on open October 17th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017044100"", ""headline"": ""Johnson & Johnson says 'confident' in product pipeline for 2024/2025"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017045400"", ""headline"": ""Johnson & Johnson expects flat procedures in MedTech in 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017045700"", ""headline"": ""U.S. stocks open lower as strong retail sales overshadow earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017045700"", ""headline"": ""Dividend Income Summary: Lanny's September 2023 Summary"", ""summary"": ""In September, we (my wife and I) received a dividend income total of $4,987.23. So close to $5,000 this month for our family.""}, {""date"": ""20231017054554"", ""headline"": ""Bank of America, Johnson & Johnson And 3 Stocks To Watch Heading Into Tuesday"", ""summary"": ""With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Johnson & Johnson (NYSE: JNJ) to report quarterly earnings at $2.51 per share on revenue of $21.04 billion before the opening bell. Johnson & Johnson shares gained 0.3% to $158.00 in after-hours trading. NetScout Systems, Inc. (NASDAQ: NTCT) reported weak preliminary results for the second quarter and lowered its FY24 guidance. NetScout Systems""}, {""date"": ""20231017061000"", ""headline"": ""Johnson & Johnson beats earnings estimates and downplays obesity drugs\u2019 impact on its med-tech business"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017062000"", ""headline"": ""Johnson & Johnson Reports Q3 2023 Results"", ""summary"": ""NEW BRUNSWICK, N.J., October 17, 2023--Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2023. \""Johnson & Johnson delivered strong results and significant pipeline advances in the third quarter, providing a solid foundation for future sustained growth,\"" said Joaquin Duato, Chairman of the Board and Chief Executive Officer. \""With a sharpened focus on Innovative Medicine and MedTech solutions, Johnson & Johnson is innovating across the spectrum of healthcare and is poised to""}, {""date"": ""20231017062001"", ""headline"": ""J&J raises annual profit forecast on strong cancer drug demand"", ""summary"": ""Johnson & Johnson on Tuesday raised its 2023 profit forecast, banking on growing demand for its newer cancer treatments such as Carvykti and Tecvayli and recorded a $21 billion gain from the spin off of its consumer health unit.  Investors are focused on how Johnson & Johnson, now a standalone pharmaceutical and medical devices company, will reach its goal of $57 billion in drug sales by 2025.  Excluding its consumer health unit, the company now expects 2023 adjusted profit of $10.07 to $10.13 per share, compared with its previous outlook of $10.00 to $10.10 per share.""}, {""date"": ""20231017062100"", ""headline"": ""U.S. stocks stay lower as strong retail sales overshadow earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017062227"", ""headline"": ""J&J begins restructuring at medical device unit after sales miss"", ""summary"": ""(Reuters) -Johnson & Johnson on Tuesday said it has embarked on a two-year restructuring program for its orthopedic business after third-quarter medical devices sales fell short of Wall Street expectations, reflecting the company's narrowed focus since spinning off its consumer health unit.  J&J said it plans to exit certain markets and stop selling some products under its orthopedic business as part of the  restructuring program.  Without its consumer health business and medical devices undergoing restructuring, pressure on J&J's large pharmaceutical unit is likely to intensify as the company aims to reach its goal of $57 billion in drug sales by 2025.""}, {""date"": ""20231017062227"", ""headline"": ""J&J lifts profit outlook on strong demand for top-seller Stelara"", ""summary"": ""(Reuters) -Johnson & Johnson raised its 2023 profit forecast in its first earnings report since spinning off its consumer health business, with the company's fortunes now tied more closely to sales of blockbusters like its arthritis drug Stelara.  Investors are focused on how J&J, now a standalone pharmaceutical and medical devices company, will reach its goal of $57 billion in drug sales by 2025.  Johnson & Johnson recorded a $21-billion gain in the third quarter from the spin-off of its consumer health unit.""}, {""date"": ""20231017062800"", ""headline"": ""These Stocks Are Moving the Most Today: J&J, Bank of America, Goldman, Lockheed, Ericsson, NetScout, and More"", ""summary"": ""Johnson & Johnson's third-quarter adjusted earnings beat analysts' estimates. Bank of America and Goldman Sachs also are scheduled to report third-quarter earnings Tuesday.""}, {""date"": ""20231017063400"", ""headline"": ""Johnson & Johnson earnings top forecasts, shares jump, on new cancer drug boost"", ""summary"": ""Johnson & Johnson's newly-structured business, which no longer includes a consumer healthcare unit, is seeing solid demand for its new cancer-focused treatments Carvykti and Tecvayli.""}, {""date"": ""20231017064000"", ""headline"": ""Johnson & Johnson Stock Rises. It Lifts Guidance in First Post-Kenvue Earnings."", ""summary"": ""The company raises its expected annual adjusted earnings to a range of $10.07 to $10.13 a share and now expects annual sales of $83.6 billion to $84 billion.""}, {""date"": ""20231017070500"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017071300"", ""headline"": ""Johnson & Johnson sees GLP-1 impact on weight loss surgeries"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017072859"", ""headline"": ""5 Things to Know Before Markets Open"", ""summary"": ""Bank of America shares rose after reporting better-than-expected earnings on higher interest income and Johnson & Johnson delivered an earnings beat on medical device and pharmaceutical sales. Here\u2019s what investors need to know today.""}, {""date"": ""20231017074002"", ""headline"": ""Johnson & Johnson (JNJ) Q3 Earnings and Revenues Surpass Estimates"", ""summary"": ""Johnson & Johnson (JNJ) delivered earnings and revenue surprises of 5.56% and 1.67%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?""}, {""date"": ""20231017075200"", ""headline"": ""Dow rises as investors digest strong retail sales and earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017081800"", ""headline"": ""Johnson & Johnson Raises Its Profit Outlook, but Its Charts Still Don't Impress"", ""summary"": ""The technical indicators of the pharmaceutical and medical device giant suggest that the bump it stands to get from its latest earnings announcement may not be sustainable.""}, {""date"": ""20231017084800"", ""headline"": ""Stocks Rise On Positive Earnings; Treasury Volatility Returns, Nvidia Stumbles: What's Driving Markets Tuesday?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017085600"", ""headline"": ""Wall Street Lunch: Sept. Retail Sales Spark Treasury Yield Surge"", ""summary"": ""The 10-yr yield surges close to 4.85%, 30-yr close to 5% after Sept. retail sales; Goldman Sachs Q3 revenue beat estimates; Bank of America posts results beat. Read more.""}, {""date"": ""20231017085700"", ""headline"": ""J&J Sees Boom in Heart Device Sales in Third Quarter"", ""summary"": ""A standout performer in Johnson & Johnson\u2019s third quarter was the group of special catheters and other [electrophysiology products](https://www.wsj.com/articles/j-j-makes-a-16-6-billion-bet-on-heart-pumps-to-lift-medical-device-sales-11667388513) used to diagnose and treat irregular heart rhythms.  \u201cWe continue to take market share with our existing products and we have plans for new products [in that space](https://www.wsj.com/articles/surge-in-heart-procedures-help-drive-johnson-johnson-revenue-1d49d5c2) to come out as early as 2024,\u201d J&J Chief Financial Officer Joseph Wolk told The Wall Street Journal.""}, {""date"": ""20231017091149"", ""headline"": ""Johnson & Johnson (JNJ) Reports Strong Q3 2023 Results with Notable Sales and EPS Growth"", ""summary"": ""Company increases full-year guidance for sales and adjusted EPS""}, {""date"": ""20231017093008"", ""headline"": ""Johnson & Johnson (JNJ) Reports Q3 Earnings: What Key Metrics Have to Say"", ""summary"": ""Although the revenue and EPS for Johnson & Johnson (JNJ) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.""}, {""date"": ""20231017095454"", ""headline"": ""Johnson & Johnson raises guidance, Q3 results top estimates"", ""summary"": ""Johnson & Johnson (JNJ) reported third quarter results that topped analyst estimates on both the top and bottom lines. The health care company also raised its full-year guidance. The report was the company's first earnings release since it spun off its consumer health business, Kenvue (KVUE). Yahoo Finance Live breaks down the numbers.\u00a0 For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.""}, {""date"": ""20231017100022"", ""headline"": ""Johnson & Johnson Is Falling, but This Tech Stock Is Really Getting Hit Hard"", ""summary"": ""Already, market participants have had a chance to respond to the latest results from some of the biggest banking institutions in the country, and now the focus will shift to other segments of the economy.  One company that a lot of market participants wanted to look at closely was Johnson & Johnson (NYSE: JNJ), as the healthcare giant offers a pulse on what's becoming an increasingly important sector of the market.  Shares of Johnson & Johnson were down almost 1% Tuesday morning.""}, {""date"": ""20231017103200"", ""headline"": ""Retail Sales Hotter at +0.7%; JNJ, BAC, GS All Beat in Q3"", ""summary"": ""Retail Sales infer a consumer willing to spend, and the outlook for Q3 GDP is likely up somewhat on this news.""}, {""date"": ""20231017103500"", ""headline"": ""The 'New' Johnson & Johnson Reports, But Where Are the Rest of the Numbers?"", ""summary"": ""On Tuesday morning, Johnson & Johnson  reported the firm's third quarter financial results.  For the three month period ended October 1st, Johnson & Johnson posted an adjusted EPS from continuing operations of $2.66  $1.69  on revenue of $21.351B.  Both the top line and adjusted bottom line results exceeded Wall Street's expectations.""}, {""date"": ""20231017104526"", ""headline"": ""J&J Stock Dips After Healthcare Giant Posts Earnings"", ""summary"": ""Johnson & Johnson ([JNJ](https://www.wsj.com/market-data/quotes/JNJ?)) raised its adjusted earnings outlook for the year after posting higher third-quarter revenue, despite a drop in sales of its Covid-19 vaccine.""}, {""date"": ""20231017105239"", ""headline"": ""Stocks to Watch Tuesday: J&J, Lockheed Martin, Goldman Sachs, Bank of America, VF"", ""summary"": ""\u2198\ufe0f [**Goldman Sachs (GS)**](https://www.wsj.com/market-data/quotes/GS): The bank posted declines in quarterly profit and revenue, but narrowly [beat consensus estimates](https://www.wsj.com/livecoverage/stock-market-today-dow-jones-10-17-2023/card/goldman-sachs-profit-falls-33--6x5YoO6CkK0jiZWvWVtB) for both.""}, {""date"": ""20231017105400"", ""headline"": ""Retail Sales Increased More Than Expected"", ""summary"": ""Retail Sales Increased More Than Expected""}, {""date"": ""20231017110216"", ""headline"": ""S&P 500 falls as Nvidia slip, rising yields overshaddow quarterly earnings"", ""summary"": ""Investing.com -- The S&P 500 fell Tuesday as investor sentiment was soured by Nvidia-led weakness in chip stocks and a jump in Treasury yields following stronger retail sales data that boosted bets on a Fed rate hike by year end.""}, {""date"": ""20231017110834"", ""headline"": ""Johnson & Johnson Raises Outlook As The Health Care Bellwether Beats Views"", ""summary"": ""Johnson & Johnson beat third-quarter forecasts Tuesday and raised its outlook for the year. JNJ stock skidded lower after the open.""}, {""date"": ""20231017115613"", ""headline"": ""J&J Beats Profit Estimates on Pharmaceutical, Medtech Sales as COVID-19 Shot Revenue Slows"", ""summary"": ""Johnson & Johnson beat profit and sales estimates and boosted its outlook as pharmaceutical and medical device sales gain while demand for COVID-19 vaccines wanes.""}, {""date"": ""20231017121331"", ""headline"": ""Stock Market Today: Dow ekes out gain, but rising Treasury yields stifle upside"", ""summary"": ""Investing.com -- The Dow eked out a gain Tuesday, but upside momentum was stifled by a jump in Treasury yields following stronger retail sales data that underscored ongoing strength in the economy, stoking fresh fears about another Federal Reserve rate hike before year end.""}, {""date"": ""20231017122400"", ""headline"": ""NEW YORK MARKET CLOSE: Blue-chips end flat but chip curbs rattle tech"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017123100"", ""headline"": ""Johnson & Johnson stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson dropped 0.91% to $156.09 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...""}, {""date"": ""20231017123200"", ""headline"": ""J&J (JNJ) Beats Q3 Earnings & Sales Estimates Post Spin-Off"", ""summary"": ""J&J (JNJ) beats estimates for third-quarter earnings and sales. It raises full-year sales and earnings guidance.""}, {""date"": ""20231017133022"", ""headline"": ""Johnson & Johnson (JNJ) Q3 2023 Earnings Call Transcript"", ""summary"": ""This is Jessica Moore, vice president of investor relations for Johnson & Johnson.  As a reminder, you can find additional materials including today's presentation and associated schedules on the Investor Relations section of the Johnson & Johnson website at investor.jnj.com.  Please note that this presentation and forward-looking statements regarding, among other things, the company's future operating and financial performance, market position, and business strategy.""}, {""date"": ""20231017151616"", ""headline"": ""Johnson & Johnson Was Saved By Its Focus On MedTech And Innovative Medicine"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) reported its third quarter results that topped Wall Street\u2019s expectations while also lifting its full year guidance fueled by a strong performance of its pharmaceutical and medical devices businesses. This is the company\u2019s first quarterly report since the biggest shakeup in its 13- year-old history when it completed the separation from its consumer health spinoff Kenvue back in August. JNJ Reported A Better Than Expected Third Quarter During the third quarter, JNJ g""}, {""date"": ""20231017160000"", ""headline"": ""Johnson & Johnson's Sharper Focus Is Already Paying Dividends for Investors"", ""summary"": ""Johnson & Johnson\u00a0(NYSE: JNJ) has spent several quarters working toward sharpening its focus on its innovative medicine and medical technology (MedTech) businesses. It took a huge step forward by completing the spin-off of its former consumer healthcare business,\u00a0Kenvue\u00a0(NYSE: KVUE), to shareholders during the third quarter.""}, {""date"": ""20231017162300"", ""headline"": ""These Stocks Moved the Most Today: Nvidia, VMware, VF Corp., Bank of America, Lucid, Wyndham, and More"", ""summary"": ""Nvidia tumbles as the Biden administration is tightening its restriction on exports of artificial intelligence chips to China, earnings from Bank of America beat Wall Street forecasts, and Lucid's third-quarter production falls.""}, {""date"": ""20231017165520"", ""headline"": ""S&P 500 Gains and Losses Today: Chipmaker Shares Drop Amid Tightening Export Rules"", ""summary"": ""The S&P 500 dipped 0.01% on Tuesday, Oct. 17, 2023, as news that retail sales jumped more than expected in September renewed concerns about more Fed rate hikes.""}, {""date"": ""20231017193000"", ""headline"": ""Stocks Face Bumpy Road As Macro Risks Remain"", ""summary"": """"}, {""date"": ""20231017203237"", ""headline"": ""J&J Weighs Third Bankruptcy Try to Settle Baby Powder Suits"", ""summary"": ""(Bloomberg) -- Johnson & Johnson is weighing a third attempt to use bankruptcy for an $8.9 billion settlement of tens of thousands of lawsuits that allege tainted talc in the company\u2019s baby powder caused cancer, the health-care giant told investors Tuesday.Most Read from BloombergGaza Hospital Blast Kills Hundreds as Israel, Hamas Trade BlameIsrael Latest: Biden to Visit as Oil Climbs After Hospital BlastTreasury Yields Climb as Hot Data Fuel Fed Wagers: Markets WrapWill Xi Jinping\u2019s Gamble on V""}, {""date"": ""20231017212800"", ""headline"": ""Hold Rating for Johnson & Johnson: A Balance of Strong Performance and Ongoing Challenges"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017213700"", ""headline"": ""Positive Analyst Outlook on Johnson & Johnson: Accelerated Growth and Raised Guidance Despite Potential Challenges"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017214500"", ""headline"": ""Positive Outlook On Johnson & Johnson's Partner Legend Biotech: Analyst Confident On Blood Cancer Drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018000355"", ""headline"": ""Q3 2023 Johnson & Johnson Earnings Call"", ""summary"": ""Q3 2023 Johnson & Johnson Earnings Call""}, {""date"": ""20231018003900"", ""headline"": ""J&J considers third bankruptcy attempt over talc claims"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018013000"", ""headline"": ""Dividend Income Update September 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018020100"", ""headline"": ""Beyond Market Price: Uncovering Johnson & Johnson's Intrinsic Value"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018025700"", ""headline"": ""Johnson & Johnson (NYSE:JNJ)\u00a0to Boost MedTech Division\u2019s Margins"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018031600"", ""headline"": ""Cantor Fitzgerald Sticks to Their Buy Rating for Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018035000"", ""headline"": ""Johnson & Johnson price target lowered to $171 from $174 at Morgan Stanley"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018040700"", ""headline"": ""Johnson & Johnson price target lowered to $178 from $186 at Wells Fargo"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018041500"", ""headline"": ""My Dividend Stock Portfolio: New September Dividend Record - 98 Holdings With 22 Buys"", ""summary"": ""The S&P 500 and Dow Jones Industrial Average saw sharp losses for the month and the quarter. Click here to read my analysis.""}, {""date"": ""20231018050200"", ""headline"": ""Analysts Are Bullish on Top Healthcare Stocks: Ligand Pharma (LGND), Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018053500"", ""headline"": ""Dow remains lower with Treasury yields near 16 year highs, oil jumping and tech earnings ahead"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018055100"", ""headline"": ""Is the \""New\"" Johnson & Johnson Stock a Buy With Its Improved Profit Outlook?"", ""summary"": ""Some things are different about J&J. But other things remain the same as they've been for a long time.""}, {""date"": ""20231018055300"", ""headline"": ""FDA approves UCB's Bimzelx for plaque psoriasis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018074800"", ""headline"": ""Genmab hits 52-week low after Q3 Darzalex sales"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018091001"", ""headline"": ""Johnson & Johnson (NYSE:JNJ) Q3 2023 Earnings Call Transcript"", ""summary"": ""Johnson & Johnson (NYSE:JNJ) Q3 2023 Earnings Call Transcript October 17, 2023 Operator: Good morning, and welcome to Johnson & Johnson\u2019s Third Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode until the question-and-answer session of the conference. This call is being recorded. If anyone has any objections, you may disconnect [\u2026]""}, {""date"": ""20231018093000"", ""headline"": ""1 Warren Buffett Stock to Buy Hand Over Fist Right Now"", ""summary"": ""Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) CEO Warren Buffett is a defensive investor at heart.  As a result, Berkshire Hathaway's portfolio is heavily tilted toward dyed-in-the-wool value stocks \u2013 many of which pay generous and sustainable dividends.  Underscoring this point, a $1,000 investment in Berkshire Hathway stock at the start of Buffett's tenure as CEO would be worth an astonishing $1.82 million today.""}, {""date"": ""20231018100500"", ""headline"": ""JNJ Beats Q3 Earnings Estimates, Raises View: ETFs in Focus"", ""summary"": ""The world's biggest healthcare products maker continued with its long streak of earnings beat and lifted the full year outlook.""}, {""date"": ""20231018123200"", ""headline"": ""Johnson & Johnson stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slipped 2.15% to $152.73 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P...""}, {""date"": ""20231018133057"", ""headline"": ""Cantor Fitzgerald Reiterates Johnson & Johnson (JNJ) Overweight Recommendation"", ""summary"": """"}, {""date"": ""20231018133101"", ""headline"": ""Raymond James Maintains Johnson & Johnson (JNJ) Outperform Recommendation"", ""summary"": """"}, {""date"": ""20231018174646"", ""headline"": ""Why Johnson & Johnson Stock Flopped Today"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) stock had a bit of a hangover Wednesday.  Following the estimates-beating third-quarter results that the company posted Tuesday, its share price fell by more than 2%.  Before the market open Wednesday, a pair of pundits tracking Johnson & Johnson stock lowered their fair value estimations of the healthcare giant.""}, {""date"": ""20231018210800"", ""headline"": ""Check Out What Whales Are Doing With JNJ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018222557"", ""headline"": ""Morgan Stanley Maintains Johnson & Johnson (JNJ) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""20231018231100"", ""headline"": ""Johnson & Johnson declares $1.19 dividend"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018231200"", ""headline"": ""CVS removing certain cold medicines containing phenylephrine, CNBC reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018231500"", ""headline"": ""7 Healthcare Stocks That Can Cure a Lackluster Portfolio"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018234000"", ""headline"": ""The 7 Best Forever Stocks To Buy Now: October 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019011300"", ""headline"": ""Johnson & Johnson price target raised to $165 from $162 at Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019014700"", ""headline"": ""7 Dividend Aristocrats That Are Built to Last"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019025900"", ""headline"": ""GLOBAL BROKER RATINGS: DZ Bank cuts P&G, but raises PepsiCo"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019030100"", ""headline"": ""Johnson & Johnson\u2019s Stock Receives Buy Rating Amid Promising MARIPOSA Trial Results and Potential Market Share Gain"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019031500"", ""headline"": ""AT&T Is Still A Mess, So Buy These 9%-Yielding Dividend Aristocrat Bargains"", ""summary"": ""AT&T stock has been a value trap for four decades. Find out two other 9%-yielding dividend aristocrat bargains capable of doubling in value every 5 years""}, {""date"": ""20231019032400"", ""headline"": ""Drug retailers, makers face mounting litigation over decongestant products"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019051500"", ""headline"": ""Video: Dow Movers: JNJ, MCD"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019061800"", ""headline"": ""Dow drops nearly 100 points on losses in shares of Merck, Amgen"", ""summary"": ""Shares of Merck and Amgen are posting losses Thursday morning, dragging the Dow Jones Industrial Average into negative territory. The Dow was most recently...""}, {""date"": ""20231019063000"", ""headline"": ""'Things were way tougher': Charlie Munger gets blunt with whiners worried about 'hardship' \u2014 plus 3 stocks Warren Buffett's right-hand man uses to supercharge his finances in tough times"", ""summary"": ""The 99-year-old investing legend has spoken.""}, {""date"": ""20231019063500"", ""headline"": ""Johnson & Johnson Enters Oversold Territory"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019064200"", ""headline"": ""Eli Lilly, Novo among notable decliners in pharma weakness"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019065300"", ""headline"": ""Is Johnson & Johnson Still a Good Dividend Stock to Buy?"", ""summary"": ""Investors wonder if the healthcare giant can keep raising its payout now that it no longer sells the consumer health brands that made it famous.""}, {""date"": ""20231019092218"", ""headline"": ""ChatGPT Stock Advice: 15 Recent Stock Recommendations"", ""summary"": ""In this article, we will take a look at the ChatGPT stock advice: 15 recent stock recommendations. To see more such companies, go directly to ChatGPT Stock Advice: 5 Recent Stock Recommendations. More and more hedge funds are starting to deploy AI for stock picking and financial analysis. And the logic behind this practice is [\u2026]""}, {""date"": ""20231019100900"", ""headline"": ""Big-Name Stock Spinoffs Are Going Mainstream. Here\u2019s Why."", ""summary"": ""Globalization and easier access to capital are encouraging prominent companies to consider spinoffs, writes Allan Sloan.""}, {""date"": ""20231019110219"", ""headline"": ""Kenvue: Very Profitable And Significantly Undervalued"", ""summary"": ""Kenvue is significantly undervalued vs. peers of similar size and with a similar product mix. Find out if now is a good time to buy KVUE stock.""}, {""date"": ""20231019123200"", ""headline"": ""Johnson & Johnson stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Johnson & Johnson slid 0.27% to $152.32 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""20231019134300"", ""headline"": ""Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2023"", ""summary"": ""NEW BRUNSWICK, N.J., October 19, 2023--Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the fourth quarter of 2023 of $1.19 per share on the company\u2019s common stock. The dividend is payable on December 5, 2023 to shareholders of record at the close of business on November 21, 2023. The ex-dividend date is November 20, 2023.""}, {""date"": ""20231019212300"", ""headline"": ""New Dengue Pill from Johnson & Johnson (NYSE:JNJ) Gives Shares a Boost"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020014300"", ""headline"": ""IN BRIEF: J&J's Janssen notes \""promising\"" data for dengue antiviral"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020023458"", ""headline"": ""Wall Street Breakfast Podcast: CVS Pulls Phenylephrine Amid Legal Woes"", ""summary"": ""Drug retailers, makers face mounting litigation over decongestant products. Toyota works out deal with Tesla to adopt NACS charging standard. Jazz Pharmaceutical exploring strategic options.""}, {""date"": ""20231020024800"", ""headline"": ""GLOBAL BROKER RATINGS: DZ likes Roche; Metzler likes Mercedes"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020040000"", ""headline"": ""First pill for dengue shows promise in human challenge trial"", ""summary"": ""A pill for dengue fever developed by Johnson & Johnson appeared to protect against a form of the virus in a handful of patients in a small human challenge trial in the United States, according to data presented by the company on Friday.  There are currently no specific treatments for dengue, a growing disease threat, the company said ahead of presentation of the data at the American Society of Tropical Medicine and Hygiene Annual Meeting in Chicago.  \u201cIt is the first ever to show antiviral activity against dengue,\u201d Marnix Van Loock, who oversees emerging pathogens research for J&J\u2019s Janssen division, said of the drug.""}, {""date"": ""20231020045700"", ""headline"": ""3 Mutual Funds to Invest in for Pro Management and Low Fees"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020051209"", ""headline"": ""Johnson & Johnson: Q3 Earnings Unveils Life After Kenvue Spinoff"", ""summary"": ""Johnson & Johnson reported Q3 earnings with a 6.8% surge in sales, reaching $21.4 billion in revenue. Click here to read my earnings analysis of the JNJ stock.""}, {""date"": ""20231020051400"", ""headline"": ""CVS Health pulls some cough-and-cold treatments with ingredient deemed ineffective by doctors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020053000"", ""headline"": ""Alvotech upgraded at Citi citing FDA nod for biosimilars"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020053300"", ""headline"": ""Janssen announces Phase 3b Week 16 results from Cohort A of VISIBLE trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020072000"", ""headline"": ""Johnson & Johnson shows antiviral effects of dengue pill in mid-stage trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020074100"", ""headline"": ""IN BRIEF: J&J's Tremfya shows positive results in psoriasis study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020095553"", ""headline"": ""Buffett's 6 Dividend Buys For October"", ""summary"": ""The article discusses Warren Buffett's dividend stocks, highlighting the top performers and providing investment insights based on YCharts data. Click here for more.""}, {""date"": ""20231020101854"", ""headline"": ""Medical device makers see limited hit from weight-loss drugs"", ""summary"": ""Intuitive, which makes a surgical robot used in several procedures including bariatrics, said on an earnings call that the U.S. growth rate for weight-loss surgery was slowing as patients consider using the new drugs instead.""}, {""date"": ""20231020123000"", ""headline"": ""Abbott Labs: Fear Is In The Air - That's Why I'm Bullish"", ""summary"": ""Abbott Laboratories reported solid growth across all segments in its third-quarter results, excluding its COVID diagnostics portfolio. Read more here.""}, {""date"": ""20231020123200"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.45% higher to $153.00 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P...""}, {""date"": ""20231020172200"", ""headline"": ""Johnson & Johnson Considers Ditching Texas Two-Step for Third Talc Bankruptcy"", ""summary"": ""The healthcare giant is exploring another bankruptcy and a Supreme Court appeal to try to resolve its mass talc liabilities.""}, {""date"": ""20231021052700"", ""headline"": ""Intuitive Surgical's Revenue Dipped: Is It Time to Sell?"", ""summary"": ""A stagnating top line isn't what investors want to see, but things might not be as bad as the surgical robot specialist's stock price performance would suggest.""}, {""date"": ""20231021062700"", ""headline"": ""These 2 Dow Stocks Moved Markets This Week"", ""summary"": ""When any of the 30 companies that are in the Dow Jones Industrials report their latest financial results, it has the potential to move the entire market.  On Tuesday morning, both Johnson & Johnson (NYSE: JNJ) and Goldman Sachs (NYSE: GS) gave investors their quarterly reports for the third quarter.""}, {""date"": ""20231021090000"", ""headline"": ""2 Attractive High Dividend Yield Buys For Your Dividend Income Portfolio"", ""summary"": ""This week, two additional companies have been added to The Dividend Income Accelerator Portfolio.""}, {""date"": ""20231021100700"", ""headline"": ""2 Warren Buffett Dividend Stocks to Buy and Hold Forever"", ""summary"": ""Famed investor Warren Buffett is known for several things, including his love for dividends and his penchant for companies whose shares he can hold forever.  It's not surprising, then, to find great dividend stocks worth holding on to for good among Berkshire Hathaway's (NYSE: BRK.A) (NYSE: BRK.B) holdings.  Two of the most attractive are Johnson & Johnson (NYSE: JNJ) and Visa (NYSE: V).""}, {""date"": ""20231021110933"", ""headline"": ""Analysts find strength in consumer stocks Hershey, P&G, J&J"", ""summary"": ""Consumer staples is the third worst performing sector this year, but early earnings results show sentiment towards the sector may soon shift.""}, {""date"": ""20231021150000"", ""headline"": ""Bank Bonds That Cut Risk Draw Ares and Blackstone: Credit Weekly"", ""summary"": ""(Bloomberg) -- Banks are reviving the sale of credit-linked notes, a type of synthetic securitization that\u2019s been relatively uncommon in the US since the financial crisis, ahead of new rules that will require them to hold more regulatory capital.Most Read from BloombergCar Owners Fall Behind on Payments at Highest Rate on RecordIsrael Latest: Gaza Air Strikes to Intensify Before \u2018Next Stage\u2019Web Summit CEO Cosgrave Quits After Israel ControversyModerna Shaves Off $7 Billion in Value After Pfizer""}, {""date"": ""20231021222000"", ""headline"": ""Psyched: Jada Pinkett-Smith's Ayahuasca Journey, RIP Dr. Roland Griffiths, Congressional VA Hearings Halted"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231022050300"", ""headline"": ""3 Foundational Blue Chip Dow Dividend Stocks for Building Generational Wealth"", ""summary"": ""When looking at potential dividend stocks, investors often compare dividend yield and a company's track record for increasing its payout.  The Home Depot (NYSE: HD), Johnson & Johnson (NYSE: JNJ), and Chevron (NYSE: CVX) have both of these qualities in abundance.  All three are also components of the Dow Jones Industrial Average (DJINDICES: ^DJI).""}, {""date"": ""20231022065000"", ""headline"": ""Down in the Double Digits, These 2 Classic Warren Buffett Stocks Make Great Buys Now"", ""summary"": ""Warren Buffett has an investing track record anyone would love.  As chairman of Berkshire Hathaway, he's delivered a compounded annual gain of nearly 20% over more than 50 years.  The billionaire has always stood by the same investing principles: Choose solid companies that are undervalued and stick with them for the long term.""}, {""date"": ""20231022093929"", ""headline"": ""11 Best Low-Risk Dividend Stocks To Invest In"", ""summary"": ""In this article, we discuss 11 best low-risk dividend stocks to invest in. You can skip our detailed analysis of dividend stocks and their performance, and go directly to read 5 Best Low-Risk Dividend Stocks To Invest In. American investors are feeling the pain as the fourth quarter begins, following a tough September that dimmed [\u2026]""}, {""date"": ""20231022124400"", ""headline"": ""Retail products giant plans a new bankruptcy filing"", ""summary"": ""The big-name brand openly talked about a potential Chapter 11 filing during its most recent earnings call.""}]","{""assetTurnoverTTM"": 0.4518, ""bookValue"": 71228, ""cashRatio"": 0.15138607167004733, ""currentRatio"": 1.2103, ""ebitPerShare"": 2.0461, ""eps"": 10.2083, ""ev"": 396807.4, ""fcfMargin"": 0.3055, ""fcfPerShareTTM"": 6.5375, ""grossMargin"": 0.7012, ""inventoryTurnoverTTM"": 2.2396, ""longtermDebtTotalAsset"": 0.1569, ""longtermDebtTotalCapital"": 0.2576, ""longtermDebtTotalEquity"": 0.3657, ""netDebtToTotalCapital"": 0.2294, ""netDebtToTotalEquity"": 0.3258, ""netMargin"": 1.2191, ""operatingMargin"": 0.2443, ""payoutRatioTTM"": 0.257, ""pb"": 5.2452, ""peTTM"": 10.7903, ""pfcfTTM"": 23.7404, ""pretaxMargin"": 0.2443, ""psTTM"": 4.4634, ""ptbv"": 10.3185, ""quickRatio"": 0.8634, ""receivablesTurnoverTTM"": 5.4551, ""roaTTM"": 0.1869, ""roeTTM"": 0.471, ""roicTTM"": 0.2997, ""rotcTTM"": 0.1218, ""salesPerShare"": 8.3739, ""sgaToSale"": 0.2988, ""tangibleBookValue"": 36207, ""totalDebtToEquity"": 0.4201, ""totalDebtToTotalAsset"": 0.1802, ""totalDebtToTotalCapital"": 0.2958, ""totalRatio"": 1.7511, ""period"": ""2023-10-01""}"
41,2023-10-22,148.30712890625,2023-10-29,141.13412475585938,-0.04836587562102246,D5,"[{""date"": ""20231021222000"", ""headline"": ""Psyched: Jada Pinkett-Smith's Ayahuasca Journey, RIP Dr. Roland Griffiths, Congressional VA Hearings Halted"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231022050300"", ""headline"": ""3 Foundational Blue Chip Dow Dividend Stocks for Building Generational Wealth"", ""summary"": ""When looking at potential dividend stocks, investors often compare dividend yield and a company's track record for increasing its payout.  The Home Depot (NYSE: HD), Johnson & Johnson (NYSE: JNJ), and Chevron (NYSE: CVX) have both of these qualities in abundance.  All three are also components of the Dow Jones Industrial Average (DJINDICES: ^DJI).""}, {""date"": ""20231022065000"", ""headline"": ""Down in the Double Digits, These 2 Classic Warren Buffett Stocks Make Great Buys Now"", ""summary"": ""Warren Buffett has an investing track record anyone would love.  As chairman of Berkshire Hathaway, he's delivered a compounded annual gain of nearly 20% over more than 50 years.  The billionaire has always stood by the same investing principles: Choose solid companies that are undervalued and stick with them for the long term.""}, {""date"": ""20231022093929"", ""headline"": ""11 Best Low-Risk Dividend Stocks To Invest In"", ""summary"": ""In this article, we discuss 11 best low-risk dividend stocks to invest in. You can skip our detailed analysis of dividend stocks and their performance, and go directly to read 5 Best Low-Risk Dividend Stocks To Invest In. American investors are feeling the pain as the fourth quarter begins, following a tough September that dimmed [\u2026]""}, {""date"": ""20231022124400"", ""headline"": ""Retail products giant plans a new bankruptcy filing"", ""summary"": ""The big-name brand openly talked about a potential Chapter 11 filing during its most recent earnings call.""}, {""date"": ""20231023002800"", ""headline"": ""J&J MedTech head stepping down in wake of lower-than-expected sales"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231023030300"", ""headline"": ""J&J report slew of positive trial results focused on various cancers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231023031600"", ""headline"": ""Cantor Fitzgerald Keeps Their Buy Rating on Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231023034900"", ""headline"": ""Quanterix announces new agreement to advance blood-based Alzheimer's detection"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231023040800"", ""headline"": ""IN BRIEF: J&J sees positive results for Tremfya in ulcerative colitis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231023050200"", ""headline"": ""See Which Of The Latest 13F Filers Holds Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231023053700"", ""headline"": ""Janssen says Rybrevant combination study showed 30% risk reduction"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231023090010"", ""headline"": ""Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It"", ""summary"": ""Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.""}, {""date"": ""20231023101000"", ""headline"": ""Charles River (CRL) Offers Access to Preclinical Cancer Research"", ""summary"": ""Charles River (CRL) contributes to 84 percent of the FDA-approved cancer medicines and provides partners with 16 oncology prospects.""}, {""date"": ""20231023120745"", ""headline"": ""Cantor Fitzgerald Reiterates Johnson & Johnson (JNJ) Overweight Recommendation"", ""summary"": """"}, {""date"": ""20231023121100"", ""headline"": ""Big name brand plans a new bankruptcy filing"", ""summary"": ""The company, which has tried to file Chapter 11 through its LTL Management affiliate but was denied by a bankruptcy court in New Jersey, has a new plan to resolve its massive liabilities.  This case has nothing to do with Johnson & Johnson's ongoing operations.""}, {""date"": ""20231023123200"", ""headline"": ""Johnson & Johnson stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slid 1.05% to $151.39 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""20231023161500"", ""headline"": ""Johnson & Johnson Announces Departure of Ashley McEvoy, Tim Schmid Named Executive Vice President, Worldwide Chairman of MedTech"", ""summary"": ""NEW BRUNSWICK, N.J., October 23, 2023--Johnson & Johnson (NYSE: JNJ) (the Company) announced today that Ashley McEvoy, Executive Vice President, Worldwide Chairman of MedTech, informed the company on October 20, 2023, that she is stepping down from her position to pursue other opportunities. Ms. McEvoy will remain with the Company into Q1 2024 to support a successful transition. Tim Schmid has been appointed Executive Vice President, Worldwide Chairman of MedTech, joining the Company\u2019s Executive""}, {""date"": ""20231024015000"", ""headline"": ""Johnson & Johnson inks licensing deal with Quanterix for Alzheimer's testing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231024015700"", ""headline"": ""Johnson & Johnson\u2019s Stock: A Stable Transition and Promising Future Despite Leadership Change"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231024044400"", ""headline"": ""VTV: A Great ETF for Value Investors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231024044500"", ""headline"": ""VTV: A Must-Watch ETF for Value Investors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231024052100"", ""headline"": ""2 Historically Cheap Dow Dividend Kings That Are Ripe for the Picking"", ""summary"": ""These inexpensive Dow components have achieved royalty status among income stocks -- more than 60 consecutive years of dividend increases.""}, {""date"": ""20231024053000"", ""headline"": ""The Best Stocks to Invest $5,000 In Right Now"", ""summary"": ""Vertex Pharmaceuticals (NASDAQ: VRTX) brings you a solid track record of growth -- plus potential for more ahead.  The company is testing a new CF treatment in phase 3 studies that may even beat Trikafta, paving the way for Vertex to hold onto its leadership at least until the late 2030s.  Meanwhile, Vertex may be about to launch its first potential blockbuster beyond CF.""}, {""date"": ""20231024074500"", ""headline"": ""3 High-Yielding Dividend Stocks Near Their 52-Week Lows"", ""summary"": ""Due to their declining share prices, Johnson & Johnson, Bank of America, and Target all yield more than 3% right now.""}, {""date"": ""20231024123200"", ""headline"": ""Johnson & Johnson stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slipped 0.11% to $151.23 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20231024141400"", ""headline"": ""Johnson & Johnson Stock Skirts a 52-Week Low. Here\u2019s What\u2019s Ailing Healthcare."", ""summary"": ""Shares of  Johnson & Johnson  approached a 52-week low Tuesday, just over a week after the drugmaker reported better than expected third-quarter financial results and raised its forecast for full-year earnings.  Johnson & Johnson  (ticker: JNJ) has entirely given up the gains it clocked in the first half of the year, when shares climbed from $150.11 in late March to $174.01 in late August.  More than one malady has struck the healthcare sector, and there\u2019s no panacea in sight.""}, {""date"": ""20231024173437"", ""headline"": ""Dividend Capture Strategy: 10 High Yield Stocks To Buy in November"", ""summary"": ""In this article, we discuss dividend capture strategy and high yield stocks to buy in November. You can skip our detailed analysis of the dividend capture approach and the performance of dividend stocks, and go directly to read Dividend Capture Strategy: 5 High Yield Stocks To Buy in November. Investing in dividend stocks is easier [\u2026]""}, {""date"": ""20231024211800"", ""headline"": ""Positive Prospects for Johnson & Johnson: Buy Rating Assigned Due to Superior Performance of Rybrevant in MARIPOSA Trials"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231024230000"", ""headline"": ""Bond Yields May Have Peaked. Consider These Stocks."", ""summary"": ""Bond yields may have peaked, making a host of stocks look attractive.""}, {""date"": ""20231025051900"", ""headline"": ""2 Exceptional Dividend Stocks Near 52-Week Lows. Are They Bargains Now?"", ""summary"": ""This hasn't been a sensational year for the dividend stocks already in investors' portfolios, but you could hardly pick a better time to be a buyer.  The risk-free returns institutional investors can receive from long-term Treasuries have risen to levels we haven't seen since before the global financial crisis kicked off about 15 years ago.  While higher interest rates are wreaking havoc on stock prices, they won't unravel the competitive advantages that allow these companies to consistently outperform.""}, {""date"": ""20231025061500"", ""headline"": ""The 7 Best Forever Stocks to Buy for October 2023"", ""summary"": ""Navigating the thunderstorm of fluctuating markets, savvy investors anchor their portfolios with the best forever stocks. These stocks have proven resilient in the face of economic uncertainties and continue to flourish amid influential megatrends. These paragons of consistency boast tremendous histories of relentless expansion rooted in sectors indispensable to our daily grind. What sets them apart is a formidable moat, be it robust brand equity, cutting-edge technology, or potent network effec""}, {""date"": ""20231025073000"", ""headline"": ""Here's what Wall Street is saying about IBM ahead of earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231025074500"", ""headline"": ""Cantor biotech/biopharma analysts hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231025123100"", ""headline"": ""Johnson & Johnson stock underperforms Wednesday when compared to competitors despite daily gains"", ""summary"": ""Shares of Johnson & Johnson inched 0.22% higher to $151.57 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the...""}, {""date"": ""20231025160404"", ""headline"": ""Dow Jones Bear Market: 3 Cheap Stocks to Buy Now"", ""summary"": ""The stock market has entered a slump. The Federal Reserve continues its campaign to limit inflation. In doing so, interest rates have soared which is likely to hurt the housing market and consumer spending. Given the uncertainty, investors have been trimming positions in vulnerable stocks. The sell-off, however, is creating an opportunity. Particularly for these three cheap Dow Jones stocks to buy, the current economic headwinds are setting up an excellent buy-the-dip situation. Johnson & Johnso""}, {""date"": ""20231026001900"", ""headline"": ""TOP NEWS: GSK subsidiary ViiV receives HIV drug approval in China"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231026012700"", ""headline"": ""ViiV Healthcare receives approval from NMPA of China for Vocabria with Rekambys"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231026025300"", ""headline"": ""Kenvue\u2019s stock slides premarket as company reports slow start to flu and cold season"", ""summary"": ""Kenvue Inc.\u2019s stock fell 2.4% in premarket trade Thursday, after the company posted in-line third-quarter earnings but tightened its full-year guidance after...""}, {""date"": ""20231026030500"", ""headline"": ""The Passive Income Snowball Path To Wealth: VYM Vs. DGRW"", ""summary"": ""WisdomTree US Quality Dividend Growth ETF and Vanguard High Dividend Yield ETF are 2 popular dividend growth ETFs. Read our take on which is the better buy right now.""}, {""date"": ""20231026054500"", ""headline"": ""Cantor biotech/biopharma analyst to hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231026064350"", ""headline"": ""UPDATE 2-Kenvue cuts annual profit forecast on soft demand for cold, flu medicines"", ""summary"": ""Kenvue on Thursday cut the higher end of its annual profit forecast, as Benadryl maker saw weakness in demand for its cold and flu medicines and an increased impact from a stronger dollar.  The consumer health company said its third-quarter net sales were hurt by a slow start to the flu season and soft demand for its products in China.  Kenvue, the spun-off unit of Johnson & Johnson, said it expects full-year organic sales growth between 5.5% and 6%, compared with its prior forecast of 5.5% to 6.5% growth.""}, {""date"": ""20231026073000"", ""headline"": ""3 Pharma Stocks That Are Screaming Buys in October"", ""summary"": ""It hasn't been the easiest of years for Johnson & Johnson (NYSE: JNJ), Amgen (NASDAQ: AMGN) and Gilead Sciences (NASDAQ: GILD).  Continued uncertainty regarding talc lawsuits is weighing on Johnson & Johnson.  Amgen's huge pipeline hasn't been fully appreciated by the market, and Gilead's settlement of an antitrust lawsuit resulted in lowering yearly earnings per share guidance.""}, {""date"": ""20231026074500"", ""headline"": ""2 Magnificent Dividend Stocks That Could Deliver a Lifetime of Passive Income"", ""summary"": ""High-quality dividend stocks are always worth loading up on.  This is doubly true for companies that offer shareholders an attractive mix of reliable income and reasonable levels of growth.  With risk-free assets, like the 10-year Treasury note, offering a near 5% yield, dividend stocks have generally underperformed growth plays in 2023.""}, {""date"": ""20231026123100"", ""headline"": ""Johnson & Johnson stock falls Thursday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slid 1.70% to $149.00 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""20231026132152"", ""headline"": ""3 Stocks to Buy (and Never Ever Sell)"", ""summary"": ""Investors have seen it all in the past three years: a pandemic, lockdown, supply chain issues, inflation, war and high interest rates. The market has shown high volatility and put investors in a state where they are only looking to invest in stocks that have already proven themselves and can survive through market turmoil. The best way to do this is to find forever stocks that have strong fundamentals, proven track records and a solid history. This will ensure that they continue to grow, no matt""}, {""date"": ""20231026212000"", ""headline"": ""Goldman Sachs Reaffirms Their Sell Rating on Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231026221700"", ""headline"": ""Is Ozempic Killing Liposuction? A Stock That Could Get Hit Hard From New Weight-Loss Drugs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231027033500"", ""headline"": ""10 High-Yield Dividend Aristocrats Perfect For What's Coming Next"", ""summary"": ""Investors are worried about soaring interest rates, a pending government shutdown, wars around the world, and a recession looming next year. Read more here.""}, {""date"": ""20231027042600"", ""headline"": ""SNY Stock Sinks 15% as Sanofi Plans Consumer Unit Spinoff"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231027043100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Universal Health (UHS), Insmed (INSM) and Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231027053200"", ""headline"": ""FDA Gives Nod To Eli Lilly's First Treatment For Type Of Inflammatory Bowel Disease, To Compete With JNJ, Pfizer, AbbVie"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231027055300"", ""headline"": ""Chevron, JPMorgan Chase share losses lead Dow's 100-point drop"", ""summary"": ""Behind negative returns for shares of Chevron and JPMorgan Chase, the Dow Jones Industrial Average is falling Friday morning. Shares of Chevron and JPMorgan...""}, {""date"": ""20231027082700"", ""headline"": ""Dow down nearly 200 points on losses for shares of Chevron, Verizon"", ""summary"": ""Shares of Chevron and Verizon are trading lower Friday afternoon, dragging the Dow Jones Industrial Average into negative territory. The Dow was most...""}, {""date"": ""20231027083900"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231027105100"", ""headline"": ""AbbVie (ABBV) Q3 Earnings Beat, Shares Down Despite Raised View"", ""summary"": ""AbbVie's (ABBV) third-quarter 2023 earnings and sales beat estimates. Though the company raised its EPS outlook for both 2023 and 2024, share price dives as some key drugs misses out on estimates.""}, {""date"": ""20231027123200"", ""headline"": ""Johnson & Johnson stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slipped 2.28% to $145.60 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""20231027173424"", ""headline"": ""UPDATE 1-J&J says DoJ seeking information related to eye products in civil investigation"", ""summary"": ""Johnson & Johnson disclosed on Friday that the U.S. Department of Justice (DOJ) in July had sought documents and information related to the drugmaker's free and discounted eye surgery products in connection with a civil investigation.  The company said it had begun complying with the DoJ's civil investigative demands.  J&J said it is in ongoing discussion with DOJ regarding the inquiry.""}, {""date"": ""20231027220300"", ""headline"": ""The Johnson & Johnson (JNJ) Company: A Short SWOT Analysis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231028050000"", ""headline"": ""Have $500? 2 Absurdly Cheap Stocks Long-Term Investors Should Buy Right Now"", ""summary"": ""Coca-Cola (NYSE: KO) is the world's largest non-alcoholic beverage company, selling drinks in more than 200 countries, but this leader still is growing.  In the most recent quarter, Coca-Cola's case volume, total revenue, and earnings per share all advanced -- and the company now expects to deliver full-year revenue growth in the double digits.  History has shown you can count on Coca-Cola's brand strength to keep customers coming back to its eponymous drink and its other popular products, such as Minute Maid juices and Dasani water.""}, {""date"": ""20231028050300"", ""headline"": ""Got $2,500? 2 Top Stocks That You Can Buy and Hold for a Lifetime"", ""summary"": ""The average holding period is less than a year.  This short-term mindset is unfortunate because frequently trading in and out of stocks can eat into investors' long-term returns by locking in losses and increasing taxes.  Holding a high-quality company long term enables investors to capitalize on its ability to compound shareholder value.""}, {""date"": ""20231029070500"", ""headline"": ""Pharma, PBMs spar over rising drug costs amid public scrutiny"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231029173506"", ""headline"": ""14 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds"", ""summary"": ""In this article, we discuss the 14 most undervalued healthcare stocks to buy according to hedge funds. To skip the detailed analysis of the healthcare industry, go directly to the 5 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds. The indispensable nature of the healthcare industry makes it an ever-growing industry. According to [\u2026]""}]",{}
42,2023-10-29,141.13412475585938,2023-11-05,146.69805908203125,0.039423026399863614,U4,"[{""date"": ""20231029070500"", ""headline"": ""Pharma, PBMs spar over rising drug costs amid public scrutiny"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231029173506"", ""headline"": ""14 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds"", ""summary"": ""In this article, we discuss the 14 most undervalued healthcare stocks to buy according to hedge funds. To skip the detailed analysis of the healthcare industry, go directly to the 5 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds. The indispensable nature of the healthcare industry makes it an ever-growing industry. According to [\u2026]""}, {""date"": ""20231030005100"", ""headline"": ""Analysts Are Bullish on Top Healthcare Stocks: Arcellx Inc (ACLX), Biogen (BIIB)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231030020200"", ""headline"": ""Johnson & Johnson: An Exploration into Its Intrinsic Value"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231030050000"", ""headline"": ""The Litigation Joker In Johnson & Johnson's Deck"", ""summary"": ""Johnson & Johnson, America's oldest and bluest chip corporation, is facing significant recurring litigation troubles. Explore more details here.""}, {""date"": ""20231030050600"", ""headline"": ""Warren Buffett's $690 Million Secret Portfolio Is Buying 3 Historically Cheap Stocks"", ""summary"": ""The Oracle of Omaha's under-the-radar investment portfolio is buying shares of three industry-leading businesses.""}, {""date"": ""20231030052541"", ""headline"": ""11 Best Immunotherapy Stocks To Buy Now"", ""summary"": ""In this article, we discuss 11 of the best immunotherapy stocks to buy now. If you want to skip our detailed discussion on the cancer and oncology industry, head directly to the 5 Best Immunotherapy Stocks To Buy Now. The global oncology landscape is continually transforming, driven by persistent efforts to explore, create, and deliver [\u2026]""}, {""date"": ""20231030054635"", ""headline"": ""11 Best Pharma Stocks To Buy Now"", ""summary"": ""In this article, we discuss the 12 best pharma stocks to buy now. You can skip our detailed analysis of the pharmaceutical sector and its outlook this year, and go directly to read the 5 Best Pharma Stocks To Buy Now. Shortly following the onset of the COVID-19 pandemic, it became evident that the world [\u2026]""}, {""date"": ""20231030055000"", ""headline"": ""Nearly 70% of Warren Buffett's $326 Billion Portfolio Is Invested in These 9 Megacap Stocks"", ""summary"": ""Warren Buffett thinks big.  It's not surprising that he has led Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) to put a lot of money into some of the biggest companies on the planet.  Nearly 70% of Buffett's $326 billion Berkshire portfolio is invested in these nine megacap stocks.""}, {""date"": ""20231030061112"", ""headline"": ""11 Best November Dividend Stocks To Buy"", ""summary"": ""In this article, we discuss 11 best November dividend stocks to buy. You can skip our detailed analysis of dividend stocks and their performance over the past years, and go directly to read 5 Best November Dividend Stocks To Buy. Dividend-paying stocks have been a preferred choice among investors for quite some time. They offer [\u2026]""}, {""date"": ""20231030080500"", ""headline"": ""Is This Year-End Rally, Like Waiting For Godot?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231030084200"", ""headline"": ""Cancer Victims Support Sen. Richard Blumenthal in Urging Johnson & Johnson to Accept Responsibility"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231030101442"", ""headline"": ""13 Best Warren Buffett Stock Picks for Beginners"", ""summary"": ""In this article, we discuss the 13 best Warren Buffett stock picks for beginners. To skip reading Warren Buffett\u2019s investment strategy and Q2 bets of Berkshire Hathaway, go directly to the 5 Best Warren Buffett Stock Picks for Beginners. The Oracle of Omaha, Warren Buffett, might not be the wealthiest man in the world, but [\u2026]""}, {""date"": ""20231030123200"", ""headline"": ""Johnson & Johnson stock rises Monday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.98% higher to $147.03 Monday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""20231030154552"", ""headline"": ""Western Digital Shares Soar as Company Splits Off Flash Memory Business"", ""summary"": ""Shares of Western Digital Corp. (WDC) surged more than 10% in early trading Monday before giving back gains, after the company said it would spin off its flash memory business into a separate company.""}, {""date"": ""20231030213100"", ""headline"": ""Analysts Conflicted on These Healthcare Names: Johnson & Johnson (JNJ), Boston Scientific (BSX) and PTC Therapeutics (PTCT)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231030233557"", ""headline"": ""PPH: A 'Shot In The Arm' For Investors Looking To Capitalize On Recent Pharmaceutical Advances"", ""summary"": ""VanEck Pharmaceutical Fund has had the strongest one-year performance of four major pharmaceutical ETF competitors. Read why I rate PPH ETF a Buy.""}, {""date"": ""20231031011359"", ""headline"": ""Is Johnson & Johnson Stock Worth Buying Following Q3 2023 Earnings?"", ""summary"": ""Johnson & Johnson's management raised its financial guidance for full-year 2023. Read why we continue upgrading JNJ stock to Outperform from Hold for next 12 months.""}, {""date"": ""20231031020900"", ""headline"": ""GSK, Arrowhead announce deal with Janssen for rights to JNJ-3989"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031053700"", ""headline"": ""GSK inks $1B deal to obtain rights to hepatitis B drug from J&J"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031060800"", ""headline"": ""Johnson & Johnson Offloads Rights For Hepatitis B Candidate To GSK"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031075704"", ""headline"": ""Ozempic, Wegovy, and other weight loss drugs\u2019 real business impact"", ""summary"": ""The potential of weight loss drugs is too appetizing for Wall Street to pass up. But they may not have the doomsday effect on food and health as some feared.""}, {""date"": ""20231031083009"", ""headline"": ""UPDATE 1-GSK to pay $1 bln for exclusive license to J&J's hepatitis B therapy"", ""summary"": ""GSK will pay about $1 billion for exclusive rights to further develop and commercialize Johnson & Johnson's hepatitis B therapy, the British drugmaker said on Tuesday.  JNJ-3989 was initially developed by Arrowhead Pharmaceuticals and licensed to Johnson & Johnson-owned Janssen in 2018.  Exclusive rights to the therapy will fuel the expansion of GSK's own hepatitis B treatment, bepirovirsen, which is currently in late-stage development, the company said.""}, {""date"": ""20231031123200"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.89% higher to $148.34 Tuesday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""20231101013900"", ""headline"": ""Amgen cleared in U.S. to market biosimilar to J&J\u2019s Stelara"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231101074400"", ""headline"": ""Can Kenvue Be a Reliable Dividend Stock to Hold for the Long Haul?"", ""summary"": ""Kenvue's operations are diverse, boasting many strong brands. Is that enough to make this a solid dividend stock to own?""}, {""date"": ""20231101101200"", ""headline"": ""3 Dividend Kings Whose Growth Streaks Could Break Before 2030"", ""summary"": ""Investors should be careful with these high-yielding dividend stocks, as they aren't as safe as they may have been even a few years ago.""}, {""date"": ""20231101123200"", ""headline"": ""Johnson & Johnson stock rises Wednesday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.24% higher to $148.69 Wednesday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""20231101143100"", ""headline"": ""Chart of the Day: Is This Bullpen Name Ready for a Call-Up?"", ""summary"": ""Johnson & Johnson  has been in the Action Alerts PLUS Bullpen for awhile now.  As one of the biggest pharmaceutical names in the world with great brand recognition, research/development and tremendous sales growth, Johnson & Johnson has our attention.  While the company still does tremendous business in drugs and medical devices, its famous consumer brands are now part of Kenvue  , a recent spinoff that includes the company's former consumer products.""}, {""date"": ""20231101161924"", ""headline"": ""Unusual Put Option Trade in Johnson & Johnson (JNJ)  Worth $4,108.00K"", ""summary"": """"}, {""date"": ""20231101212900"", ""headline"": ""EXCLUSIVE: Roundhill Launches Dividend Kings ETF With 'The Gold Standard Of Dividend Growers,' Companies With 'Incredible Resilience'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231101220300"", ""headline"": ""Amgen Wins Big With FDA, Analyst Sees Soaring Potential"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102015300"", ""headline"": ""Johnson & Johnson Stock (NYSE:JNJ): Time to Buy the Dip?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102040000"", ""headline"": ""New Biosense Webster QDOT MICRO\u2122 Catheter Data Demonstrate Very High-Power, Short-Duration Ablations Improved Quality of Life and Reduced Healthcare Utilization for AFib Patients"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102042700"", ""headline"": ""Vor Bio announces clinical data on treating AML to be presented at ASH meeting"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102050000"", ""headline"": ""Pfizer: Value Investment Opportunity After Recent Price Decline"", ""summary"": ""Pfizer still generates significant gross profit and has a strong revenue growth rate. Read why I feel PFE stock presents a value investment opportunity now.""}, {""date"": ""20231102075000"", ""headline"": ""Looking Into Johnson & Johnson's Recent Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102082709"", ""headline"": ""Smith+Nephew plays down concerns about weight-loss drugs"", ""summary"": ""British medical products maker Smith+Nephew said weight-loss drugs could help previously ineligible overweight patients get approval for joint replacement surgery, playing down concerns about the impact of the new therapies on its business.  that healthcare companies, including Smith+ Nephew that treat obese and overweight patients for knee-related issues, will be hurt by powerful new obesity drugs known as GLP-1s like Novo Nordisk's Wegovy.  \""As patients presumably benefit from GLP-1, you could actually see some of these patients who are previously ineligible for joint replacement become eligible for that surgery,\"" CEO Deepak Nath told Reuters in an interview.""}, {""date"": ""20231102123200"", ""headline"": ""Johnson & Johnson stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson rose 1.04% to $150.24 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20231102131400"", ""headline"": ""Johnson & Johnson's Long-Term Charts Got a Boo-boo"", ""summary"": ""Johnson & Johnson  is a household name and I used to live near its corporate headquarters.  The company is a major employer in New Jersey, and a member of the Dow Jones industrial average, with a 2.94% weight at the moment.  The Moving Average Convergence Divergence (MACD) oscillator has been correcting to the downside since early 2021 and is below the zero line.""}, {""date"": ""20231102151800"", ""headline"": ""Key Lawyer in Johnson & Johnson Talc Litigation Supports Call to Rethink Legal Strategies in Light of Failure of Texas Two-Step"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231103050000"", ""headline"": ""3 Healthcare Stocks to Buy Hand Over Fist in November"", ""summary"": ""Biotech CRISPR Therapeutics (NASDAQ: CRSP) may soon score its first product approval.  Healthcare giants Johnson & Johnson (NYSE: JNJ) and Medtronic (NYSE: MDT) have increased earnings over time -- and they've both gone through recent transformations that should spur growth in the coming quarters.  CRISPR Therapeutics might soon reach a major milestone.""}, {""date"": ""20231103084256"", ""headline"": ""The 3 Best Forever Stocks to Buy in November"", ""summary"": ""Anytime you bring up the concept of \u201cforever stocks,\u201d you\u2019re running the risk of incurring a serious tail risk. Obviously, forever is a long time \u2013 long enough for something to go wrong. Still, certain entities stand out because they basically command permanent relevance. To be sure, my ideas for forever stocks are boring \u2013 there\u2019s no way getting around that. And while I could elect some spicier enterprises, here\u2019s the problem: I just don\u2019t know if such entities would be around for the long haul""}, {""date"": ""20231103090010"", ""headline"": ""Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.""}, {""date"": ""20231103123200"", ""headline"": ""Johnson & Johnson stock rises Friday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.73% higher to $151.34 Friday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""20231104050000"", ""headline"": ""5 Relatively Secure And Cheap Dividend Stocks To Invest In - November 2023"", ""summary"": ""This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering large discounts to their historical norms. Read more here.""}, {""date"": ""20231104053000"", ""headline"": ""Looking for a Lifetime of Passive Income? 2 Top Dividend Stocks to Buy and Hold Forever"", ""summary"": ""Dividend stocks are great because they offer you payments no matter how they perform -- and no matter how the market performs.  High levels of free cash flow, paired with a reasonable cash dividend payout ratio, suggest the company can afford to make these payouts and even lift its dividend.  AbbVie (NYSE: ABBV) formed in 2013 when it split from healthcare giant Abbott Laboratories.""}, {""date"": ""20231104225400"", ""headline"": ""Pharmacy Workers Strike At CVS and Walgreens, Echoing Wider Pharma Sector Unrest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231105070600"", ""headline"": ""Compass Pathways: Private Placement Buys Less Time Than Expected"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231105082400"", ""headline"": ""Beloved, albeit controversial brand back from bankruptcy brink"", ""summary"": ""The beloved institution filed for bankruptcy in 2020 after over 80,000 men made claims that they were sexually abused while they were Boy Scouts.  A court allowed the BSA to keep operating while it reached a $2.4 billion settlement deal that will include payment to most who claimed abuse.  \""This is a significant milestone for the BSA as we emerge from a three-year financial restructuring process with a global resolution approved with overwhelming support of more than 85% of the survivors involved in the case,\"" said then-CEO Roger Mosby.""}, {""date"": ""20231105125700"", ""headline"": ""Beloved brand back from Chapter 11 bankruptcy brink"", ""summary"": ""The beloved institution filed for bankruptcy in 2020 after over 80,000 men made claims that they were sexually abused while they were Boy Scouts.  A court allowed the BSA to keep operating while it reached a $2.4 billion settlement deal that will include payment to most who claimed abuse.  \""This is a significant milestone for the BSA as we emerge from a three-year financial restructuring process with a global resolution approved with overwhelming support of more than 85% of the survivors involved in the case,\"" said then-CEO Roger Mosby.""}]",{}
43,2023-11-05,146.69805908203125,2023-11-12,142.73350524902344,-0.027025264395562965,D3,"[{""date"": ""20231104225400"", ""headline"": ""Pharmacy Workers Strike At CVS and Walgreens, Echoing Wider Pharma Sector Unrest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231105070600"", ""headline"": ""Compass Pathways: Private Placement Buys Less Time Than Expected"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231105082400"", ""headline"": ""Beloved, albeit controversial brand back from bankruptcy brink"", ""summary"": ""The beloved institution filed for bankruptcy in 2020 after over 80,000 men made claims that they were sexually abused while they were Boy Scouts.  A court allowed the BSA to keep operating while it reached a $2.4 billion settlement deal that will include payment to most who claimed abuse.  \""This is a significant milestone for the BSA as we emerge from a three-year financial restructuring process with a global resolution approved with overwhelming support of more than 85% of the survivors involved in the case,\"" said then-CEO Roger Mosby.""}, {""date"": ""20231105125700"", ""headline"": ""Beloved brand back from Chapter 11 bankruptcy brink"", ""summary"": ""The beloved institution filed for bankruptcy in 2020 after over 80,000 men made claims that they were sexually abused while they were Boy Scouts.  A court allowed the BSA to keep operating while it reached a $2.4 billion settlement deal that will include payment to most who claimed abuse.  \""This is a significant milestone for the BSA as we emerge from a three-year financial restructuring process with a global resolution approved with overwhelming support of more than 85% of the survivors involved in the case,\"" said then-CEO Roger Mosby.""}, {""date"": ""20231105210300"", ""headline"": ""J&J\u2019s patent win against Viatris referred back to lower court"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231105220200"", ""headline"": ""The doctor lowering drug prices for 1 million patients, with help from Mark Cuban, Sam Altman \u2013 and Martin Shkreli"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231106035700"", ""headline"": ""Mind-altering ketamine becomes latest pain treatment, despite little research or regulation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231106035700"", ""headline"": ""Mind-altering ketamine becomes new pain treatment, despite little research or regulation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231106063700"", ""headline"": ""J&J links radiofrequency catheter to improved quality of life in atrial fibrillation study"", ""summary"": ""Scores on a quality-of-life scale improved and use of antiarrhythmic drugs fell after people underwent treatment with the device.""}, {""date"": ""20231106084531"", ""headline"": ""Quanterix Corporation: Going For Three In A Row"", ""summary"": ""Learn about Quanterix Corporation, a life sciences company with strong financials, positive quarterly results, and insider buying. Click here for more on QTRX.""}, {""date"": ""20231106104453"", ""headline"": ""IHE: You Better Like Eli Lilly And Johnson & Johnson To Buy This"", ""summary"": ""The iShares U.S. Pharmaceuticals ETF offers targeted exposure to the pharmaceutical industry with a concentrated portfolio. Read more about IHE here.""}, {""date"": ""20231106112812"", ""headline"": ""November Dogs Of The Dow: 3 Buyable, 4 Watchable"", ""summary"": ""Learn about the Dow Jones Industrial Average and the top-performing stocks in November. Click to see our exclusive list of dividend stocks we consider buyable now.""}, {""date"": ""20231106113200"", ""headline"": ""Johnson & Johnson stock underperforms Monday when compared to competitors despite daily gains"", ""summary"": ""Shares of Johnson & Johnson inched 0.24% higher to $151.70 Monday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""20231106133058"", ""headline"": ""Long-Term Winners: Ray Dalio\u2019s Top 3 Stock Recommendations for a Prosperous Future"", ""summary"": ""Amid the intricacies in the investment realm, Ray Dalio stock picks continue to resonate with both budding and seasoned investors. Since he stepped down from active leadership at Bridgewater Associates, Dalio, with his wealth of experience and visionary outlook, has continued to guide its strategy from the boardroom. His recent warnings about an overbought U.S. stock market after its bull run in the first half of the year shouldn\u2019t be ignored. Citing political and economic risks, he paints a pic""}, {""date"": ""20231106160200"", ""headline"": ""Controversial brand back, survives Chapter 11 bankruptcy"", ""summary"": ""The beloved institution filed for bankruptcy in 2020 after over 80,000 men made claims that they were sexually abused while they were Boy Scouts.  A court allowed the BSA to keep operating while it reached a $2.4 billion settlement deal that will include payment to most who claimed abuse.  \""This is a significant milestone for the BSA as we emerge from a three-year financial restructuring process with a global resolution approved with overwhelming support of more than 85% of the survivors involved in the case,\"" said then-CEO Roger Mosby.""}, {""date"": ""20231107031000"", ""headline"": ""Johnson & Johnson to seek FDA nod to trial general surgery robot in H2 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231107032200"", ""headline"": ""Morning Brew: Johnson & Johnson's Ottava Delay, Uber's Q3 Miss, and Intel's Foundry Business"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231107053700"", ""headline"": ""2 Magnificent Dividend Stocks Trading Near 52-Week Lows to Buy Now and Hold at Least a Decade"", ""summary"": ""Taking advantage of the discounted prices these stocks have been trading at could do wonders for your passive income stream.""}, {""date"": ""20231107065400"", ""headline"": ""J&J targets 2024 for Ottava FDA filing"", ""summary"": ""The company expects to file a submission for an\u00a0investigational device exemption\u00a0in the second half of 2024 that will allow it to begin clinical trials for the robotic surgery system.""}, {""date"": ""20231107082823"", ""headline"": ""High Yield Stock Watchlist - November 2023"", ""summary"": ""The majority of the 22 stocks on my high yield watchlist for November 2023 are undervalued based on dividend yield theory. Click here for the complete list.""}, {""date"": ""20231107113200"", ""headline"": ""Johnson & Johnson stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slumped 0.53% to $150.90 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20231107140624"", ""headline"": ""ESSA Pharma: Unique N-Terminal Domain Approach Might Hinder mCRPC Resistance"", ""summary"": ""ESSA's EPI-7386 shows promise in treating advanced prostate cancer, with positive PSA data presented. Read my analysis of EPIX stock here.""}, {""date"": ""20231107231300"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Bluebird Bio (BLUE), Biogen (BIIB) and Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231107232118"", ""headline"": ""5 Kings And Aristocrats Selling At Decade High Dividend Yields"", ""summary"": ""Long-duration US Treasuries may not be a good investment. Find out a better alternative to buying long duration government debt.""}, {""date"": ""20231108003000"", ""headline"": ""Johnson & Johnson\u2019s Growth Potential: Ottava Robotic System and Untapped General Surgery Robotics Market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231108014100"", ""headline"": ""Grab these 2 funds with rich 11%-12% yields while you can"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231108023800"", ""headline"": ""Jim Cramer Asks Why The World's Largest Healthcare Products Company Has 'An Ill-Advised Strategy'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231108062800"", ""headline"": ""IN BRIEF: J&J reports positive data for arthritis treatment, Tremfya"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231108072300"", ""headline"": ""Bausch + Lomb: Not A Good Time To Buy (Rating Downgrade)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231108094500"", ""headline"": ""3 Brilliant Artificial Intelligence Stocks to Buy and Hold Forever"", ""summary"": ""Healthcare stocks are widely expected to be a prime beneficiary of the AI revolution. These three names could be the best of the bunch.""}, {""date"": ""20231108111000"", ""headline"": ""Pharma ETFs in Focus Post Q3 Earnings"", ""summary"": ""Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.""}, {""date"": ""20231108113200"", ""headline"": ""Johnson & Johnson stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Johnson & Johnson slid 0.36% to $150.35 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""20231108145348"", ""headline"": ""15 Best American Dividend Stocks To Buy Now"", ""summary"": ""In this article, we discuss 15 best American dividend stocks to buy now. You can skip our detailed analysis of dividend stocks and their previous performance, and go directly to read 5 Best American Dividend Stocks To Buy Now. In the third quarter of this year, the U.S. economy expanded at a rate of 4.9% [\u2026]""}, {""date"": ""20231109033100"", ""headline"": ""7 Safe Stocks to Buy if You Think Q3\u2019s Gangbuster Growth Won\u2019t Last"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231109040639"", ""headline"": ""11 Best S&P 500 Stocks To Buy According to Ray Dalio\u2019s Bridgewater Associates"", ""summary"": ""In this article, we discuss the 11 best S&P 500 stocks to buy according to Bridgewater Associates. To skip the details about the firm\u2019s performance and Q2 bets, go directly to the 5 Best S&P 500 Stocks To Buy according to Bridgewater Associates. Bridgewater Associates was founded by Ray Dalio in 1975, merely two years [\u2026]""}, {""date"": ""20231109050000"", ""headline"": ""Did Warren Buffett Trade Stocks Berkshire Hathaway Owned In His Private Stock Portfolio?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231109052100"", ""headline"": ""2 Magnificent Dow Stocks to Buy in November and 1 to Avoid Like the Plague"", ""summary"": ""Two of the Dow's 30 components are historically cheap, while concerns are mounting for another time-tested business.""}, {""date"": ""20231109053500"", ""headline"": ""3 Dividend Stocks to Buy for Consistent Income"", ""summary"": ""In the dynamic world of investing, dividend stocks have always been a consistent way for investors to generate income. These stalwarts not only offer a steady income stream but also demonstrate the power of compounding returns. Imagine a scenario where your portfolio receives a consistent boost, safeguarding your investments against the unpredictable waves of market fluctuations. Moreover, the dividends from these stocks carry a positive connotation, often reflecting the underlying company\u2019s fin""}, {""date"": ""20231109053600"", ""headline"": ""JNJ December 29th Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231109075237"", ""headline"": ""3 Dividend Stocks That Could Pay for Your Holiday Shopping"", ""summary"": ""The holiday season is here, and if you haven\u2019t budgeted for your shopping, now is the perfect time to do so. With inflation under control and consumer spending slowly improving, we will have a good holiday season. If you do not want to use your credit card for purchases or haven\u2019t set aside an amount, you might want to consider making your money work for you. Investing in dividend stocks allows you to enjoy passive income to help pay for your holiday shopping. Savvy investors know that certain s""}, {""date"": ""20231109113200"", ""headline"": ""Johnson & Johnson stock falls Thursday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson shed 1.95% to $147.42 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""20231109213000"", ""headline"": ""Cantor biotech/biopharma analysts hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231110055200"", ""headline"": ""Big Players' Recent Trades in JNJ Options"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231110073800"", ""headline"": ""12 Dogs of the Dow Dividend Stocks to Buy"", ""summary"": ""In this article, we discuss 12 Dogs of the Dow dividend stocks to buy. You can skip our detailed analysis of the dogs of the Dow strategy and its returns over the years, and go directly to read 5 Dogs of the Dow Dividend Stocks to Buy. Many investors who prioritize dividends find dividend yields [\u2026]""}, {""date"": ""20231110074846"", ""headline"": ""13 Best DRIP Stocks To Own"", ""summary"": ""In this article, we discuss 13 best DRIP stocks to own. You can skip our detailed analysis of the dividend reinvestment plan and the overall performance of dividend stocks, and go directly to read 5 Best DRIP Stocks To Own. A dividend reinvestment plan, or DRIP, is a strategy where investors use the dividends earned [\u2026]""}, {""date"": ""20231110110535"", ""headline"": ""U.S. Wide-Moat Stocks On Sale - The November 2023 Heat Map"", ""summary"": ""Discover our 3-step process for identifying attractive, undervalued stocks with wide economic moats - Morningstar approved. Click here to read more.""}, {""date"": ""20231110113200"", ""headline"": ""Johnson & Johnson stock falls Friday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson shed 0.12% to $147.25 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20231111040000"", ""headline"": ""Why You Should Aim For $2 Million For Retirement"", ""summary"": ""Retirement goals should be set based on individual situations and factors like your pre-retirement earnings. Explore more details here.""}, {""date"": ""20231111050000"", ""headline"": ""Cautious Investor? 2 Safe Stocks You Also Can Count on For Growth"", ""summary"": ""Eli Lilly (NYSE: LLY) may be a big pharma company, but it's looking like a high-growth player with a lineup of products driving double-digit percentage revenue growth.  In Q3, new products accounted for $1.44 billion of sales, and growth products, most of which won't lose patent protection in the near future, represented nearly $5 billion in revenue.  Zepbound is the same molecule as Lilly's type 2 diabetes drug, Mounjaro -- which was already one of the blockbusters driving the company's growth.""}, {""date"": ""20231111080000"", ""headline"": ""Strategic Portfolio Allocation With Risk/Reward Optimization: A Deep Dive Into My Dividend Portfolio"", ""summary"": ""Exploring the concentration and risk levels of a financial writer's personal investment portfolio, and its deviation from a new investment approach.""}, {""date"": ""20231111144055"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of November 12"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the November 12 weekly update.""}, {""date"": ""20231112004732"", ""headline"": ""High-Quality Dividend Growth Near 52-Week Lows: Pfizer Is Phenomenal"", ""summary"": ""Pfizer appears to be a good investment opportunity due to its high quality, future growth projections, and sustainable dividend. Explore more details here.""}, {""date"": ""20231112014807"", ""headline"": ""Imminent Magic Catheter Approval Will Spike Stereotaxis Stock"", ""summary"": ""Stereotaxis will soon submit a PMA for FDA approval of the Magic catheter 180 days after submission. Find out why STXS stock is a Strong Buy.""}, {""date"": ""20231112170615"", ""headline"": ""Passive Income Snowball: How Does VYM Stack Up Against 6 Competing ETFs?"", ""summary"": ""Vanguard High Dividend Yield Index Fund ETF is a well-diversified, low-cost dividend growth fund for passive income. Find out why VYM is a Hold.""}]",{}
44,2023-11-12,142.73350524902344,2023-11-19,145.1956024169922,0.0172496090786336,U2,"[{""date"": ""20231112004732"", ""headline"": ""High-Quality Dividend Growth Near 52-Week Lows: Pfizer Is Phenomenal"", ""summary"": ""Pfizer appears to be a good investment opportunity due to its high quality, future growth projections, and sustainable dividend. Explore more details here.""}, {""date"": ""20231112014807"", ""headline"": ""Imminent Magic Catheter Approval Will Spike Stereotaxis Stock"", ""summary"": ""Stereotaxis will soon submit a PMA for FDA approval of the Magic catheter 180 days after submission. Find out why STXS stock is a Strong Buy.""}, {""date"": ""20231112170615"", ""headline"": ""Passive Income Snowball: How Does VYM Stack Up Against 6 Competing ETFs?"", ""summary"": ""Vanguard High Dividend Yield Index Fund ETF is a well-diversified, low-cost dividend growth fund for passive income. Find out why VYM is a Hold.""}, {""date"": ""20231112220400"", ""headline"": ""FMC Corp Takes the Spotlight in Tweedy Browne's Latest 13F Filing with a 1.56% Portfolio Impact"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231112220500"", ""headline"": ""Meta Platforms Inc Takes a Hit in Jeremy Grantham's Latest Portfolio Adjustments"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231112234500"", ""headline"": ""LONDON BROKER RATINGS: Diageo gets price target cuts; JPMorgan ups M&G"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231113000300"", ""headline"": ""Unlocking Intrinsic Value: Analysis of Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231113062000"", ""headline"": ""MedTech stocks gain after Novo Nordisk data for weight loss therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231113062400"", ""headline"": ""Investors seeking triple-A rated U.S. corporate debt only have these two choices \u2014 for now"", ""summary"": ""If Moody's downgrades the U.S. rating, it may not bode well for the two remaining triple-A corporate credits.""}, {""date"": ""20231113100300"", ""headline"": ""4 Large Drug Stocks Likely to Sail Through Industry Woes"", ""summary"": ""Drug, biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), J&J (JNJ) and AbbVie (ABBV) are worth retaining in your portfolio.""}, {""date"": ""20231113113100"", ""headline"": ""Johnson & Johnson stock underperforms Monday when compared to competitors despite daily gains"", ""summary"": ""Shares of Johnson & Johnson inched 0.26% higher to $147.63 Monday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""20231113141412"", ""headline"": ""Dividend Kings Ranked By Yield: Top 25"", ""summary"": ""In this article, we discuss 25 dividend kings with the highest dividend yields. You can skip our detailed analysis of dividend-growing stocks and their performance over the years, and go directly to read Dividend Kings Ranked By Yield: Top 10. Dividend Kings are a select group of publicly traded companies that have consistently increased their [\u2026]""}, {""date"": ""20231113160502"", ""headline"": ""Ray Dalio's Bridgewater Associates Adjusts Portfolio, Notably Reduces Johnson & Johnson Stake"", ""summary"": ""Insight into Bridgewater's Q3 Moves: Dalio's Strategy Reflects in Latest 13F Filings""}, {""date"": ""20231113203600"", ""headline"": ""UCB launches newly approved psoriasis drug Bimzelx in US"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231113214900"", ""headline"": ""Johnson & Johnson's Monarch approved in China for lung cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231113234900"", ""headline"": ""Addex Therapeutics completes recruitment of patients in ADX71149"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231114024800"", ""headline"": ""Berkshire Hathaway buys Sirius XM, exits General Motors in Q3"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231114031100"", ""headline"": ""Analysts Have Conflicting Sentiments on These Healthcare Companies: Cormedix (CRMD), Immatics (IMTX) and Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231114034733"", ""headline"": ""Turner Awarded $65 Million in Contracts to Expand Johnson & Johnson Vision Manufacturing Plant"", ""summary"": ""Turner Construction Company was chosen as the contractor for a $65 million expansion to the Johnson & Johnson disposable contact lens manufacturing plant in Jacksonville, Florida.The expansion is...""}, {""date"": ""20231114042500"", ""headline"": ""It\u2019s Time to Buy These 3 Dividend Aristocrats Trading Near 52-Week Lows"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231114052400"", ""headline"": ""Blue-Chip Bargains: Top 3 Oversold Aristocrats for Value Investors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231114053000"", ""headline"": ""3 Dividend Giants to Grow Wealth no Matter What the Market Is Doing"", ""summary"": ""It's a great idea to include a bit of both in your portfolio to support performance through any market environment.  You can either keep these payments and enjoy the passive income or reinvest the dividends to further grow your position in a particular stock.  Now, the big question is: How should you choose a winning dividend player for your portfolio?""}, {""date"": ""20231114061900"", ""headline"": ""Merck: Tracking Well Above The Industry"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231114074200"", ""headline"": ""Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, J&J and AbbVie"", ""summary"": ""Eli Lilly, Novo Nordisk, J&J and AbbVie are part of the Zacks Industry Outlook article.""}, {""date"": ""20231114080000"", ""headline"": ""All Dividend Companies Have One Big Problem In Common"", ""summary"": ""Dividend investing is struggling in the current macroeconomic environment due to high interest rates. Click here to read more.""}, {""date"": ""20231114111700"", ""headline"": ""Why a derailed $11 trillion corporate bond market looks ripe for a comeback as U.S. inflation slows"", ""summary"": ""Bonds issued by America's most valuable companies are steaming ahead after sinking to their lowest prices in about 20 years.""}, {""date"": ""20231114113200"", ""headline"": ""Johnson & Johnson stock rises Tuesday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.02% higher to $147.66 Tuesday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""20231114202100"", ""headline"": ""Buffett\u2019s Berkshire Sells JNJ and UPS Stocks; Should You Follow?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231114204300"", ""headline"": ""A Quick Look At Berkshire Hathaway\u2019s Recent Moves"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231114204900"", ""headline"": ""Buffett's Berkshire Trimmed Chevron Stake While Cashing Out Of GM And This COVID Stock: Here's How The Sage Of Omaha Adjusted His Portfolio In Q3"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231114224000"", ""headline"": ""Ray Dalio's Bridgewater Bets Big On Retail With Stakes In Coca-Cola, Costco, And Walmart Among Top Holdings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231114225100"", ""headline"": ""Warren Buffett's Berkshire Hathaway exits GM, Activision bets in Q3"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231115003000"", ""headline"": ""Donville Kent Asset Management October 2023 Insights"", ""summary"": ""In Q3 newsletter, DKAM discusses the phenomenon of market cycles, the current cycle, the impact on stock valuations, and inflation implications. Click here to read more.""}, {""date"": ""20231115031000"", ""headline"": ""My Dividend Stock Portfolio: New October Dividend Record - 98 Holdings With 23 Buys"", ""summary"": ""S&P 500 and Dow Jones dropped for the third straight month in October, just before staging a remarkable reversal in November. Click here to read more.""}, {""date"": ""20231115040458"", ""headline"": ""Janssen Pharmaceutical - New VOYAGER PAD Analyses Reinforce Benefit of XARELTO plus Aspirin across High-Risk and Complex Patient Populations with Peripheral Artery Disease"", ""summary"": ""TITUSVILLE - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses from the Phase 3 VOYAGER PAD clinical trial reinforcing the benefit of XARELTO over...""}, {""date"": ""20231115045700"", ""headline"": ""JNJ February 2024 Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231115071500"", ""headline"": ""Greece fines local branches of J&J and Colgate-Palmolive for allegedly breaching a profit cap"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231115080100"", ""headline"": ""Buffett's firm sells off several smaller investments, including GM and UPS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231115084449"", ""headline"": ""Arcellx: A Strong Contender In The CAR-T Multiple Myeloma Market"", ""summary"": ""Arcellx's CART-ddBCMA reported strong and competitive data in late-line multiple myeloma patients. Read more to see our analysis on ACLX stock.""}, {""date"": ""20231115090009"", ""headline"": ""Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know"", ""summary"": ""Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.""}, {""date"": ""20231115095705"", ""headline"": ""Berkshire Hathaway exits GM, Johnson & Johnson positions"", ""summary"": ""Warren Buffett's Berkshire Hathaway (BRK-A, BRK-B) has exited positions and sold its stakes in several companies like General Motors (GM) and Johnson & Johnson (JNJ) that recently underwent or announced new business ventures. Meanwhile, Apple (APPL), Bank of America (BAC), and American Express (AXP) continue to stand as Berkshire's top holdings. Yahoo Finance's Rachelle Akuffo and Akiko Fujita analyze Berkshire Hathaway's portfolio adjustments. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.""}, {""date"": ""20231115100700"", ""headline"": ""2 Dividend Stocks Near Their 52-Week Lows to Buy and Hold Forever"", ""summary"": ""If size were directly correlated with stock market performance, CVS Health (NYSE: CVS) and Johnson & Johnson (NYSE: JNJ) would always perform well as they are among the largest healthcare stocks in the U.S. However, both corporations have faced company-specific issues that have held them back, and as of this writing, they aren't that far off from their 52-week lows.  Despite their struggles, CVS Health and Johnson & Johnson have some major redeeming qualities, especially for income-seeking and long-term investors.  Let's find out why these healthcare stocks are still worth buying and holding forever.""}, {""date"": ""20231115113200"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.77% higher to $148.80 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""20231115115701"", ""headline"": ""12 Monthly Dividend Stocks with Over 5% Yield"", ""summary"": ""In this article, we discuss 12 monthly dividend stocks with over 5% yield. You can skip our detailed analysis of dividend stocks and their performance in the past, and go directly to read 5 Monthly Dividend Stocks with Over 5% Yield. During periods of financial instability, investors often focus on stocks that generate consistent income [\u2026]""}, {""date"": ""20231115163124"", ""headline"": ""15 Developed Countries with Lowest Autism Rates"", ""summary"": ""In this article, we will discuss 15 developed countries with lowest autism rates. If you want to skip our discussion on the autism industry, you can go directly to the 5 Developed Countries with Lowest Autism Rates. According to Fortune Business Insights, the autism spectrum disorder market was assessed at $1.93 billion in 2022. The [\u2026]""}, {""date"": ""20231115210000"", ""headline"": ""Pharma Is Out of Favor. 5 Drug Stocks With Room to Grow."", ""summary"": ""Despite Eli Lilly's monster 66.8% gain on the year because of weight-loss drugs, the S&P 500 Pharmaceuticals index is down 2.3%.""}, {""date"": ""20231115210722"", ""headline"": ""Storm-Proof Income: 7 Dividend Aristocrats to Fortify Your Portfolio"", ""summary"": ""With the possibility that the fourth quarter\u2019s economic results might disappoint given the stellar print of Q3, investors may want to consider dividend aristocrats. If you\u2019re looking for some of the best dividend stocks for income, you can\u2019t go wrong with this label. It refers to S&P 500 companies that have increased their payouts to shareholders for at least 25 years. Fundamentally, the major benefit of dividend aristocrats centers on incentivized performance. No one wants to lead the team that""}, {""date"": ""20231115223000"", ""headline"": ""Kenvue initiated with a Neutral at Piper Sandler"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231115234700"", ""headline"": ""Thoughts For Thursday: The Market Is Firming Higher, Tread Carefully"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116010000"", ""headline"": ""Major Buyout Firms Eye Sanofi's Consumer Health Division Spinoff Valued Over $20B"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116035700"", ""headline"": ""Pfizer: Undervalued At Peak Pessimism in the Post-COVID-19 Era"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116040100"", ""headline"": ""Ex-Dividend Reminder: Johnson & Johnson, STERIS and Prudential Financial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116055000"", ""headline"": ""Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On"", ""summary"": ""Maybe you could find out which stocks a well-known company that has been successful for a long time really likes -- a company such as Johnson & Johnson (NYSE: JNJ).  Here are the three stocks that J&J is betting the most on.  As of Sept. 30, 2023, Johnson & Johnson's biggest investment was in Legend Biotech (NASDAQ: LEGN).""}, {""date"": ""20231116061700"", ""headline"": ""Johnson & Johnson(JNJ) 2022 CEO Joaquin Duato's Shareholder Letter: Navigating Challenges ..."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116062600"", ""headline"": ""JNJ July 2024 Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116071800"", ""headline"": ""Buffett, Dalio, Einhorn, Ackman: The Masters Of Wall Street Shuffle Their Stock Decks In Q3"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116073000"", ""headline"": ""Johnson & Johnson to Host Enterprise Business Review"", ""summary"": ""NEW BRUNSWICK, N.J., November 16, 2023--Johnson & Johnson (NYSE: JNJ) (the \u2018Company\u2019) will hold an Enterprise Business Review for the investment community on Tuesday, December 5, 2023. During the event, Company leaders will share a detailed review of the Innovative Medicine and MedTech businesses and their respective pipelines as well as discuss the Company\u2019s long-term strategy to deliver sustained growth and value to shareholders.""}, {""date"": ""20231116113009"", ""headline"": ""Johnson & Johnson (JNJ) Down 2.6% Since Last Earnings Report: Can It Rebound?"", ""summary"": ""Johnson & Johnson (JNJ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.""}, {""date"": ""20231116113200"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.87% higher to $150.10 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""20231116121351"", ""headline"": ""10 States With The Most Doctors Per Capita In 2023"", ""summary"": ""In this article, we will discuss the 10 states with the most doctors per capita in 2023. If you want to skip our discussion on the healthcare industry in the United States, you can go directly to the 5 States With The Most Doctors Per Capita In 2023. In the ever-changing healthcare landscape in the [\u2026]""}, {""date"": ""20231116130948"", ""headline"": ""3 Strong-Buy Dividend Stocks That Analysts Love"", ""summary"": ""For much of 2022 and 2023, investors could take shelter in dividend stocks. They were, as the saying goes, the best houses in a bad neighborhood (the equity markets). It\u2019s not that the analysts loved these stocks, but they hated them less. That sentiment is changing which makes it a good time to look for strong buy dividend stocks. What are analysts seeing? For starters, they\u2019re noticing that interest rates may have peaked. That doesn\u2019t mean they\u2019ll come down anytime soon, but the Federal Reserv""}, {""date"": ""20231116133157"", ""headline"": ""3 Must-Buy Stocks on Every Market Dip"", ""summary"": ""The stock market is flying high in November, propelled by economic data showing that inflation and the U.S. economy are slowing. Another catalyst lies in expectations that the U.S. Federal Reserve is likely finished raising interest rates. After declining for three consecutive months, the benchmark S&P 500 index has risen 7% so far in November as a year-end Santa Claus rally appears to be taking hold. Investors welcome this news as stocks of many well-known companies climbing higher. Yet despite""}, {""date"": ""20231116183028"", ""headline"": ""J&J settles first talc cases to go to trial after failed bankruptcies"", ""summary"": ""Johnson & Johnson on Thursday said it has settled two lawsuits claiming its talc products caused cancer, the first such cases to go to trial since a federal court rejected the company's plan to move its talc liabilities into bankruptcy court.  The settlements resolved lawsuits brought by two men, Rosalino Reyes and Marlin Eagles, who said they developed mesothelioma related to asbestos in J&J talc powder, and was part of a broader deal to settle all talc cases brought by the law firm representing them, Kazan, McClain, Satterley & Greenwood, the company said.""}, {""date"": ""20231116200800"", ""headline"": ""Senator's Bearish Tesla Bet Under Scrutiny As He Buys Put Options Ahead Of Elon Musk-Led Company's Q3 Results That Set Stock Slide In Motion"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116210400"", ""headline"": ""21 Analysts Have This to Say About Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116211100"", ""headline"": ""The Buckle (NYSE:BKE) Blasts Up After a Mixed Earnings Report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116213000"", ""headline"": ""Notable Friday Option Activity: JNJ, VRT, PLL"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116214000"", ""headline"": ""Intuitive Surgical (NASDAQ:ISRG) Gains after Analyst Approval"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231117012600"", ""headline"": ""Dividend Roundup: General Mills, Nike, Johnson & Johnson, Marriott, and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231117020000"", ""headline"": ""Why Warren Buffett, Ray Dalio's Hedge Funds Are Selling Top-Ranking Dividend King"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231117020600"", ""headline"": ""Warren Buffett, Ray Dalio's Hedge Funds Are Selling Top-Ranking Dividend King"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231117024300"", ""headline"": ""J&J settles first talc-related lawsuits since dismissal of bankruptcy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231117033200"", ""headline"": ""Johnson & Johnson Resolves 2 Major Talc Cases As Legal Battles Continue"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231117044500"", ""headline"": ""Cantor biotech/biopharma analysts hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231117060300"", ""headline"": ""Johnson & Johnson Is Eyeing Intuitive Surgical's Market, But Can It Win?"", ""summary"": ""Johnson & Johnson (NYSE: JNJ) won't be breathing down Intuitive Surgical's (NASDAQ: ISRG) neck anytime soon.  With J&J's plans to produce a robotic surgical unit in full swing, a competitive showdown is now inevitable, and it'll play out over the rest of the decade.  The stakes are quite high for Intuitive, so let's evaluate what's going on.""}, {""date"": ""20231117070500"", ""headline"": ""Talc Lawyer: Johnson & Johnson Settlements Undermine Bankruptcy Strategy, Serve as Acknowledgment That Baby Powder Contained Asbestos"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231117092118"", ""headline"": ""Morning Brew: Market Eyes Late-Cycle Quality Stocks and Housing Gains"", ""summary"": ""Market Eyes Late-Cycle Quality Stocks and Housing Gains""}, {""date"": ""20231117113200"", ""headline"": ""Johnson & Johnson stock falls Friday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slipped 0.21% to $149.79 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""20231117152334"", ""headline"": ""7 High-Yield Blue Chips Suitable for Any Retiree"", ""summary"": ""Before extolling the benefits of high-yield blue-chip stocks, it\u2019s important to acknowledge the reality that many investors are feeling. Long-term stock investors have had to muddle through challenging macroeconomic headwinds in 2023. High inflation, rising interest rates, bank failures, two government shutdowns averted, and a new war that is fueling concerns about a broader conflict. Have I missed anything? Probably. 2023 has been a year many investors would like to forget. It\u2019s times like thes""}, {""date"": ""20231117212600"", ""headline"": ""Cantor Fitzgerald Sticks to Its Buy Rating for Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231118214100"", ""headline"": ""Stock Market This Week \u2013 Sunday, Nov. 19"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231119060200"", ""headline"": ""M&A, GLP-1s to dominate healthcare themes in 2024 as COVID fades: survey"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231119140545"", ""headline"": ""Ray Dalio\u2019s Latest 13F Portfolio: Top 15 Stocks"", ""summary"": ""In this piece, we will take a look at Ray Dalio\u2019s latest 13F portfolio: top 15 stocks. If you want to skip our introduction to the well-known investor and want to jump ahead to the top stocks in this list, then head on over to Ray Dalio\u2019s Latest 13F Portfolio: Top 5 Stocks. Ray Dalio is [\u2026]""}]",{}
45,2023-11-19,145.1956024169922,2023-11-26,149.00624084472656,0.026244861168663203,U3,"[{""date"": ""20231118214100"", ""headline"": ""Stock Market This Week \u2013 Sunday, Nov. 19"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231119060200"", ""headline"": ""M&A, GLP-1s to dominate healthcare themes in 2024 as COVID fades: survey"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231119140545"", ""headline"": ""Ray Dalio\u2019s Latest 13F Portfolio: Top 15 Stocks"", ""summary"": ""In this piece, we will take a look at Ray Dalio\u2019s latest 13F portfolio: top 15 stocks. If you want to skip our introduction to the well-known investor and want to jump ahead to the top stocks in this list, then head on over to Ray Dalio\u2019s Latest 13F Portfolio: Top 5 Stocks. Ray Dalio is [\u2026]""}, {""date"": ""20231119222900"", ""headline"": ""What You Missed On Wall Street On Monday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231120043205"", ""headline"": ""Thinking about trading options or stock in Meta Platforms, Johnson & Johnson, PENN Entertainment, Bristol-Myers Squibb, or Cadence Design Systems?"", ""summary"": ""NEW YORK, Nov. 20, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for META, JNJ, PENN, BMY, and CDNS. ...""}, {""date"": ""20231120044200"", ""headline"": ""Suit says J&J, Kenvue failed to flag decongestant issue in IPO, Bloomberg reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231120050420"", ""headline"": ""Johnson & Johnson's Dividend Analysis"", ""summary"": ""Johnson & Johnson (NYSE:JNJ) recently announced a dividend of $1.19 per share, payable on 2023-12-05, with the ex-dividend date set for 2023-11-20.  As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates.  Using the data from GuruFocus, let's look into Johnson & Johnson's dividend performance and assess its sustainability.""}, {""date"": ""20231120051900"", ""headline"": ""Kenvue may be activist target amid recent 13-F filing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231120055649"", ""headline"": ""25 States with the Highest Poverty Rates in the US"", ""summary"": ""In this article, we will be navigating through the poverty situation in the US, the disparity in state-level poverty, while covering the 25 states with the highest poverty rates in the country. If you wish to skip our detailed analysis, you can move directly to the 5 States with the Highest Poverty Rates in the [\u2026]""}, {""date"": ""20231120060700"", ""headline"": ""Behind the Scenes of Johnson & Johnson's Latest Options Trends"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231120065224"", ""headline"": ""20 Most Valuable Healthcare Companies in the World"", ""summary"": ""In this article, we will look into the 20 most valuable healthcare companies in the world. If you want to skip our detailed analysis, you can go directly to the 5 Most Valuable Healthcare Companies in the World. Healthcare Services Industry: A Market Analysis According to a report by Verified Market Research, the global healthcare [\u2026]""}, {""date"": ""20231120071500"", ""headline"": ""Bayer ends large blood thinner trial for \u2018inferior efficacy\u2019"", ""summary"": ""Company shares fell by one-fifth after study monitors called for halting a planned 18,000-person trial because Bayer\u2019s\u00a0experimental drug wasn\u2019t working as well as Eliquis.""}, {""date"": ""20231120072100"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231120074200"", ""headline"": ""Bristol Myers slumps as Bayer trial failure casts doubt on $5 billion drug"", ""summary"": ""German drugmaker Bayer scrapped a late-stage trial of an experimental blood thinner that could have major implications for Bristol Myers.""}, {""date"": ""20231120081400"", ""headline"": ""J&J's Janssen submits FDA application for Rybrevant for cancer form"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231120120219"", ""headline"": ""Bristol-Myers Squibb, 2seventy Bio Shares Fall as FDA Delays Decision on Cancer Drug"", ""summary"": ""Bristol-Myers Squibb and 2seventy bio shares dropped after the FDA said it would not make a decision on expanded use of the companies' cancer drug next month.""}, {""date"": ""20231120194938"", ""headline"": ""Tracking Ray Dalio's Bridgewater Associates 13F Portfolio - Q3 2023 Update"", ""summary"": ""Bridgewater Associates' 13F portfolio value increased by approximately 2% to $16.55 billion in Q3 2023. Click here for a detailed analysis.""}, {""date"": ""20231120201100"", ""headline"": ""Pfizer (NYSE:PFE) Sued Re:Low-Quality ADHD Drug for Kids"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231120201700"", ""headline"": ""How Is The Market Feeling About Johnson & Johnson?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231120205100"", ""headline"": ""Dividend Aristocrats In Focus: Kenvue"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231120212726"", ""headline"": ""Intuitive Surgical: Monopoly Days May Be Over"", ""summary"": ""Intuitive Surgical's Da Vinci Surgical Systems excel in performing precise surgeries and are positioned in a growing market. See why ISRG stock is hold rated.""}, {""date"": ""20231120233144"", ""headline"": ""Merck: A Dividend Growth Stock Worth Considering"", ""summary"": ""Merck reports positive quarterly earnings and consistent dividend growth over 12 years. Read why MRK stock is well-positioned for potential future success.""}, {""date"": ""20231121010000"", ""headline"": ""A Golden Age of Vaccines Is Here. What It Means for You."", ""summary"": ""Pharmaceutical companies are currently developing vaccines for a range of purposes, from preventing disease to treating cancers.""}, {""date"": ""20231121063700"", ""headline"": ""J&J, Merck, Bristol Myers CEOs asked to testify before Senate panel on drug prices"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231121074900"", ""headline"": ""Pfizer (NYSE:PFE) Sued for Low-Quality ADHD Drug for Kids"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231121113100"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.81% higher to $151.12 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the...""}, {""date"": ""20231121115340"", ""headline"": ""17 Stocks Warren Buffett Just Bought and Sold"", ""summary"": ""In this article, we will take a look at the 17 stocks Warren Buffett just bought and sold. To see more such companies, go directly to 5 Stocks Warren Buffett Just Bought and Sold. Warren Buffett is one of the most successful investors of all time. His net worth stands at about $120 billion as [\u2026]""}, {""date"": ""20231121124100"", ""headline"": ""J&J (JNJ) Seeks Expanded Use of Lung Cancer Drug Rybrevant"", ""summary"": ""J&J's (JNJ) sBLA seeks label expansion for Rybrevant plus chemotherapy to treat patients with EGFR-mutated NSCLC whose disease progressed on or after treatment with AstraZeneca's Tagrisso (osimertinib).""}, {""date"": ""20231121140700"", ""headline"": ""Top Analyst Reports for Novo Nordisk, Bank of America & Netflix"", ""summary"": ""Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), Bank of America Corporation (BAC) and Netflix, Inc. (NFLX).""}, {""date"": ""20231121144435"", ""headline"": ""Hormel Foods Corporation: Thankful For 57 Years Of Growing Dividends"", ""summary"": ""Hormel Foods stock offers potential for capital appreciation and a high yield on cost for long-term holders. Read here to know why we rate HRL stock a buy.""}, {""date"": ""20231121161515"", ""headline"": ""Tracking Jeremy Grantham's GMO Capital Portfolio - Q3 2023 Update"", ""summary"": ""Jeremy Grantham's 13F portfolio value declined by 2% to $21.17B in Q3 2023. Microsoft, UnitedHealth, Alphabet, J&J, and Meta Platforms are top holdings.""}, {""date"": ""20231121205100"", ""headline"": ""Market Whales and Their Recent Bets on JNJ Options"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231122035900"", ""headline"": ""GSK: Undervalued At Peak Pessimism"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231122050600"", ""headline"": ""5 Longtime Holdings Warren Buffett Completely Sold During the Third Quarter"", ""summary"": ""These brand-name companies had been fixtures in Berkshire Hathaway's portfolio for the past 11 to 18 years.""}, {""date"": ""20231122052200"", ""headline"": ""JNJ January 2024 Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231122094300"", ""headline"": ""The Zacks Analyst Blog Highlights Novo Nordisk  Bank of America, Netflix, Johnson & Johnson and TotalEnergies"", ""summary"": ""Novo Nordisk, Bank of America, Netflix, Johnson & Johnson and TotalEnergies are part of the Zacks top Analyst Blog.""}, {""date"": ""20231122113200"", ""headline"": ""Johnson & Johnson stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slipped 0.20% to $150.82 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""20231122130118"", ""headline"": ""Worried About Market Volatility? Invest In These High-Yield Dividend Stocks For Consistent Passive Income"", ""summary"": ""While the stock market has been recovering since the pullback last year, market volatility remains high as geopolitical tensions persist. The recent crisis in the Middle East has sparked concerns regarding broader regional instability. The weakening economy has caused investors to cause the November rally to halt, with the Dow Jones Industrial Average index declining marginally intraday on Tuesday. The National Retail Federation expects retail sales to grow at the slowest pace in the last five y""}, {""date"": ""20231123055000"", ""headline"": ""Thoughts On 35 Stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231123130000"", ""headline"": ""How To Build A Dividend Portfolio Allocating $100,000 Among November's Top 20 Dividend Companies"", ""summary"": ""I will show you how you can build a dividend portfolio by allocating $100,000 among November\u00e2\u0080\u0099s top 20 dividend companies as well as one ETF. Read more here.""}, {""date"": ""20231123171138"", ""headline"": ""15 Best Income Stocks To Invest In"", ""summary"": ""In this article, we discuss 15 best income stocks to invest in. You can skip our detailed analysis of income stocks and the performance of dividend stocks in the past, and go directly to read 5 Best Income Stocks To Invest In. On November 22, the U.S. stock market closed with gains, driven by the positive [\u2026]""}, {""date"": ""20231123223300"", ""headline"": ""Johnson & Johnson stock rises Friday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231124000739"", ""headline"": ""South Africa, Colombia and others are fighting drugmakers over access to TB and HIV drugs"", ""summary"": ""South Africa, Colombia and other countries that lost out in the global race for coronavirus vaccines are taking a more combative approach towards drugmakers and pushing back on policies that deny cheap treatment to millions of people with tuberculosis and HIV.  In the COVID-19 pandemic, rich countries bought most of the world\u2019s vaccines early, leaving few shots for poor countries and creating a disparity the World Health Organization called \u201ca catastrophic moral failure.\u201d  Now, poorer countries are trying to become more self-reliant \u201cbecause they\u2019ve realized after COVID they can\u2019t count on anyone else,\u201d said Brook Baker, who studies treatment-access issues at Northeastern University.""}, {""date"": ""20231124034922"", ""headline"": ""Goldman Sachs Value Stocks: Top 12 Stock Picks"", ""summary"": ""In this piece, we will take a look at the top value stock picks of the investment bank Goldman Sachs. If you want to skip our introduction to the investment bank, some relevant news, and a primer on value investing, then you can skip ahead to Goldman Sachs Value Stocks: Top 5 Stock Picks. Value investing [\u2026]""}, {""date"": ""20231124040000"", ""headline"": ""AVLV: Add A Quality Tilt To Your Broad Market Index Funds With This Active Large Cap ETF"", ""summary"": """"}, {""date"": ""20231124063700"", ""headline"": ""Pneumonia outbreak in China is no reason for alarm: WHO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231124082000"", ""headline"": ""3 Dividend Stocks You Can Safely Hold for Decades"", ""summary"": ""Many high-profile stocks can come with risks and uncertainties that make them less than ideal for investors who prioritize reliable dividend income.  While it's impossible to know where a stock will be in 20 years, certain attributes in a company increase the likelihood that it will be able to maintain its dividends well into the future.  Emerson Electric (NYSE: EMR) is a diversified industrial company that offers a broad range of products, including electrical equipment, valves, control and measurement devices, regulators, welding equipment, and automation software.""}, {""date"": ""20231125002232"", ""headline"": ""3 Reasons You Should Stay The Course With Dividend Stocks"", ""summary"": ""With bond yields at levels last seen before the Great Recession, it is difficult to argue against the attractiveness of fixed-income investments. Read more here.""}, {""date"": ""20231125065300"", ""headline"": ""See Which Of The Latest 13F Filers Holds Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231125162254"", ""headline"": ""11 Best Fortune 500 Dividend Stocks To Buy Now"", ""summary"": ""In this article, we discuss 11 best Fortune 500 dividend stocks to buy now. You can skip our detailed analysis of large-cap dividend stocks and their performance in the past, and go directly to read 5 Best Fortune 500 Dividend Stocks To Buy Now. The Fortune 500 is an annual list compiled and published by [\u2026]""}, {""date"": ""20231126055608"", ""headline"": ""12 Best Medical Technology Stocks To Buy Now"", ""summary"": ""In this article, we discuss 12 of the best medical device stocks to buy now. If you want to skip our detailed healthcare and medical technology industry discussion, head directly to the 5 Best Medical Technology Stocks To Buy Now. The medical technology (MedTech) sector plays a significant role in healthcare, focusing primarily on developing [\u2026]""}, {""date"": ""20231126063000"", ""headline"": ""Johnson & Johnson and Intuitive Surgical Might Become Ozempic's Next Victims. Are They Still Worth Buying?"", ""summary"": ""It's a bit of a harrowing time to be in the business of selling solutions for bariatric surgery.  Thanks to Novo Nordisk's drugs like Ozempic and Wegovy for type 2 diabetes and obesity, and competing medicines like Mounjaro and Zepbound made by Eli Lilly, people now have access to powerful and noninvasive weight-loss tools.  In fact, leaders of two of the largest companies in healthcare, Intuitive Surgical (NASDAQ: ISRG) and Johnson & Johnson (NYSE: JNJ), are already explicitly linking the rise of treatments like Ozempic to new headwinds for certain segments of their businesses.""}, {""date"": ""20231126065103"", ""headline"": ""15 Best Drug Stocks To Invest In"", ""summary"": ""In this article, we discuss the 15 best drug stocks to invest in. You can skip our detailed analysis of the drug and pharmaceutical sector and its outlook this year, and go directly to read the 5 Best Drug Stocks To Invest In. Healthcare expands on the defensive concept, encompassing a myriad of companies. This [\u2026]""}, {""date"": ""20231126070019"", ""headline"": ""Johnson & Johnson's (NYSE:JNJ) Intrinsic Value Is Potentially 60% Above Its Share Price"", ""summary"": ""Key Insights Using the 2 Stage Free Cash Flow to Equity, Johnson & Johnson fair value estimate is US$244 Johnson...""}, {""date"": ""20231126071500"", ""headline"": ""Got $1,500? You Can Confidently Add These 3 Stocks to Your Portfolio"", ""summary"": ""There's a lot of uncertainty in the world today. Higher interest rates have many investors growing worried that the economy could slow down considerably over the next year and potentially experience a recession.""}]",{}
46,2023-11-26,149.00624084472656,2023-12-03,154.7515411376953,0.03855744739547995,U4,"[{""date"": ""20231126055608"", ""headline"": ""12 Best Medical Technology Stocks To Buy Now"", ""summary"": ""In this article, we discuss 12 of the best medical device stocks to buy now. If you want to skip our detailed healthcare and medical technology industry discussion, head directly to the 5 Best Medical Technology Stocks To Buy Now. The medical technology (MedTech) sector plays a significant role in healthcare, focusing primarily on developing [\u2026]""}, {""date"": ""20231126063000"", ""headline"": ""Johnson & Johnson and Intuitive Surgical Might Become Ozempic's Next Victims. Are They Still Worth Buying?"", ""summary"": ""It's a bit of a harrowing time to be in the business of selling solutions for bariatric surgery.  Thanks to Novo Nordisk's drugs like Ozempic and Wegovy for type 2 diabetes and obesity, and competing medicines like Mounjaro and Zepbound made by Eli Lilly, people now have access to powerful and noninvasive weight-loss tools.  In fact, leaders of two of the largest companies in healthcare, Intuitive Surgical (NASDAQ: ISRG) and Johnson & Johnson (NYSE: JNJ), are already explicitly linking the rise of treatments like Ozempic to new headwinds for certain segments of their businesses.""}, {""date"": ""20231126065103"", ""headline"": ""15 Best Drug Stocks To Invest In"", ""summary"": ""In this article, we discuss the 15 best drug stocks to invest in. You can skip our detailed analysis of the drug and pharmaceutical sector and its outlook this year, and go directly to read the 5 Best Drug Stocks To Invest In. Healthcare expands on the defensive concept, encompassing a myriad of companies. This [\u2026]""}, {""date"": ""20231126070019"", ""headline"": ""Johnson & Johnson's (NYSE:JNJ) Intrinsic Value Is Potentially 60% Above Its Share Price"", ""summary"": ""Key Insights Using the 2 Stage Free Cash Flow to Equity, Johnson & Johnson fair value estimate is US$244 Johnson...""}, {""date"": ""20231126071500"", ""headline"": ""Got $1,500? You Can Confidently Add These 3 Stocks to Your Portfolio"", ""summary"": ""There's a lot of uncertainty in the world today. Higher interest rates have many investors growing worried that the economy could slow down considerably over the next year and potentially experience a recession.""}, {""date"": ""20231126205100"", ""headline"": ""This Is What Whales Are Betting On Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231126212900"", ""headline"": ""Biden Plans to Boost Drug Production Using Cold-War Era Law"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231127000400"", ""headline"": ""Johnson & Johnson: An Exploration into Its Intrinsic Value"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231127010900"", ""headline"": ""Gracell initiated with an Outperform at Evercore ISI"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231127025311"", ""headline"": ""Buy 6 December Dividend Kings, 4 More On Watch"", ""summary"": ""An analysis of the top Dividend Kings and their impressive long-term dividend payouts is presented. Click here to find out the six December Dividend Kings.""}, {""date"": ""20231127033300"", ""headline"": ""The Shocking Stock That Warren Buffet Just Bought (and 2 He Sold)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231127051603"", ""headline"": ""J&J : applies for an extended indication for Rybrevant"", ""summary"": ""J&J announces that its Janssen pharmaceutical companies have applied to the European Medicines Agency for an extension of the indication for Rybrevant in combination with chemotherapy for the...""}, {""date"": ""20231127053000"", ""headline"": ""5 Stocks You Can Confidently Invest $500 In Right Now"", ""summary"": ""Amazon (NASDAQ: AMZN) is the leader in two markets growing in the double-digits: e-commerce and cloud computing.  Amazon recently improved its cost structure, which should pay off over time.  The company's moves in e-commerce include making its fulfillment process more efficient, and in cloud computing include major investments in artificial intelligence (AI).""}, {""date"": ""20231127071500"", ""headline"": ""President Biden to use 1950 law to boost essential drug production"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231127095646"", ""headline"": ""Roku upgraded, Lucid Group downgraded: Wall Street's top analyst calls"", ""summary"": ""Roku upgraded, Lucid Group downgraded: Wall Street's top analyst calls""}, {""date"": ""20231127103843"", ""headline"": ""3 Biotech Stocks To Watch Before December 2023"", ""summary"": ""Biotech stocks to check out in the stock market today.""}, {""date"": ""20231127113200"", ""headline"": ""Johnson & Johnson stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson sank 0.80% to $151.28 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""20231127231100"", ""headline"": ""3 Robotics Stocks That Could Be Multibaggers in the Making"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231127231200"", ""headline"": ""Google Alum's Biotech Startup Cradle Raises $24M To Boost AI-Powered Protein Design And Engineering"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231127232100"", ""headline"": ""Analysts Conflicted on These Healthcare Names: Johnson & Johnson (JNJ), Masimo (MASI) and Regeneron (REGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231128001100"", ""headline"": ""Johnson & Johnson price target lowered to $170 from $178 at Wells Fargo"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231128030606"", ""headline"": ""10 Dividend Growth Stocks For November 2023"", ""summary"": ""Discover the top 10 dividend growth stocks for potential investment, ranked by their defensiveness scores. Click here to read my analysis.""}, {""date"": ""20231128045800"", ""headline"": ""FDA investigating serious risk of T-cell malignancies in CAR-T cell therapy patients"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231128050102"", ""headline"": ""J&J : Wells Fargo remains positive, lowers target"", ""summary"": ""Wells Fargo reaffirms its 'overweight' recommendation on Johnson & Johnson despite a price target lowered from $178 to $170, based on a ratio of around 15 times its 2025 EPS assumption for the...""}, {""date"": ""20231128053700"", ""headline"": ""Cabaletta Bio, Gracell slide as FDA probes risk of CAR T cell immunotherapies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231128054100"", ""headline"": ""2 Unstoppable Dividend Stocks Trading Near 52-Week Lows to Buy Now"", ""summary"": ""With clear advantages over the competition, these divided payers could deliver market-beating gains to patient investors.""}, {""date"": ""20231128062600"", ""headline"": ""FDA probing serious risk of T-cell malignancies in CAR-T cell therapy patients (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231128113200"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.23% higher to $151.63 Tuesday, on what proved to be an all-around positive trading session for the stock market, with...""}, {""date"": ""20231128133441"", ""headline"": ""AWS expands big pharma partnerships in manufacturing, AI, and R&D"", ""summary"": ""Pfizer and Amazon Web Services are just another example of how artificial intelligence is working in the background in healthcare.""}, {""date"": ""20231128234300"", ""headline"": ""Alvotech stock gains on positive results for J&J arthritis drug biosimilar"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231129004300"", ""headline"": ""The 7 Biggest Dividend Stocks in Warren Buffett\u2019s Portfolio"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231129012300"", ""headline"": ""Why Johnson & Johnson is a Top 25 Dividend Giant (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231129023400"", ""headline"": ""Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell Therapies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231129050000"", ""headline"": ""3 medtech spinoffs that reshaped the industry in 2023, and what to expect next"", ""summary"": ""GE HealthCare, Johnson & Johnson and Danaher completed transactions this year. Baxter, 3M and Medtronic are now on deck.""}, {""date"": ""20231129051711"", ""headline"": ""J&J : to present its medical advances in San Diego"", ""summary"": ""Johnson & Johnson announced today that more than 85 abstracts from its hematology portfolio and pipeline will be presented at the 65th annual meeting of the American Society of Hematology , to be held...""}, {""date"": ""20231129062526"", ""headline"": ""Why I Made Big Changes To My Dividend Growth Portfolio"", ""summary"": ""How to make significant changes to your portfolio, for when buying a new house and selling stocks for cash? Click here to read about my strategy.""}, {""date"": ""20231129090010"", ""headline"": ""Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It"", ""summary"": ""Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.""}, {""date"": ""20231129100001"", ""headline"": ""Biogen: LAQEMBI's $10 Billion Potential"", ""summary"": ""Biogen's latest Alzheimer's drug, Aduhelm, faced challenges after FDA approval. Click here to read why we still rate the BIIB stock as a 'Strong Buy'.""}, {""date"": ""20231129113200"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.32% higher to $152.11 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""20231129114835"", ""headline"": ""Johnson & Johnson, Ben Graham, And Defensive Stocks"", ""summary"": ""Johnson & Johnson satisfies all the requirements that Benjamin Graham promoted for picking defensive stocks. Read more on JNJ stock here.""}, {""date"": ""20231129171840"", ""headline"": ""15 States with the Best Economy Right Now"", ""summary"": ""In this article, we will discuss the 15 states with the best economy right now. If you want to skip our detailed analysis, you can go directly to the 5 States with the Best Economy Right Now. According to a report by Goldman Sachs, the economy of the United States is on track to beat expectations [\u2026]""}, {""date"": ""20231129174508"", ""headline"": ""Johnson & Johnson (JNJ) Ascends While Market Falls: Some Facts to Note"", ""summary"": ""In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $152.11, denoting a +0.32% change from the preceding trading day.""}, {""date"": ""20231129180442"", ""headline"": ""20 Countries With The Lowest Retirement Ages in The World"", ""summary"": ""This article takes a look at the 20 countries with the lowest retirement ages in the world. If you wish to skip our detailed analysis on navigating aging populations, you may go to 5 Countries with The Lowest Retirement Ages in The World. On Navigating Aging Populations According to the World Health Organization, the population [\u2026]""}, {""date"": ""20231129195033"", ""headline"": ""Tracking Tweedy, Browne Portfolio - Q3 2023 Update"", ""summary"": ""Tweedy, Browne's 13F portfolio value decreased by 2% to $1.87B this quarter. Click here to read more about its holdings and trades for Q3 2023.""}, {""date"": ""20231129223200"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Hyperfine (HYPR) and Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231129224100"", ""headline"": ""J&J appoints Eugene Woods to its board"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130030600"", ""headline"": ""Fresh on the Market: 3 Top Picks From the Renaissance IPO ETF"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130031800"", ""headline"": ""J&J revises EPS guide after $400M deal to buy Laminar"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130032859"", ""headline"": ""Johnson & Johnson highlights its preeminent leadership in hematology through differentiated blood cancer portfolio and pipeline with new clinical and real-world data at ASH"", ""summary"": ""RARITAN - Johnson & Johnson announced today that more than 85 presentations from the Company's robust hematology portfolio and pipeline will be presented at the 65th Annual American Society of...""}, {""date"": ""20231130033500"", ""headline"": ""Texas Sues Pfizer For \""Misrepresenting COVID-19 Vaccine Efficacy\"" And \""Conspiring To Censor Public Discourse\"""", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130034000"", ""headline"": ""Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Johnson & Johnson (JNJ) and Walgreens Boots Alliance (WBA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130040600"", ""headline"": ""Johnson & Johnson buys medical device maker Laminar, cuts full-year earnings guidance"", ""summary"": ""Johnson & Johnson said Thursday that its medical technology segment has acquired medical device maker Laminar Inc. in a deal that will reduce its full-year...""}, {""date"": ""20231130042204"", ""headline"": ""Johnson & Johnson Buys Laminar For $400 Million, Trims Profit Outlook"", ""summary"": ""By Will Feuer Johnson & Johnson said it has bought Laminary, a privately held medical device company, for an upfront payment of $400 million. J&J also cut its full-year adjusted profit...""}, {""date"": ""20231130045600"", ""headline"": ""JNJ January 2024 Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130051100"", ""headline"": ""Income Kings: 7 Blue-Chip Dividend Stocks for Reliable Returns"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130053000"", ""headline"": ""J&J Hired Thousands of Data Scientists. Will The Strategy Pay Off?"", ""summary"": ""The 137-year-old pharmaceutical and medical-device company is taking a new direction in its efforts to discover drugs""}, {""date"": ""20231130054532"", ""headline"": ""Johnson & Johnson : By the numbers"", ""summary"": ""Each year, more people die of lung cancer than colon, breast and prostate cancers combined. Learn how Johnson & Johnson is dedicated to improving outcomes by integrating the company's MedTech and...""}, {""date"": ""20231130055602"", ""headline"": ""J&J : EPS target lowered after Laminar acquisition"", ""summary"": ""Johnson & Johnson announced on Thursday that it had lowered its earnings per share target for 2023 to take into account the acquisition of Laminar, made official today.This transaction, valued at...""}, {""date"": ""20231130060018"", ""headline"": ""Johnson & Johnson (NYSE:JNJ) is largely controlled by institutional shareholders who own 71% of the company"", ""summary"": ""Key Insights Institutions' substantial holdings in Johnson & Johnson implies that they have significant influence over...""}, {""date"": ""20231130060400"", ""headline"": ""Johnson & Johnson (NYSE:JNJ) Revised Earnings Don\u2019t Balk Investors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130062600"", ""headline"": ""7 Blue-Chip Stocks to Buy for 2024, According to AI"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130063100"", ""headline"": ""Johnson & Johnson\u2019s (NYSE:JNJ) Revised Earnings Don\u2019t Worry Investors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130065900"", ""headline"": ""IN BRIEF: Johnson & Johnson MedTech business acquires Laminar"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130072100"", ""headline"": ""J&J heats up LAA closure competition with $400M Laminar buy"", ""summary"": ""Just days after Medtronic announced it would launch a LAA device, J&J said it has acquired a company that is developing a new treatment for LAA closure.""}, {""date"": ""20231130084000"", ""headline"": ""Johnson & Johnson MedTech Acquires Laminar, Inc."", ""summary"": ""NEW BRUNSWICK, N.J., November 30, 2023--Johnson & Johnson MedTech1 today announced the completion of the acquisition2 of Laminar, Inc., a privately-held medical device company focused on eliminating the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation (AFib). Johnson & Johnson MedTech acquired Laminar for an upfront payment of $400 million, subject to customary adjustments, with additional potential clinical and regulatory milestone payments in 2024 and beyond. Lamin""}, {""date"": ""20231130101159"", ""headline"": ""Johnson & Johnson: Sleep Well At Night With The Only AAA-Rated Dividend Aristocrat"", ""summary"": ""JNJ maintains a rock-solid balance sheet, which operationally shields it from the higher for longer rate narrative. Click here to read my analysis of the stock.""}, {""date"": ""20231130113200"", ""headline"": ""Johnson & Johnson stock rises Thursday, outperforms market"", ""summary"": ""Shares of Johnson & Johnson advanced 1.68% to $154.66 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P...""}, {""date"": ""20231130123700"", ""headline"": ""Johnson & Johnson Names Eugene Woods as Board Member"", ""summary"": ""By Sabela Ojea Johnson &amp; Johnson added Eugene Woods, chief executive of Advocate Health, to the board of directors. The healthcare company's chief...""}, {""date"": ""20231130163000"", ""headline"": ""Johnson & Johnson Names Eugene A. Woods, Chief Executive Officer of Advocate Health, to its Board of Directors"", ""summary"": ""NEW BRUNSWICK, N.J., November 30, 2023--Johnson & Johnson (NYSE: JNJ) announced today that Eugene A. Woods, MBA, MHA, Chief Executive Officer of Advocate Health, has been appointed to its Board of Directors.""}, {""date"": ""20231130171624"", ""headline"": ""UPDATE 2-Pfizer is sued by Texas over COVID vaccine claims"", ""summary"": ""Pfizer has been sued by Texas Attorney General Ken Paxton, who on Thursday accused the drugmaker of misrepresenting the efficacy of its widely-used COVID-19 vaccine.  In a complaint filed in a Lubbock County state court, Paxton said it was misleading for Pfizer to claim its vaccine was 95% effective because it offered a \""relative risk reduction\"" for people to who took it.  Paxton said the claim was based on only two months of clinical trial data, and vaccine recipients' \""absolute risk reduction\"" showed that the vaccine was just 0.85% effective.""}, {""date"": ""20231130210300"", ""headline"": ""Catalyst Watch: McDonald's event, Lululemon earnings and GameStop volatility redux"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130222500"", ""headline"": ""What You Missed On Wall Street On Friday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130225200"", ""headline"": ""Johnson & Johnson upgraded to Buy from Neutral at UBS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130230600"", ""headline"": ""Analysts Are Bullish on Top Healthcare Stocks: Johnson & Johnson (JNJ), Humana (HUM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231201001200"", ""headline"": ""Johnson & Johnson upgraded to Buy at UBS ahead of analyst day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231201003600"", ""headline"": ""J&J gets upgrade from UBS with \""high conviction\"" in outlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231201004200"", ""headline"": ""J&J gets upgrade from UBS with 'high conviction' in outlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231201010400"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Harmony Biosciences Holdings (HRMY) and Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231201013603"", ""headline"": ""J&J : Eugene A. Woods joins the Board of Directors"", ""summary"": ""Johnson & Johnson has announced the appointment of Eugene A. Woods, CEO of Advocate Health, to its Board of Directors. Woods, CEO of Advocate Health, to the Board of Directors.'M. Woods has an...""}, {""date"": ""20231201030100"", ""headline"": ""Wealth From Wellness: 7 Healthcare Stocks to Inoculate Your Portfolio"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231201030800"", ""headline"": ""Investors Should Not Pay More Than A 15 P/E Ratio When Buying A Stock"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231201044403"", ""headline"": ""Johnson & Johnson : the stock benefits from a positive opinion from UBS"", ""summary"": ""Johnson & Johnson shares are bucking the downward trend on Wall Street on Friday, thanks to a recommendation upgrade from UBS, which sees the American healthcare giant exceeding market expectations.A...""}, {""date"": ""20231201070200"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231201071100"", ""headline"": ""Johnson & Johnson Gets Analyst Upgrade Noting Bullish Pharma & MedTech Projections"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231201093235"", ""headline"": ""Elastic upgraded, Alibaba downgraded: Wall Street's top analyst calls"", ""summary"": ""Elastic upgraded, Alibaba downgraded: Wall Street's top analyst calls""}, {""date"": ""20231201112012"", ""headline"": ""My Dividend Growth Portfolio November Update - Thankful For Dividend Raises"", ""summary"": ""Don't miss out on potential bargains in a rising market.""}, {""date"": ""20231201113200"", ""headline"": ""Johnson & Johnson stock rises Friday, outperforms market"", ""summary"": ""Shares of Johnson & Johnson rallied 2.41% to $158.38 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20231201123300"", ""headline"": ""Johnson & Johnson Stock Gains a Bull Ahead of Analyst Day"", ""summary"": ""Shares are lower this year, thanks to an ongoing legal situation, but UBS says those worries are factored into the stock.""}, {""date"": ""20231201184330"", ""headline"": ""UBS Upgrades Johnson & Johnson (JNJ)"", ""summary"": """"}, {""date"": ""20231202040000"", ""headline"": ""5 Relatively Secure And Cheap Dividend Stocks To Invest In - December 2023"", ""summary"": ""Discover five large-cap dividend-paying companies with discounts to their historical norms, selected from over 7,500 U.S. traded companies. Click for our picks!""}, {""date"": ""20231202050000"", ""headline"": ""Stocks To Watch: Big Week On Tap For McDonald's, Shopify, GameStop, And Johnson & Johnson"", ""summary"": ""Stay informed on upcoming key events in the market with Seeking Alpha's Stocks to Watch newsletter, covering IPOs, earnings reports, and more.""}, {""date"": ""20231202090000"", ""headline"": ""How To Build A High-Potential Dividend Portfolio Combining Dividend Income With Dividend Growth"", ""summary"": ""Learn how to build a diversified dividend portfolio that combines income and growth for an attractive total return. Read the article for more details on the portfolio.""}, {""date"": ""20231202140553"", ""headline"": ""JP Morgan\u2019s Top 15 Stock Picks for 2023 and Now"", ""summary"": ""In this piece, we will take a look at JP Morgan\u2019s top 15 stock picks for 2023 and most recent stock picks. If you want to skip our introduction to the world\u2019s biggest bank in terms of assets, its latest performance, and other details, then check out JP Morgan\u2019s Top 5 Stock Picks for 2023. [\u2026]""}, {""date"": ""20231202203500"", ""headline"": ""Supreme Court Decision Looms Over Purdue Pharma's $6B Opioid Settlement And Sackler Family Immunity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231202230032"", ""headline"": ""Abbott Laboratories: A 'Must-Have' In A Defensive Dividend Growth Portfolio"", ""summary"": ""Abbott Laboratories had a difficult last three years, with its stock price trading sideways as sales driven by COVID-19 plummeted. Read more on ABT stock here.""}, {""date"": ""20231203021023"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of December 3"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the update for the week of December 3.""}, {""date"": ""20231203053000"", ""headline"": ""Warren Buffett Just Closed His Position in This Dividend Giant. Should You?"", ""summary"": ""Warren Buffett is known for owning shares in some of America's leading companies, in industries from financials to oil.  One particular area he hasn't invested too heavily in, though, is healthcare -- the risks of drug development, high costs of research, and complexity of the science behind many pharma pipelines are all elements that don't go hand-in-hand with the billionaire's investment strategy.  Considering Buffett's top stock picking skills and long-term performance, you may be temped to sell or avoid J&J too.""}, {""date"": ""20231203070000"", ""headline"": ""Warren Buffett sold a whopping $7B worth of stock in Q3 \u2014 and even unloaded 2 giant American 'dividend kings.' But here's why the Oracle of Omaha could be dead wrong"", ""summary"": ""It's surely a bad sign for the US economy, right? Not so fast.""}, {""date"": ""20231203080000"", ""headline"": ""Second-Largest U.S. Pension Sold AMC, NIO, Spotify, and JNJ Stock"", ""summary"": ""California State Teachers' Retirement System, or Calsters, cut positions in AMC Entertainment, NIO, Spotify, and Johnson & Johnson in the third quarter.""}, {""date"": ""20231203080000"", ""headline"": ""The Second-Largest U.S. Pension Slashed Its AMC Stock Stake"", ""summary"": ""California State Teachers' Retirement System, or Calsters, cut positions in AMC Entertainment, NIO, Spotify, and Johnson & Johnson in the third quarter.""}]",{}
47,2023-12-03,154.7515411376953,2023-12-10,150.8822479248047,-0.025003261256363096,D3,"[{""date"": ""20231202203500"", ""headline"": ""Supreme Court Decision Looms Over Purdue Pharma's $6B Opioid Settlement And Sackler Family Immunity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231202230032"", ""headline"": ""Abbott Laboratories: A 'Must-Have' In A Defensive Dividend Growth Portfolio"", ""summary"": ""Abbott Laboratories had a difficult last three years, with its stock price trading sideways as sales driven by COVID-19 plummeted. Read more on ABT stock here.""}, {""date"": ""20231203021023"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of December 3"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the update for the week of December 3.""}, {""date"": ""20231203053000"", ""headline"": ""Warren Buffett Just Closed His Position in This Dividend Giant. Should You?"", ""summary"": ""Warren Buffett is known for owning shares in some of America's leading companies, in industries from financials to oil.  One particular area he hasn't invested too heavily in, though, is healthcare -- the risks of drug development, high costs of research, and complexity of the science behind many pharma pipelines are all elements that don't go hand-in-hand with the billionaire's investment strategy.  Considering Buffett's top stock picking skills and long-term performance, you may be temped to sell or avoid J&J too.""}, {""date"": ""20231203070000"", ""headline"": ""Warren Buffett sold a whopping $7B worth of stock in Q3 \u2014 and even unloaded 2 giant American 'dividend kings.' But here's why the Oracle of Omaha could be dead wrong"", ""summary"": ""It's surely a bad sign for the US economy, right? Not so fast.""}, {""date"": ""20231203080000"", ""headline"": ""Second-Largest U.S. Pension Sold AMC, NIO, Spotify, and JNJ Stock"", ""summary"": ""California State Teachers' Retirement System, or Calsters, cut positions in AMC Entertainment, NIO, Spotify, and Johnson & Johnson in the third quarter.""}, {""date"": ""20231203080000"", ""headline"": ""The Second-Largest U.S. Pension Slashed Its AMC Stock Stake"", ""summary"": ""California State Teachers' Retirement System, or Calsters, cut positions in AMC Entertainment, NIO, Spotify, and Johnson & Johnson in the third quarter.""}, {""date"": ""20231203232000"", ""headline"": ""J&J gets FDA breakthrough status for TAR-200 in bladder cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231204011900"", ""headline"": ""Purdue Pharma bankruptcy settlement heads to Supreme Court review"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231204022300"", ""headline"": ""Top Contenders Emerge in Johnson & Johnson's Race for New CEO, Plans Under Spotlight After Unexpected Departure"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231204025109"", ""headline"": ""December Dogs Of The Dow: 3 Buyable, 5 Watchable"", ""summary"": ""Some of these Dow Industrials are too pricey and reveals only skinny dividends. Read here about 3 of the 5 lowest-priced Dogs of the Dow which are ready to buy.""}, {""date"": ""20231204032500"", ""headline"": ""The 7 Best Ways to Invest $1,000 in the Stock Market Now"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231204043208"", ""headline"": ""Thinking about buying stock in Johnson & Johnson, Fortress Biotech, MicroStrategy, Neximmune, or ShiftPixy?"", ""summary"": ""NEW YORK, Dec. 4, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for JNJ, FBIO, MSTR, NEXI, and PIXY. ...""}, {""date"": ""20231204045800"", ""headline"": ""JNJ Makes Bullish Cross Above Critical Moving Average"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231204053000"", ""headline"": ""The Executives Who Could Be Johnson & Johnson\u2019s Next CEO"", ""summary"": ""Leading contenders for the helm of one of the world\u2019s biggest healthcare companies are pharmaceuticals chief Jennifer Taubert and CFO Joseph Wolk.""}, {""date"": ""20231204060054"", ""headline"": ""The past one-year earnings decline for Johnson & Johnson (NYSE:JNJ) likely explains shareholders long-term losses"", ""summary"": ""The simplest way to benefit from a rising market is to buy an index fund. But if you buy individual stocks, you can do...""}, {""date"": ""20231204073300"", ""headline"": ""J&J CFO, pharma head reportedly in running to be next CEO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231204080011"", ""headline"": ""Buffett Just Sold Dividend Kings Johnson & Johnson And Procter & Gamble - Buy This One Instead"", ""summary"": ""Buffett recently sold 2 popular Dividend Kings. Read more to see a high yielding Dividend King that we think looks very attractively priced at the moment.""}, {""date"": ""20231204113200"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.32% higher to $158.88 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P...""}, {""date"": ""20231204130434"", ""headline"": ""Pfizer: This Year's Disaster Should Set The Stage For A Strong 2024"", ""summary"": ""Read about Pfizer's challenges in 2023, including decreased demand for COVID-19 vaccines and antiviral products, a destructive tornado, and a weight-loss treatment.""}, {""date"": ""20231204193600"", ""headline"": ""GLOBAL BRIEFING: EU trade deal with South America hangs in the balance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231204195504"", ""headline"": ""Johnson & Johnson Vs. Pfizer: Better Pharma Stock?"", ""summary"": ""We compared Johnson & Johnson with Pfizer Inc., the two largest pharmaceutical companies in the US. Read why JNJ stock is a Buy and PFE stock is a Hold.""}, {""date"": ""20231204201800"", ""headline"": ""Johnson & Johnson's Strategic Forecast: Targets 5%-6% Operational Sales Growth For FY24"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231204215600"", ""headline"": ""Johnson & Johnson: Navigating Growth and Regulatory Challenges in Medical Technology"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231204223300"", ""headline"": ""What You Missed On Wall Street On Tuesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231204234500"", ""headline"": ""Is Buffett Turning Bearish? 7 Stocks Warren Completely Dumped in Q3"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231205012000"", ""headline"": ""Johnson & Johnson sees FY24 adjusted EPS $10.55-$10.75, consensus $10.78"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231205014800"", ""headline"": ""Johnson & Johnson sets 2024 guidance impacted from Laminar buyout"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231205022700"", ""headline"": ""J&J\u2019s stock slightly higher as company offers guidance for 2024 and longer term"", ""summary"": ""Johnson & Johnson\u2019s stock was slightly higher premarket Tuesday, after the healthcare company set guidance for 2024 and for the longer term, ahead of an...""}, {""date"": ""20231205024700"", ""headline"": ""Johnson & Johnson said to be pushing to settle talc lawsuits"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231205031247"", ""headline"": ""Take-Two Interactive, Designer Brands fall premarket;  CVS, Autozone rise"", ""summary"": ""Investing.com -- U.S. futures traded lower Tuesday, with investors turning cautious ahead of the release of job opening data, as a precursor to Friday\u2019s official monthly payrolls number.""}, {""date"": ""20231205032400"", ""headline"": ""TOP NEWS: J&J expects strong long-term growth in three key drivers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231205032700"", ""headline"": ""Nasdaq 100 Forecast: Stocks Slip For A Second Day With Jobs Data In Focus"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231205032800"", ""headline"": ""Johnson & Johnson (NYSE:JNJ) Shares Key Long Term Growth Drivers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231205032912"", ""headline"": ""Johnson & Johnson : long-term objectives unveiled"", ""summary"": ""Johnson & Johnson unveiled its long-term financial targets on Tuesday, saying it wanted to become a leader in the healthcare market as a result of the wave of innovation currently affecting the...""}, {""date"": ""20231205035600"", ""headline"": ""Goldman Sachs: Top 30 mutual fund underweight holdings, including Apple and Tesla"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231205040048"", ""headline"": ""Johnson & Johnson's Investigational TAR-200 Granted U.S. FDA Breakthrough Therapy Designation for the Treatment of High-Risk Non-Muscle-Invasive Bladder Cancer"", ""summary"": ""RARITAN - Johnson & Johnson announced today that the U.S. Food and Drug Administration has granted TAR-200 Breakthrough Therapy Designation for the potential future treatment of patients with...""}, {""date"": ""20231205040600"", ""headline"": ""Buy Rating Affirmed for Johnson & Johnson: Long-Term Growth and Strategic Positioning Underpin Optimistic Outlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231205040700"", ""headline"": ""Unleashing Growth Potential: Johnson & Johnson Surpasses Expectations with Strong Performance and Increasing Profits"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231205041500"", ""headline"": ""Johnson & Johnson (NYSE:JNJ) Shares Its Key Long Term Growth Drivers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231205054200"", ""headline"": ""Publication in Bloomberg Law: \u2018A Third J&J Bankruptcy Attempt Won\u2019t Resolve Victims\u2019 Talc Claims\u2019 by Andy Birchfield"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231205060100"", ""headline"": ""J&J pitches investors on sales growth from cancer, immune disease drugs"", ""summary"": ""The company expects its pharmaceutical division to deliver 20 new medicines through the end of the decade, including several it believes could earn peak annual sales of more than $5 billion.""}, {""date"": ""20231205060600"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231205071500"", ""headline"": ""Johnson & Johnson Announces Key Drivers for Long-Term Competitive Growth at Enterprise Business Review"", ""summary"": ""NEW BRUNSWICK, N.J., December 05, 2023--Johnson & Johnson (NYSE: JNJ) (the \u2018Company\u2019) is hosting a meeting today with the investment community at the New York Stock Exchange to present the Company\u2019s overarching strategy, its diverse and robust Innovative Medicine and MedTech pipelines and long-term financial outlook.""}, {""date"": ""20231205071752"", ""headline"": ""Johnson & Johnson forecasts as much as 6% sales growth in 2024"", ""summary"": ""(Reuters) -Johnson & Johnson on Tuesday forecast revenue growth of 5-6% for 2024, its first full year after hiving off its consumer health unit, on strong demand for cancer treatments Darzalex and Carvykti, and blockbuster psoriasis drug Stelara.  \""I think they can earn closer to $10.85 vs the $10.55-10.75 guidance,\"" said Jeff Jonas, portfolio manager at Gabelli Funds, adding the company's profit per share target is \""always very conservative.\""  Sales of Stelara in Europe are expected to come under pressure as a key patent on the drug expires next year.""}, {""date"": ""20231205074000"", ""headline"": ""J&J's (JNJ) Bladder Cancer Drug Gets FDA's Breakthrough Tag"", ""summary"": ""FDA grants Breakthrough Therapy Designation to J&J's (JNJ) TAR-200 for high-risk non-muscle-invasive bladder cancer based on data from the phase IIb SunRISe-1 study.""}, {""date"": ""20231205075700"", ""headline"": ""Johnson & Johnson Targets Sales Growth in Years Ahead"", ""summary"": ""Johnson & Johnson is targeting sales growth of as much as 7% a year in the coming years, driven by its innovative medicine and MedTech operations.""}, {""date"": ""20231205080700"", ""headline"": ""Johnson & Johnson Stock Edges Higher After Guidance Release"", ""summary"": ""Johnson & Johnson  stock was edging higher after the pharmaceutical and medical-device company shared its long-term financial outlook.  In a release before a meeting with the investment community at the New York Stock Exchange on Tuesday, the company said it expects operational sales growth in the range of 5% to 6% in 2024, which excludes revenue from the Covid-19 vaccine.  Analysts had called for sales growth of 3.3%, according to FactSet.""}, {""date"": ""20231205111400"", ""headline"": ""NEW YORK MARKET CLOSE: Stocks mixed as soft jobs data backs pivot view"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231205113200"", ""headline"": ""Johnson & Johnson stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Johnson & Johnson slid 0.21% to $158.55 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""20231205120350"", ""headline"": ""UPDATE 1-Johnson & Johnson forecasts as much as 6% sales growth in 2024"", ""summary"": ""Johnson & Johnson on Tuesday forecast revenue growth of 5-6% for 2024, its first full year after hiving off its consumer health unit, on strong demand for cancer treatments Darzalex and Carvykti, and blockbuster psoriasis drug Stelara.  \""I think they can earn closer to $10.85 vs the $10.55-10.75 guidance,\"" said Jeff Jonas, portfolio manager at Gabelli Funds, adding the company's profit per share target is \""always very conservative.\""  Sales of Stelara in Europe are expected to come under pressure as a key patent on the drug expires next year.""}, {""date"": ""20231205151400"", ""headline"": ""Top Analyst Reports for Johnson & Johnson, T-Mobile & Caterpillar"", ""summary"": ""Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), T-Mobile US, Inc. (TMUS) and Caterpillar Inc. (CAT).""}, {""date"": ""20231205174510"", ""headline"": ""Johnson & Johnson (JNJ) Sees a More Significant Dip Than Broader Market: Some Facts to Know"", ""summary"": ""In the latest trading session, Johnson & Johnson (JNJ) closed at $158.55, marking a -0.21% move from the previous day.""}, {""date"": ""20231205182345"", ""headline"": ""J&J says it has settled some talc claims, will continue bankruptcy strategy"", ""summary"": ""Johnson & Johnson's worldwide vice president for litigation said on Tuesday that the company has recently reached settlements with several law firms over their clients' claims that J&J talc products caused cancer.  The settlements were reached \""with a goal to facilitate our pursuit of a consensual prepackaged bankruptcy resolution,\"" Erik Haas said on an investor call.  J&J said in October that it was considering a new bankruptcy filing to resolve talc claims.""}, {""date"": ""20231205215300"", ""headline"": ""Elliott Wave Technical Analysis: Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231205232100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Merus (MRUS), Johnson & Johnson (JNJ) and IGM Biosciences (IGMS)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231206003400"", ""headline"": ""White House to back controversial patent ploy to fight drug costs, STAT says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231206005100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Ping An Healthcare and Technology Company (OtherPANHF), Healthequity (HQY) and Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231206005100"", ""headline"": ""Citi opens 'positive catalyst watch' on Legend Biotech"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231206012123"", ""headline"": ""J&J hernia mesh settlement prompts judge to dismiss more than 200 cases"", ""summary"": ""The company and\u00a0claimants in Georgia\u00a0filed to dismiss cases related to Ethicon\u2019s Physiomesh\u00a0in late November.""}, {""date"": ""20231206013800"", ""headline"": ""Johnson & Johnson price target raised by $5 at Stifel, here's why"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231206014200"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), CVS Health (CVS) and Vertex Pharmaceuticals (VRTX)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231206023000"", ""headline"": ""Pharma Stocks With Nice Dividends: The RX Investors Need"", ""summary"": ""Many healthcare stocks have been under the weather this year amid concerns about the advent of weight-loss drugs, weaker Covid-related sales, and the market\u2019s narrow focus on a handful of tech names.  \u201cThe demographics alone are a huge tailwind for this sector,\u201d says Stephanie Link, chief investment strategist at Hightower Advisors.  No doubt, 2023 has been a forgettable year for many healthcare stocks.""}, {""date"": ""20231206024700"", ""headline"": ""Johnson & Johnson Settles Multiple Lawsuits Over Talc Cancer Claims, Eyes Prepackaged Bankruptcy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231206033500"", ""headline"": ""How To Live Off Of Dividends For Potentially Life-Changing Passive Income"", ""summary"": ""Achieving financial independence through passive income can truly be life changing. Find out why and how to do this and some of our top picks.""}, {""date"": ""20231206034400"", ""headline"": ""Johnson & Johnson price target raised to $181 from $178 at RBC Capital"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231206042900"", ""headline"": ""The Zacks Analyst Blog Highlights Johnson & Johnson, T-Mobile US, Caterpillar, Broadcom and Starbucks"", ""summary"": ""Johnson & Johnson, T-Mobile US, Caterpillar, Broadcom and Starbucks are included in this Analyst Blog.""}, {""date"": ""20231206052200"", ""headline"": ""Top stocks with highest hedge fund + mutual fund positions, according to GS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231206053000"", ""headline"": ""JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231206054000"", ""headline"": ""Top 30 stocks with highest hedge fund + mutual fund short positions \u2013 GS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231206055558"", ""headline"": ""5 takeaways from J&J\u2019s investor day"", ""summary"": ""The company outlined its long-term growth expectations and confirmed that it has no plans to separate its medtech and pharma segments.""}, {""date"": ""20231206060900"", ""headline"": ""30 Stocks shunned by hedge and mutual funds - GS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231206065955"", ""headline"": ""His dad worked on the factory floor at Johnson & Johnson. Now he\u2019s the CFO"", ""summary"": ""Joe Wolk, with J&J for over 25 years, talks about his path and the company's focus on innovation.""}, {""date"": ""20231206085621"", ""headline"": ""Bargain Buys: 7 Stocks Lagging the S&P 500 With Big Potential"", ""summary"": ""With the S&P 500 index stunningly back to its winning ways, it may be time to get on the bandwagon but with bargain stocks with potential. In other words, these enterprises presently lag the benchmark on a year-to-date basis. However, they could offer better bang for the buck over the intermediate to long term. First, while the broader equities space has responded positively to strong holiday sales, it\u2019s not entirely clear that the underlying consumer base can keep up the spending. For example,""}, {""date"": ""20231206112900"", ""headline"": ""J&J (JNJ) Announces 2024 and Long-Term Financial Outlook"", ""summary"": ""J&J (JNJ) expects operational sales growth in the range of 5-6% in 2024, driven by both its Innovative Medicine and MedTech divisions.""}, {""date"": ""20231206113200"", ""headline"": ""Johnson & Johnson stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slipped 1.22% to $156.62 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P...""}, {""date"": ""20231206123500"", ""headline"": ""Johnson & Johnson says it's finally making 'progress' on disturbing cancer lawsuits"", ""summary"": ""Johnson & Johnson (J&J) has been under fire for a decade for a myriad of cases alleging that its talc-based baby powder has caused cancer.  In a meeting at the New York Stock Exchange on Tuesday, J&J  in-house lawyer Eric Haas told investors that the company has made \""progress\"" in the last few weeks by \""resolving\"" some of the cases it's facing, according to a report by Bloomberg.  J&J is facing over 50,000 cases that claim it hid the cancer risk that comes with using its baby powder.""}, {""date"": ""20231206210300"", ""headline"": ""Strong Growth Ahead: Buy Rating for Johnson & Johnson Amid Exceeding Long-Term Projections"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231207010400"", ""headline"": ""Vanda Pharmaceuticals acquires U.S. and Canadian rights to PONVORY"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231207012200"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), Johnson & Johnson (JNJ) and Veeva Systems (VEEV)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231207014300"", ""headline"": ""Vanda stock jumps on $100M license deal for MS drug from J&J unit"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231207015100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN), Johnson & Johnson (JNJ) and Elanco Animal Health (ELAN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231207031700"", ""headline"": ""(JNJ) - Analyzing Johnson & Johnson's Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231207040400"", ""headline"": ""Biggest stock movers today: Google, AMD, GameStop, C3.AI, Chewy and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231207041600"", ""headline"": ""Cantor Fitzgerald healthcare analysts hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231207054200"", ""headline"": ""Kenvue gains amid hearing on purported Tylenol linkage to austism in children"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231207060000"", ""headline"": ""Kenvue gains amid hearing on purported Tylenol linkage to autism in children"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231207063700"", ""headline"": ""Vanda Pharmaceuticals Acquires Rights To Multiple Sclerosis Drug From Johnson & Johnson's Company"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231207073800"", ""headline"": ""Kenvue gains amid hearing on purported Tylenol linkage to autism in children (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231207074500"", ""headline"": ""Walgreens\u2019 stock soars 8% to lead Dow gainers but is still on track for worst year since 1972"", ""summary"": ""Walgreens' stock rose ahead of a ruling on what scientific evidence can be cited in lawsuits alleging that use of Tylenol by pregnant women can lead to...""}, {""date"": ""20231207085259"", ""headline"": ""A CEO contender left Johnson & Johnson. Was she penalized for saying she wanted to be a CEO?"", ""summary"": ""The exit of a Johnson & Johnson exec raises an age-old question about women's ambition.""}, {""date"": ""20231207111901"", ""headline"": ""Johnson & Johnson to Participate in the 42nd Annual J.P. Morgan Healthcare Conference"", ""summary"": ""Johnson & Johnson will participate in the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8th, at the Westin St. Francis in San Francisco, CA. Joaquin Duato, Chairman and Chief...""}, {""date"": ""20231207112016"", ""headline"": ""Top 20 Most Valuable American Companies Today"", ""summary"": ""In this article, we will be taking a look at the top 20 most valuable American companies today. To skip our detailed analysis, you can go directly to see the top 5 most valuable American companies today. When the U.S. sneezes, the world catches a cold. This one saying illustrates the importance of the U.S. [\u2026]""}, {""date"": ""20231207113200"", ""headline"": ""Johnson & Johnson stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Johnson & Johnson slid 0.78% to $155.40 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""20231207115052"", ""headline"": ""15 Stocks ChatGPT Says Will Make Me Rich in 10 Years"", ""summary"": ""In this article, we will take a detailed look at the 15 Stocks ChatGPT Says Will Make Me Rich in 10 Years. For a quick overview of the 5 such stocks, read our article 5 Stocks ChatGPT Says Will Make Me Rich in 10 Years. Picking individual stocks to beat the market is getting harder by the [\u2026]""}, {""date"": ""20231207124744"", ""headline"": ""20 Countries with Free Health Care"", ""summary"": ""In this article, we will be taking a look at the 20 countries with free health care. To skip our detailed analysis, you can go directly to see the 5 countries with free health care. The U.S. is one of the only advanced countries in the world to not have free healthcare, which is said [\u2026]""}, {""date"": ""20231207130000"", ""headline"": ""My Top 10 High Dividend Yield Companies For December 2023"", ""summary"": ""High dividend yield companies can provide investors with several benefits, such as generation of income and reduction of portfolio volatility. Read more here.""}, {""date"": ""20231207135344"", ""headline"": ""Investing in the Aging Population: 3 Healthcare Stocks to Watch"", ""summary"": ""In 2016, there were 49 million Americans aged 65 or older. Analysts forecast that will grow to 73 million retirement-age Americans in 2030 and an eye-opening 95 million in the year 2060. Needless to say, America\u2019s aging population will be an investing megatrend in the years to come. Given America\u2019s prosperity, a ton of money will go into healthcare companies that can extend lifespans and give people more quality time in their golden years. These three healthcare stocks, in particular, are set to""}, {""date"": ""20231208001800"", ""headline"": ""Nanobiotix initiated with an Outperform at Leerink"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231208021209"", ""headline"": ""New Jersey Appellate Court Reverses Plaintiff Jury Verdict In Talc Litigation Based On Improperly Admitted Plaintiff Expert Opinions"", ""summary"": ""On October 3, 2023, a three-judge panel from the Superior Court of New Jersey Appellate Division reversed a jury verdict against Johnson & Johnson over accusations its asbestos-tainted talcum powder...""}, {""date"": ""20231208065400"", ""headline"": ""Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231208073000"", ""headline"": ""7 Tech Stocks to Light Up Your Portfolio This Holiday Season"", ""summary"": ""As the festive season rolls in, finding the best tech stocks to buy is exciting, lighting up various sectors with innovative energy. These industry giants are showing impressive resilience and growth across diverse fields, from groundbreaking pharmaceuticals and cloud services to AI-powered customer interactions, cutting-edge semiconductor technology, and the expanding world of streaming platforms. Pfizer (PFE) Source: photobyphm / Shutterstock.com One of Pfizer\u2019s (NYSE:PFE) significant strength""}, {""date"": ""20231208080027"", ""headline"": ""Insiders At Johnson & Johnson Sold US$5.6m In Stock, Alluding To Potential Weakness"", ""summary"": ""Over the past year, many Johnson & Johnson ( NYSE:JNJ ) insiders sold a significant stake in the company which may have...""}, {""date"": ""20231208113200"", ""headline"": ""Johnson & Johnson stock falls Friday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slipped 0.63% to $154.42 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""20231208120031"", ""headline"": ""The 4 Key Qualities Of Dividend Stocks That You Can Retire On"", ""summary"": ""Four essential qualities are needed in a dividend stock to make it a worthy holding in your passive income portfolio. Click here to read our stock picks with these qualities.""}, {""date"": ""20231209040000"", ""headline"": ""How To Invest $100,000 Today In A Sleep Well Portfolio"", ""summary"": ""The economic cycles have always been with us. But the frequency of boom and bust cycles has certainly increased in the last couple of decades. Read more here.""}, {""date"": ""20231209055100"", ""headline"": ""3 Dividend Stocks You Can Safely Hold for Decades"", ""summary"": ""Remember Montgomery Ward, Lehman Brothers, and Pan Am?  Investors who bought those stocks counting on receiving steady dividends throughout their lifetimes were sorely disappointed.  Here are three dividend stocks that you can safely hold for decades.""}]",{}
48,2023-12-10,150.8822479248047,2023-12-17,151.6053009033203,0.004792167325582186,U1,"[{""date"": ""20231210203900"", ""headline"": ""Blood Cancer Player Arcellx's Lead Product Exceeds Expectations, Analysts Say"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231210214300"", ""headline"": ""Life-Changing Investments: 3 Stocks That Will Set You Up for the Long Haul"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231210223300"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231211000500"", ""headline"": ""Johnson & Johnson: An Exploration into Its Intrinsic Value"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231211050600"", ""headline"": ""5 Phenomenal Stocks in Warren Buffett's \""Secret\"" Portfolio That Are Screaming Buys in 2024"", ""summary"": ""The Oracle of Omaha's $610 million hidden portfolio has five amazing bargains hiding in plain sight.""}, {""date"": ""20231211053000"", ""headline"": ""2 Top Dividend Stocks to Buy Now"", ""summary"": ""This is exactly what dividend stocks offer you: the promise of regular payments each year no matter what the market is doing.  The passive income can limit your losses during market downturns and boost your winnings when stocks are soaring.  Which dividend stocks should you choose?""}, {""date"": ""20231211061800"", ""headline"": ""Gilead Sciences Battles Rising Threat of Drug Counterfeiting, Initiates Legal Actions"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231211065649"", ""headline"": ""Should You Consider Adding Kenvue(KVUE) to Your Portfolio?"", ""summary"": ""Mayar Capital, an investment management firm, released its \u201cMayar Responsible Global Equity Fund\u201d third quarter 2023 investor letter. A copy of the same can be downloaded here. The fund was down -5.26% net of all expenses and fees, while the MSCI World Index decreased by -4.31% in the same period. The fund has increased 168.57% [\u2026]""}, {""date"": ""20231211121833"", ""headline"": ""The Cooper Companies: Not In My Sight Yet"", ""summary"": ""The Cooper Companies, Inc., with a growing medical device business and market share in CooperVision, offers better value. Click for my take on COO stock now.""}, {""date"": ""20231211161500"", ""headline"": ""Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results"", ""summary"": ""NEW BRUNSWICK, N.J., December 11, 2023--Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, January 23rd to review fourth-quarter results. Joaquin Duato, Chairman and CEO, Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Jessica Moore, Vice President, Investor Relations will host the call.""}, {""date"": ""20231211174518"", ""headline"": ""Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) closed at $155.06 in the latest trading session, marking a +0.41% move from the prior day.""}, {""date"": ""20231212013600"", ""headline"": ""Johnson & Johnson price target lowered by $1 at Morgan Stanley, here's why"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231212044400"", ""headline"": ""The biopharma stocks to own in 2024, according to Morgan Stanley"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231212045007"", ""headline"": ""Why heart device makers are investing in left atrial appendage closure"", ""summary"": ""Medtronic and Johnson & Johnson are pursuing\u00a0a market that leader Boston Scientific predicts could hit $6 billion by 2030.""}, {""date"": ""20231212061200"", ""headline"": ""J&J: Data from Phase 3 PERSEUS study shows improvement in outcomes for patients"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231212062200"", ""headline"": ""Johnson & Johnson Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231212065600"", ""headline"": ""Eli Lilly: The Party Is Over"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231212072100"", ""headline"": ""JNJ multiple myeloma therapy outperforms standard of care by 58%"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231212112227"", ""headline"": ""10 A-Rated Stocks Billionaires Are Loading Up On"", ""summary"": ""In this piece, we will take a look at the ten A-Rated stocks billionaires are loading up on. If you want to skip our overview of the stock market and the latest news, then you can take a look at 5 A-Rated Stocks Billionaires Are Loading Up On. The stock market is made of thousands [\u2026]""}, {""date"": ""20231212113200"", ""headline"": ""Johnson & Johnson stock rises Tuesday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.01% higher to $155.07 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""20231212141000"", ""headline"": ""Secular Bull Market - Part III"", ""summary"": ""2024 should be another positive year for capital market returns, specifically the major equity and fixed income benchmark indices.""}, {""date"": ""20231212145139"", ""headline"": ""Kenvue: A High-Quality Consumer Health Company on Sale"", ""summary"": ""This newly created health and beauty company is undervalued""}, {""date"": ""20231212221400"", ""headline"": ""What You Missed On Wall Street On Wednesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231212230900"", ""headline"": ""Johnson & Johnson just downgraded at Wells Fargo, here's why"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231213001800"", ""headline"": ""Integra to acquire Acclarent from Johnson & Johnson for $275M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231213013600"", ""headline"": ""GLOBAL BROKER RATINGS: UBS raises BASF; JPMorgan cuts LVMH"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231213014100"", ""headline"": ""Protagonist earns $10M payment for milestone in Phase 2b ANTHEM-UC study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231213015100"", ""headline"": ""D.R. Horton To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231213024700"", ""headline"": ""Economic Safety Nets: 7 Defensive Stocks Providing Portfolio Stability"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231213033819"", ""headline"": ""Ford cut to Neutral on dwindling F-150 EV truck demand outlook: 4 big analyst cuts"", ""summary"": ""Reports from earlier this week indicated that Ford plans to halve the production of its F-150 Lightning electric pickup truck in 2024, citing \""changing market demand\"" as the reason. This move reflects a broader industry trend of reducing electric vehicle investments due to slower-than-expected sales growth.""}, {""date"": ""20231213035100"", ""headline"": ""Microsoft initiated, Hertz downgraded: Wall Street's top analyst calls"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231213041900"", ""headline"": ""Video: Dow Movers: JNJ, AAPL"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231213042100"", ""headline"": ""Key Talc Lawyers: Planned \u201cPrepack\u201d J&J Bankruptcy is \u201cFarce\u201d and Improper Litigation Tactic"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231213042803"", ""headline"": ""J&J : promising results in multiple myeloma"", ""summary"": ""Johnson & Johnson has announced new results from a Phase III study of Carvykti in adults with relapsed lenalidomide-refractory multiple myeloma who have received one to three prior lines of therapy ....""}, {""date"": ""20231213050003"", ""headline"": ""J&J : new positive data in multiple myeloma"", ""summary"": ""Johnson & Johnson has announced that initial data from a Phase 3 study demonstrate significant clinical improvement in newly diagnosed multiple myeloma patients eligible for transplantation with a...""}, {""date"": ""20231213052200"", ""headline"": ""Pfizer hits 52-week low, drags COVID vaccine peers on weak guidance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231213052400"", ""headline"": ""Neurosurgery Focused Integra LifeSciences Bolsters Its ENT Portfolio With $275M Acquisition Deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231213055604"", ""headline"": ""J&J : shares fall behind Pfizer and an analyst downgrade"", ""summary"": ""On Wednesday, Johnson & Johnson posted the second biggest drop in the Dow Jones index, penalized by Pfizer's disappointing forecasts and a downgrading by Wells Fargo analysts.A little less than an...""}, {""date"": ""20231213062932"", ""headline"": ""20 Biggest Multinational Companies Headquartered in the US"", ""summary"": ""In this article, we will take a look at the 20 biggest multinational companies headquartered in the US. If you want to skip our detailed analysis, you can go directly to 5 Biggest Multinational Companies Headquartered in the US. The Future of Multinational Companies According to a report by Deloitte, a sweeping international tax policy [\u2026]""}, {""date"": ""20231213065000"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231213070000"", ""headline"": ""Seeking Passive Income? 7 Dividend Stocks You Don\u2019t Want to Miss."", ""summary"": ""The quest for the passive income from a stable investment avenues beckons toward dividend stocks. Enter a realm where industry giants don their strategic armor, ready to navigate the tides of market dynamics and consumer demands. The stage is set for an enthralling exploration of seven passive income juggernauts. Each is an emblem of innovation and resilience in their respective domains. These passive income plays offer investors a panoramic view of the dividend stock landscape in the ever-evolv""}, {""date"": ""20231213071100"", ""headline"": ""Wells Fargo lowers J&J to equal weight, cites Stelara patent cliff"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231213080020"", ""headline"": ""Johnson & Johnson's (NYSE:JNJ) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?"", ""summary"": ""Johnson & Johnson (NYSE:JNJ) has had a rough three months with its share price down 5.3%. However, the company's...""}, {""date"": ""20231213090011"", ""headline"": ""Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know"", ""summary"": ""Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.""}, {""date"": ""20231213113200"", ""headline"": ""Johnson & Johnson stock rises Wednesday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.46% higher to $155.79 Wednesday, on what proved to be an all-around positive trading session for the stock market, with...""}, {""date"": ""20231213121700"", ""headline"": ""Johnson & Johnson Earnings to Be Hit by Loss of Stelara Exclusivity, Wells Fargo Says"", ""summary"": ""Johnson & Johnson  stock was trading lower Wednesday after a Wells Fargo analyst cited concerns over the company\u2019s future earnings growth.  The healthcare company stands to lose exclusive U.S. rights to a major drug, Stelara, in 2025.  Wells Fargo analyst Larry Biegelsen downgraded J&J shares to Equal Weight from Overweight and lowered his price target to $163 from $170.""}, {""date"": ""20231214013000"", ""headline"": ""Rain Oncology Goes Private Just Two Years After $120M NASDAQ Debut"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214023400"", ""headline"": ""Ryan Cohen Plans to Save GameStop By Becoming Warren Buffett"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214044900"", ""headline"": ""Vertex Pharmaceuticals: Growth Is Still a Better Choice"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214045000"", ""headline"": ""Cantor Fitzgerald healthcare analysts hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231214080539"", ""headline"": ""Wells Fargo Downgrades Johnson & Johnson (JNJ)"", ""summary"": """"}, {""date"": ""20231214113200"", ""headline"": ""Johnson & Johnson stock rises Thursday, outperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.69% higher to $156.87 Thursday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""20231214145641"", ""headline"": ""3 Dow Stocks I Wouldn\u2019t Touch With a 10-Foot Pole"", ""summary"": ""The Dow Jones Industrial Average, or Dow 30, is an index of 30 blue-chip stocks that, taken together, is supposed to serve as a bellwether for the American economy. But that doesn\u2019t mean that every stock in the Dow is a strong performer. Quite the opposite. Many of the stocks in the Dow are of companies that have grown long in the tooth and are now considered to be value traps. Critics of the Dow point to the current crop of underperforming stocks and claim that the index is outdated and no long""}, {""date"": ""20231214210500"", ""headline"": ""The Dogs of the Dow May Pay Big Dividends in 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231215012600"", ""headline"": ""AC Immune reports ACI-35.030 advances into Phase 2b trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231215075200"", ""headline"": ""AC Immune Alzheimer's drug advanced into Phase 2b testing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231215105400"", ""headline"": ""IXJ: Healthcare Dashboard For December"", ""summary"": ""iShares Global Healthcare is a global alternative to Healthcare Select Sector SPDR Fund. Click here to read an analysis on IXJ ETF here.""}, {""date"": ""20231215113200"", ""headline"": ""Johnson & Johnson stock falls Friday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson shed 1.09% to $155.16 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""20231215122622"", ""headline"": ""The 7 Most Undervalued Dividend Stocks to Buy in December"", ""summary"": ""2023 has been mixed for growth stocks but I believe the worst is over. There is high optimism in the stock market as we end the year on a high note. However, if you want to secure your portfolio from such ups and downs and are looking for ways to generate passive income, considering top dividend stocks to buy is the best way forward. But, all dividend stocks aren\u2019t the same and some are more promising than many others. You need to look for companies that have shown steady growth, and resilience""}, {""date"": ""20231216123033"", ""headline"": ""12 Best Slow Growth Stocks To Buy According To Hedge Funds"", ""summary"": ""In this article, we will take a detailed look at the 12 Best Slow Growth Stocks To Buy According To Hedge Funds. For a quick overview of such stocks, read our article 5 Best Slow Growth Stocks To Buy According To Hedge Funds. It would be interesting to see how markets react to the latest events after a statement [\u2026]""}, {""date"": ""20231216235000"", ""headline"": ""BTIG makes top medtech stock picks for 2024, sees sector stabilizing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231217060000"", ""headline"": ""\u2018You'll be a millionaire when you're 65': Kevin O'Leary says you must save this percentage of your income for a healthy retirement \u2014 and even gives his 3 top stocks for new investors"", ""summary"": ""'You can't assume someone will be there for you,' says the Shark Tank star.""}, {""date"": ""20231217060125"", ""headline"": ""Is Johnson & Johnson (NYSE:JNJ) Using Too Much Debt?"", ""summary"": ""David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...""}, {""date"": ""20231217140000"", ""headline"": ""3 of the Most Attractive Dividend Stocks in the Pharma Space"", ""summary"": ""In the realm of investment, pharma dividend stocks are a beacon for both stability and growth. This sector not only enhances the quality of life on a global scale but also presents lucrative opportunities for long-term investors. Moreover, given the evergreen nature of healthcare demand which remains sturdy across economic cycles, pharma businesses exhibit remarkable resilience. They channel substantial investments into research and development. And, they effectively pave the way for innovative""}, {""date"": ""20231217163447"", ""headline"": ""Tracking Prem Watsa's Fairfax Financial Holdings Portfolio - Q3 2023 Update"", ""summary"": ""Prem Watsa's 13F portfolio value decreased slightly to $1.86B this quarter. Click here to read more about Fairfax Financial's holdings and trades for Q3 2023.""}]",{}
49,2023-12-17,151.6053009033203,2023-12-24,151.8984375,0.0019335511023235163,U1,"[{""date"": ""20231216235000"", ""headline"": ""BTIG makes top medtech stock picks for 2024, sees sector stabilizing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231217060000"", ""headline"": ""\u2018You'll be a millionaire when you're 65': Kevin O'Leary says you must save this percentage of your income for a healthy retirement \u2014 and even gives his 3 top stocks for new investors"", ""summary"": ""'You can't assume someone will be there for you,' says the Shark Tank star.""}, {""date"": ""20231217060125"", ""headline"": ""Is Johnson & Johnson (NYSE:JNJ) Using Too Much Debt?"", ""summary"": ""David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...""}, {""date"": ""20231217140000"", ""headline"": ""3 of the Most Attractive Dividend Stocks in the Pharma Space"", ""summary"": ""In the realm of investment, pharma dividend stocks are a beacon for both stability and growth. This sector not only enhances the quality of life on a global scale but also presents lucrative opportunities for long-term investors. Moreover, given the evergreen nature of healthcare demand which remains sturdy across economic cycles, pharma businesses exhibit remarkable resilience. They channel substantial investments into research and development. And, they effectively pave the way for innovative""}, {""date"": ""20231217163447"", ""headline"": ""Tracking Prem Watsa's Fairfax Financial Holdings Portfolio - Q3 2023 Update"", ""summary"": ""Prem Watsa's 13F portfolio value decreased slightly to $1.86B this quarter. Click here to read more about Fairfax Financial's holdings and trades for Q3 2023.""}, {""date"": ""20231218020100"", ""headline"": ""Sanofi: The Current Price Makes No Sense"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231218040000"", ""headline"": ""Janssen treatment of ADPKD granted FDA orphan designation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231218044325"", ""headline"": ""13 Most Profitable Pharmaceutical Stocks Now"", ""summary"": ""In this article, we discuss the 13 most profitable pharmaceutical stocks to buy. You can skip our detailed analysis of the pharmaceutical sector and its outlook this year, and go directly to read the 5 Most Profitable Pharmaceutical Stocks Now. The healthcare sector encompasses a diverse range of companies, spanning pharmaceuticals, medical equipment and device [\u2026]""}, {""date"": ""20231218050900"", ""headline"": ""The Zacks Analyst Blog Highlights JPMorgan Chase, Abbott Laboratories, Qualcomm, Johnson & Johnson and BHP"", ""summary"": ""JPMorgan Chase, Abbott Laboratories, Qualcomm, Johnson & Johnson and BHP are included in this Analyst Blog.""}, {""date"": ""20231218061108"", ""headline"": ""XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector"", ""summary"": ""XLV comprises major healthcare industry players and offers a convenient and cost-effective way to invest in the sector. Find out my analysis of XLV ETF.""}, {""date"": ""20231218113200"", ""headline"": ""Johnson & Johnson stock rises Monday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.18% higher to $155.44 Monday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""20231218174519"", ""headline"": ""Johnson & Johnson (JNJ) Increases Yet Falls Behind Market: What Investors Need to Know"", ""summary"": ""In the latest trading session, Johnson & Johnson (JNJ) closed at $155.44, marking a +0.18% move from the previous day.""}, {""date"": ""20231219022300"", ""headline"": ""Kenvue shares rise after favorable court ruling in Tylenol litigation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231219032200"", ""headline"": ""Kenvue's stock rises after favorable court ruling in Tylenol litigation"", ""summary"": ""Kenvue shares gained nearly 5% Tuesday morning after a federal court's ruling in a product-liability case appeared to work in the Tylenol maker's favor.""}, {""date"": ""20231219043900"", ""headline"": ""J&J spinoff rises following favorable Tylenol court ruling"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231219045400"", ""headline"": ""Kenvue gains as ruling in Tylenol case likely collapses plaintiffs case - analyst"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231219050000"", ""headline"": ""3 Healthcare Stocks That Could Help Make You a Millionaire"", ""summary"": ""These stocks each have reached an important turning point that could signal growth ahead.""}, {""date"": ""20231219054900"", ""headline"": ""Kenvue\u2019s stock rises after favorable court ruling in Tylenol litigation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231219064800"", ""headline"": ""See How Johnson & Johnson Ranks Among Analysts' Top Dow 30 Picks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231219071600"", ""headline"": ""Video: Dow Analyst Moves: JNJ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231219085110"", ""headline"": ""7 New Year\u2019s Stocks to Buy to Get 2024 Off to a Bright Start"", ""summary"": ""With another year in the global markets coming to a close, now is a great time to consider stocks to buy for 2024. Part of the reason is to establish a framework for navigating the myriad uncertainties that could lie ahead. For example, there\u2019s a lot of talk about the Federal Reserve\u2019s monetary policy these days. With the central bank broadcasting the acknowledgment of a possible policy pivot, the development sparked considerable enthusiasm of what could lie ahead. That helps fuel motivation for""}, {""date"": ""20231219113200"", ""headline"": ""Johnson & Johnson stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.66% higher to $156.46 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""20231219132100"", ""headline"": ""Kenvue Shares Are Rising. Tylenol Litigation Fades Into the Rearview."", ""summary"": ""A ruling hurts litigation against Kenvue that alleges a link between prenatal exposure to the company\u2019s Tylenol and autism spectrum disorder or ADHD.""}, {""date"": ""20231219155226"", ""headline"": ""Lawsuits claiming Tylenol causes autism lack scientific support, judge finds"", ""summary"": ""A judge has barred expert witnesses from testifying that Johnson & Johnson spin-off Kenvue's painkiller Tylenol can cause autism if mothers take it during pregnancy, finding that they failed to support their conclusions with scientific evidence.  The ruling on Monday by U.S. District Judge Denise Cote in Manhattan federal court likely means the end of a consolidated mass tort litigation of about 500 lawsuits over the popular over-the-counter drug, unless plaintiffs get it reversed on appeal.  Cote, in a 148-page ruling, found that none of the five expert witnesses proposed by the plaintiffs had offered a sound scientific methodology to support their opinion that Tylenol's active ingredient, acetaminophen, could cause autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD).""}, {""date"": ""20231219170050"", ""headline"": ""Forever Favorites: 7 Dividend Stocks to Buy and Never Sell"", ""summary"": ""Some investments just look after themselves. They are \u201cset it and forget it\u201d kind of stocks. Typically they pay dividends because dividend stocks tend to be profitable businesses that have been through the mill a time or two. They want to share their success with their investors. The asset managers at Hartford Funds looked at the performance of the benchmark S&P 500 going all the way back to 1930. They found dividends contributed 40% to the total return of the index over that 93-year period. Mor""}, {""date"": ""20231220020000"", ""headline"": ""IUSV: An Old Value ETF Beating Most Competitors"", ""summary"": ""iShares Core S&P U.S. Value ETF is a well-diversified and consistently outperforming fund for long-term investors and tactical traders. Find out more on IUSV.""}, {""date"": ""20231220020100"", ""headline"": ""Lantheus Holdings Is Charting a Path to Sustainable Growth and Value"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231220031217"", ""headline"": ""11 Best Roth IRA Stocks To Buy According To Hedge Funds"", ""summary"": ""In this article, we discuss the 11 best Roth IRA stocks to buy according to hedge funds. If you want to read about some more Roth IRA stocks, go directly to 5 Best Roth IRA Stocks To Buy According To Hedge Funds. In 2022, recession fears had clouded the marketplace as the Federal Reserve in [\u2026]""}, {""date"": ""20231220045300"", ""headline"": ""Judge Bars Testimony Linking Kenvue's Pain Killer Tylenol to Autism in Pregnancy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231220050000"", ""headline"": ""COVAX Global Initiative For COVID-19 Vaccines Comes To An End Amid Shift To Regular Programs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231220113100"", ""headline"": ""Johnson & Johnson stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Johnson & Johnson slipped 2.04% to $153.27 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P...""}, {""date"": ""20231220151040"", ""headline"": ""11 Best Fundamental Stocks to Buy"", ""summary"": ""In this article, we discuss the 11 best fundamental stocks to buy. If you want to skip our detailed analysis of these stocks, go directly to the 5 Best Fundamental Stocks to Buy. The United States economy is one of the most resilient in the world. This is aptly illustrated by the fact that the [\u2026]""}, {""date"": ""20231220201100"", ""headline"": ""Noteworthy Thursday Option Activity: JNJ, CTAS, AON"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231220202600"", ""headline"": ""J&J submits sBLA to FDA for Rybrevant combo in non-small cell lung cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231220204900"", ""headline"": ""J&J submits sBLA and NDA to FDA for approval of Rybrevant combo in NSCLC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231221010500"", ""headline"": ""MeiraGTx announces asset purchase agreement with Janssen for bota-vec"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231221021500"", ""headline"": ""Warren Buffett's Wealth-Building Formula: Consider VIG Instead Of Berkshire Hathaway"", ""summary"": ""We examine several Buffett quotes that encapsulate his wealth-building formula and look at why VIG could be a better option than Berkshire Hathaway.""}, {""date"": ""20231221034402"", ""headline"": ""Johnson & Johnson : Janssen Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval of Lazertinib, in combination with RYBREVANT\u00ae\u25bc (amivantamab), for the First-Line Treatment of Patients with EGFR-Mutated Non-Small Cell Lung Cancer"", ""summary"": ""News Release Media Contacts: Zayn Qureshi +44 7760 334666 Email: zqureshi@its.jnj.com Investor...""}, {""date"": ""20231221035400"", ""headline"": ""Johnson & Johnson Stock (NYSE:JNJ): A Smart Dividend Pick for 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231221052100"", ""headline"": ""Got $1,000? 5 of the Safest Stocks to Buy for 2024"", ""summary"": ""Regardless of what's thrown Wall Street's way in the new year, these tried-and-true companies can deliver for their shareholders.""}, {""date"": ""20231221070700"", ""headline"": ""J&J bets bigger on\u00a0MeiraGTx\u2019s eye gene therapy"", ""summary"": ""Ahead of a Phase 3 readout that could come next year, the pharma is paying $130 million in upfront and near-term cash for rights to the retinitis pigmentosa treatment that it didn\u2019t already own.""}, {""date"": ""20231221090222"", ""headline"": ""7 Stocks That Might Win on Election Year Uncertainty"", ""summary"": ""Soon, it will be that favorite time of the quadrennial cycle where American citizens will decide the future of this great nation, subsequently necessitating a discussion about election year stocks. On surface level, you might think that such periods would be rather disastrous for equities, especially with the vituperative environment. However, the hard numbers suggest otherwise. According to Morningstar, \u201chistorical data suggests that elections are not synonymous with market selloffs. A deeper l""}, {""date"": ""20231221113200"", ""headline"": ""Johnson & Johnson stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson rose 1.02% to $154.84 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""20231221123710"", ""headline"": ""35 Best Countries For Raising Kids"", ""summary"": ""In this article, we are going to discuss the 35 Best Countries For Raising Kids. You can skip our detailed analysis based on Reddit threads and go directly to 10 Best Countries For Raising Kids. When choosing the best place to raise kids, there are many factors to consider, such as the cost of living, education [\u2026]""}, {""date"": ""20231221162724"", ""headline"": ""15 Stocks That Will Make You Rich in 5 Years According to ChatGPT"", ""summary"": ""In this article, we will take a detailed look at the 15 Stocks That Will Make You Rich in 5 Years According to ChatGPT. For a quick overview of such stocks, read our article 5 Stocks That Will Make You Rich in 5 Years According to ChatGPT. All anyone in the Wall Street could talk about [\u2026]""}, {""date"": ""20231221164514"", ""headline"": ""Build Your Future Portfolio: 3 Generous Dividend Stocks"", ""summary"": ""You heard it here: 2024 could be an excellent year for stocks. The economy is improving, and specifically the third-quarter results were better than expected. This means we could see a significant upside in stocks in the coming months. However, if you are looking to make a steady income in 2024, it is advisable to invest in dividend stocks. Look for stocks that show capital appreciation and continue to generate steady income for you in the coming years. You\u2019ll need to identify companies that hav""}, {""date"": ""20231221201300"", ""headline"": ""Legend Biotech, J&J's Carvykti drug gets label update to include warning on blood cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231222030201"", ""headline"": ""Janssen Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval of Lazertinib, in combination with RYBREVANT, for the First-Line Treatment of Patients with EGFR-Mutated Non-Small Cell Lung Cancer"", ""summary"": ""BELGIUM - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of a marketing authorisation application to the European Medicines Agency seeking approval of...""}, {""date"": ""20231222030203"", ""headline"": ""Johnson & Johnson Submits Supplemental Biologics License Application and New Drug Application to U.S. FDA Seeking Approval of RYBREVANT Plus Lazertinib for the Treatment of Patients with EGFR-Mutated Non-Small Cell Lung Cancer"", ""summary"": ""New Jersey - Johnson & Johnson announced today the submission of a supplemental Biologics License Application to the U.S. Food and Drug Administration together with a New Drug Application seeking...""}, {""date"": ""20231222032806"", ""headline"": ""J&J : seeks FDA approval for Rybrevant"", ""summary"": ""Johnson & Johnson announced that it has applied to the FDA for approval of Rybrevant in combination with lazertinib as a first-line treatment for adult patients with EGFR-mutated locally advanced or...""}, {""date"": ""20231222040019"", ""headline"": ""29 Undervalued Dividend Aristocrats: December 2023"", ""summary"": ""The S&P 500 Dividend Aristocrats Index contains 67 dividend growth stocks called the Dividend Aristocrats. Click here to read more.""}, {""date"": ""20231222040106"", ""headline"": ""J&J : EU marketing authorization application for Rybrevant"", ""summary"": ""Johnson & Johnson announces that it has submitted a marketing authorization application to the European Medicines Agency seeking approval of lazertinib + Rybrevant for the first-line treatment of...""}, {""date"": ""20231222040500"", ""headline"": ""Check Out What Whales Are Doing With JNJ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231222085137"", ""headline"": ""14 Cheap DRIP Stocks To Buy Now"", ""summary"": ""In this article, we discuss 14 cheap DRIP stocks to buy now. You can skip our detailed analysis of dividend reinvestment plans and performance of dividend stocks in the past, and go directly to read 5 Cheap DRIP Stocks To Buy Now. Investing in dividend stocks is often seen as a game for patient investors [\u2026]""}, {""date"": ""20231222113100"", ""headline"": ""Johnson & Johnson stock outperforms market on strong trading day"", ""summary"": ""Shares of Johnson & Johnson inched 0.40% higher to $155.46 Friday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""20231222183519"", ""headline"": ""Johnson & Johnson: Ottava Surgical Robot Is A Growth Tailwind"", ""summary"": ""Johnson & Johnson enters surgical robotics market with Ottava system, offering competitive advantages over da Vinci. Read about the buy thesis for JNJ stock.""}, {""date"": ""20231223012100"", ""headline"": ""What To Do With High-Flying Tech At The Start Of 2024?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231223050000"", ""headline"": ""5 Top Stocks to Buy With Your End-of-the-Year Bonus"", ""summary"": ""Your bonus could become the gift that keeps on giving.""}, {""date"": ""20231223110000"", ""headline"": ""Strategically Building A $50,000 Dividend Portfolio With Only 3 ETFs And 3 Stocks"", ""summary"": ""This dividend portfolio serves as a buy-and-hold portfolio. It provides investors with an extensive diversification across companies. Read more here.""}, {""date"": ""20231223194054"", ""headline"": ""Dividend Contenders List Ranked By Yield: Top 25"", ""summary"": ""In this article, we discuss top 25 dividend contenders according to yields. You can skip our detailed analysis of dividend stocks and their previous performance, and go directly to read Dividend Contenders List Ranked By Yield: Top 10. Dividend contenders typically refer to companies that have consistently increased their dividends for at least 10 consecutive [\u2026]""}, {""date"": ""20231223230200"", ""headline"": ""3 Worst Performing Dow Jones Stocks In 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231224042800"", ""headline"": ""6 Reasons to Avoid Johnson & Johnson (JNJ) At All Costs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231224051200"", ""headline"": ""2 Top Dividend Stocks You Can Buy and Hold Forever"", ""summary"": ""These companies pay very durable dividends.""}, {""date"": ""20231224180025"", ""headline"": ""25 Happiest States In The US"", ""summary"": ""In this article, we will take a look at the 25 happiest states in the US in 2023. If you want to skip our discussion on the happiness measurement metrics, you can go directly to the 5 Happiest States In The US. For the longest time, people have believed that happiness is not quantifiable; it [\u2026]""}]",{}
50,2023-12-24,151.8984375,2023-12-31,153.14910888671875,0.008233602710487009,U1,"[{""date"": ""20231223194054"", ""headline"": ""Dividend Contenders List Ranked By Yield: Top 25"", ""summary"": ""In this article, we discuss top 25 dividend contenders according to yields. You can skip our detailed analysis of dividend stocks and their previous performance, and go directly to read Dividend Contenders List Ranked By Yield: Top 10. Dividend contenders typically refer to companies that have consistently increased their dividends for at least 10 consecutive [\u2026]""}, {""date"": ""20231223230200"", ""headline"": ""3 Worst Performing Dow Jones Stocks In 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231224042800"", ""headline"": ""6 Reasons to Avoid Johnson & Johnson (JNJ) At All Costs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231224051200"", ""headline"": ""2 Top Dividend Stocks You Can Buy and Hold Forever"", ""summary"": ""These companies pay very durable dividends.""}, {""date"": ""20231224180025"", ""headline"": ""25 Happiest States In The US"", ""summary"": ""In this article, we will take a look at the 25 happiest states in the US in 2023. If you want to skip our discussion on the happiness measurement metrics, you can go directly to the 5 Happiest States In The US. For the longest time, people have believed that happiness is not quantifiable; it [\u2026]""}, {""date"": ""20231225000100"", ""headline"": ""The Art of Valuation: Discovering Johnson & Johnson's Intrinsic Value"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231225050302"", ""headline"": ""Capital Gain/Loss On Holdings And Trading Gain/Loss With Cash Cows"", ""summary"": ""I highlight the importance of trade income, capital gains, dividend collection, and tax harvesting in my investment approach. Read more here.""}, {""date"": ""20231225063600"", ""headline"": ""How Is The Market Feeling About Johnson & Johnson?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231225213748"", ""headline"": ""7 Rock-Solid Dividend Stocks to Trust in Difficult Times"", ""summary"": ""While the upcoming new year generally brings optimistic sentiment to the market, investors should be prepared for anything, which is why solid dividend stocks represent an incredibly relevant topic. Much like playing the hot corner, you\u2019ve got to be ready for anything. In baseball, hard-hit balls can end up anywhere on the field. However, they generally tend to scream toward third base. That\u2019s why you\u2019ve got to have some quick hands to play this position. As well, you\u2019ve got to be smart because""}, {""date"": ""20231225232400"", ""headline"": ""Nanobiotix says LianBio enters NBTXR3 development pact with Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231226033555"", ""headline"": ""Integra LifeSciences: M&A Masks Operational Struggles"", ""summary"": ""Integra LifeSciences is a leader in neurosurgical solutions, regenerative technologies, and surgical instrumentation. Find out my analysis of IART stock.""}, {""date"": ""20231226043205"", ""headline"": ""Thinking about trading options or stock in NVIDIA, Marvell Technology, Johnson & Johnson, Stratasys, or Digital World Acquisition Corp?"", ""summary"": ""NEW YORK, Dec. 26, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NVDA, MRVL, JNJ, SSYS, and DWAC. ...""}, {""date"": ""20231226054300"", ""headline"": ""Johnson & Johnson inks licensing deal with LianBio (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231226075800"", ""headline"": ""Nasdaq Leads Over NYSE in IPO Listings, Drawing Major Tech and Global Firms in 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231226080009"", ""headline"": ""Johnson & Johnson's (NYSE:JNJ) Intrinsic Value Is Potentially 57% Above Its Share Price"", ""summary"": ""Key Insights Johnson & Johnson's estimated fair value is US$245 based on 2 Stage Free Cash Flow to Equity Current share...""}, {""date"": ""20231226103938"", ""headline"": ""Best Stocks To Buy In 2024? 2 Blue Chip Stocks In Focus"", ""summary"": ""2 blue chip stocks for your 2024 watchlist.""}, {""date"": ""20231226113200"", ""headline"": ""Johnson & Johnson stock rises Tuesday, outperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.44% higher to $156.14 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""20231227040200"", ""headline"": ""J&J's Janssen signs licensing deal worth up to $1.7B with LegoChem"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231227052100"", ""headline"": ""3 No-Brainer Stocks to Buy With $200 Right Now"", ""summary"": ""A reasonably modest amount of money can go a long way when it's invested in innovation-driven businesses.""}, {""date"": ""20231227054407"", ""headline"": ""J&J : licensing agreement with Korea's LegoChem in ADCs"", ""summary"": ""LegoChem Biosciences announced yesterday the conclusion of an exclusive licensing agreement with Janssen Biotech, under which the South Korean laboratory will grant the J&J subsidiary the rights to...""}, {""date"": ""20231227061200"", ""headline"": ""Is It Time to Buy the Dow Jones' 3 Worst Performing Stocks This Year?"", ""summary"": ""These stocks have significantly underperformed the market. But are they really \""cheap\""?""}, {""date"": ""20231227063400"", ""headline"": ""FDA\u2019s new drug approvals for 2023 rise 51% from last year"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231227073900"", ""headline"": ""Can JNJ reverse loss in 2024 on EPS growth, eyes on talc litigation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231227093900"", ""headline"": ""A Tale of Two Pharmas: Can Obesity Firms Continue Their Outperformance in 2024?"", ""summary"": ""In pharma, a company can take a larger slice of the healthcare pie than peers, but it is still constrained by the size of the pie.""}, {""date"": ""20231227113200"", ""headline"": ""Johnson & Johnson stock rises Wednesday, still underperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.13% higher to $156.35 Wednesday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""20231227173153"", ""headline"": ""Healthcare Heroes: 3 Stocks Innovating in Medicine and Wellness"", ""summary"": ""The United States leads globally in the healthcare sector, with its innovative healthcare stocks drawing attention from an impressive $4.3 trillion in spending. As the American Medical Association highlights, this expenditure equals nearly $13,000 per person, contributing 18.3% to the nation\u2019s GDP. This level of investment showcases its commitment to health and underscores its role as a frontrunner in medical advancements and innovations. Amidst this landscape, the U.S. emerges as a powerhouse i""}, {""date"": ""20231227185924"", ""headline"": ""20 Most Expensive Drugs in the World"", ""summary"": ""In this article, we will take a look at the 20 most expensive drugs in the world. If you want to skip our discussion on the pharmaceutical industry, you can go directly to the 5 Most Expensive Drugs in the World. The health of the global population is being adversely affected due to numerous factors, [\u2026]""}, {""date"": ""20231227193552"", ""headline"": ""11 Hot Healthcare Stocks To Buy Now"", ""summary"": ""In this article, we will be taking a look at 11 hot healthcare stocks to buy now. To skip our detailed analysis of the healthcare sector, you can go directly to see the 5 Hot Healthcare Stocks To Buy Now. Healthcare is a vital part of daily living for everyone, whether it be to cure [\u2026]""}, {""date"": ""20231227204400"", ""headline"": ""Contagious Opportunities: Norovirus Cases Are On The Rise, These Are The Stocks That May Be Impacted"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231228032600"", ""headline"": ""Pharmaceutical Giants Brace for Showdown as Medicare Drug Price Negotiations Are Poised For 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231228053900"", ""headline"": ""February 2024 Options Now Available For Johnson & Johnson (JNJ)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231228053900"", ""headline"": ""Warren Buffett Dumped These 2 Top Dividend Stocks. Should You Follow His Lead?"", ""summary"": ""Buffett didn't say why he closed positions in two stocks with underlying businesses that are doing well at the moment.""}, {""date"": ""20231228055937"", ""headline"": ""Top 15 Value Stocks to Buy for 2024"", ""summary"": ""In this article, we discuss top 15 value stocks to buy for 2024 picked by Joel Greenblatt. To skip the details about Mr. Greenblatt\u2019s life, portfolio performance, and investment strategy, go directly to Top 5 Value Stocks to Buy for 2024. Investing offers an exciting and effective way of growing wealth over time. Value investing is [\u2026]""}, {""date"": ""20231228061247"", ""headline"": ""11 Set-It-and-Forget-It Stocks to Buy According to Financial Media"", ""summary"": ""In this article, we discuss the 11 set-it-and-forget-it stocks to buy according to financial media. To skip the overview of set-it-and-forget-it stocks and portfolios, go directly to the 5 Set-It-and-Forget-It Stocks to Buy According to Financial Media. Some stocks are meant to be kept forever according to financial media and investors. The set-it-and-forget-it stock portfolio [\u2026]""}, {""date"": ""20231228113200"", ""headline"": ""Johnson & Johnson stock rises Thursday, outperforms market"", ""summary"": ""Shares of Johnson & Johnson inched 0.15% higher to $156.58 Thursday, on what proved to be an all-around favorable trading session for the stock market, with...""}, {""date"": ""20231228131637"", ""headline"": ""Safe Havens: 3 Fixed-Income Securities for a Balanced Portfolio in 2024"", ""summary"": ""Although next year looks to be a good time to invest in risk assets like Bitcoin (BTC-USD), investors with a lower risk tolerance look toward safe havens to grow their income. Some of these haven assets provide diversification benefits for investors who engage in risky positions elsewhere. Bonds and other instruments are inversely correlated to broader indices like the S&P 500. This article will explore three types of safe-haven assets that investors can tap into for reliable income. I\u2019ve select""}, {""date"": ""20231228174517"", ""headline"": ""Johnson & Johnson (JNJ) Laps the Stock Market: Here's Why"", ""summary"": ""In the most recent trading session, Johnson & Johnson (JNJ) closed at $156.58, indicating a +0.15% shift from the previous trading day.""}, {""date"": ""20231228205300"", ""headline"": ""Johnson & Johnson holders allowed to sue as a class over talc disclosures, judge rules"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231229025900"", ""headline"": ""From \u2018Putin\u2019s chef\u2019 to Henry Kissinger, Jim Brown to Bobby Knight, and Harry Belafonte to Tina Turner \u2014 plus Charlie Munger \u2014 these were the notable deaths of 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231229050150"", ""headline"": ""Disaster-Proof Dividends: 3 Stocks with Resilient Payouts in Tough Times"", ""summary"": ""Whether you are a beginner or a professional investor, a small amount can go a long way. Investing in dividend stocks can not only help build a strong portfolio, but also generate steady passive income for you. Several companies have raised their payouts in the third quarter, and as the economy improves, we could see better numbers in the coming years. This is great for investors, but the trick is to look for companies that steadily pay dividends and are generous with their payout. Reinvestment""}, {""date"": ""20231229064700"", ""headline"": ""Unpacking the Latest Options Trading Trends in Johnson & Johnson"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231229083628"", ""headline"": ""15 Best Dow Stocks To Buy Now"", ""summary"": ""In this article, we discuss the 15 best Dow stocks to buy now. If you want to skip our detailed analysis of these stocks, go directly to 5 Best Dow Stocks To Buy Now. The Dow Jones Industrial Average, also known as Dow Jones or Dow, is one of the oldest and most followed equity [\u2026]""}, {""date"": ""20231229084746"", ""headline"": ""11 Best Psychedelic Stocks to Buy in 2024"", ""summary"": ""In this article, we discuss 11 of the best psychedelic stocks to buy in 2024. If you want to see more stocks in this selection, check out 5 Best Psychedelic Stocks to Buy. Unlike substances like marijuana or cocaine, psychedelics are potent and serve as a form of gateway to an \u2018alternate reality\u2019 for those [\u2026]""}, {""date"": ""20231229095446"", ""headline"": ""Your New Year's Resolution For 2024: Invest $10,000 In These 5 Stocks"", ""summary"": ""Discover five world-class companies that offer strong dividend growth potential in this article on long-term investing strategies. Click here to read more.""}, {""date"": ""20231229100000"", ""headline"": ""There Are Only 5 Dow Stocks I Wouldn't Buy in 2024"", ""summary"": ""There's a lot to like about Apple, Microsoft, and most of the Dow Jones Industrial Average components in 2024.""}, {""date"": ""20231229113200"", ""headline"": ""Johnson & Johnson stock underperforms Friday when compared to competitors despite daily gains"", ""summary"": ""Shares of Johnson & Johnson inched 0.10% higher to $156.74 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P...""}, {""date"": ""20231229133037"", ""headline"": ""REFILE-Judge certifies Johnson & Johnson shareholder class action over talc disclosures"", ""summary"": ""A federal judge said Johnson & Johnson shareholders may pursue as a class action their lawsuit accusing the company of fraudulently concealing how its talc products were contaminated by cancer-causing asbestos.  U.S. District Judge Zahid Quraishi in Trenton, New Jersey, on Friday allowed shareholders from Feb. 22, 2013 to Dec. 13, 2018 to pursue their securities fraud claims as a group.  He rejected J&J's argument that any class period be at least a year shorter because some events that allegedly caused its stock price to fall contained no \""new\"" information.""}, {""date"": ""20231229133416"", ""headline"": ""Judge certifies Johnson & Johnson shareholder class action over talc disclosures"", ""summary"": ""A federal judge said Johnson & Johnson shareholders may pursue as a class action their lawsuit accusing the company of fraudulently concealing how its talc products were contaminated by cancer-causing asbestos.  U.S. District Judge Zahid Quraishi in Trenton, New Jersey, on Friday allowed shareholders from Feb. 22, 2013 to Dec. 13, 2018 to pursue their securities fraud claims as a group.  He rejected J&J's argument that any class period be at least a year shorter because some events that allegedly caused its stock price to fall contained no \""new\"" information.""}, {""date"": ""20231229163547"", ""headline"": ""UPDATE 1-Judge certifies Johnson & Johnson shareholder class action over talc disclosures"", ""summary"": ""A federal judge said Johnson & Johnson shareholders may pursue as a class action their lawsuit accusing the company of fraudulently concealing how its talc products were contaminated by cancer-causing asbestos.  U.S. District Judge Zahid Quraishi in Trenton, New Jersey, on Friday allowed shareholders from Feb. 22, 2013, to Dec. 13, 2018, to pursue their securities fraud claims as a group.  He rejected J&J's argument that any class period be at least a year shorter because some events that allegedly caused its stock price to fall contained no \""new\"" information.""}, {""date"": ""20231229224800"", ""headline"": ""Dow Dogs Gain Some Respect In Q4 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231230032000"", ""headline"": ""Dividend Stock Watch List: January 2024 Edition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231230081500"", ""headline"": ""2 Best Warren Buffett Stocks to Buy for the Long Haul"", ""summary"": ""These companies need no introduction.""}, {""date"": ""20231230092741"", ""headline"": ""These are the largest publicly-traded companies in each US state"", ""summary"": ""Yahoo Finance compiled a list of the biggest publicly traded companies in each state and Washington, D.C. based on market cap.""}, {""date"": ""20231230214947"", ""headline"": ""Bristol-Myers Squibb's Winning Formula: Dividends, M&A, And Innovation"", ""summary"": ""Bristol-Myers Squibb is a well-known blue-chip stock with a dividend yield exceeding 4.6%. Read why I'm rating BMY stock a Buy at this point.""}, {""date"": ""20231231000000"", ""headline"": ""Legacy Investments: 7 Stocks to Make Your Grandkids Millionaires"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231231061419"", ""headline"": ""January's 54 Dividend Kings: Buy 8, Watch 5"", ""summary"": ""Discover the top Dividend Kings for January, including Altria Group, with high yields and potential for net-gains according to brokers.""}, {""date"": ""20231231074400"", ""headline"": ""3 Beaten-Down Dow Jones Stocks That Dividend Investors Should Scoop Up in 2024"", ""summary"": ""These \""Dogs of the Dow\"" offer attractive dividend yields and upside potential.""}]",{}
